Last chance! Join us tomorrow, Nov 17 at 1pm ET for a panel turning key Annual Meeting discussions on early-phase oncology drug development into accessible insights for patients. Register today: friendsofcancerresearch.org/event/advocates-webinar-annua…. #patientadvocacy
Friends of Cancer Research
Friends of Cancer Research is a non-profit cancer research think tank and advocacy organization based in Washington, D.C. More on Wikipedia
-
Friends of Cancer Research
@CancerResrch
-
Friends of Cancer Research
@CancerResrch
Hillary Andrews joined the IPZO facto podcast to discuss how Friends of Cancer Research works with the FDA, industry and academia to keep oncology science in step with patient needs, exploring TMB harmonization, ctDNA validation, and AI imaging. Watch: www.youtube.com/watch?v=mFK5rZOldcU.
-
Friends of Cancer Research
@CancerResrch
Thanks to everyone who joined our 19th Annual Meeting. Leaders across oncology explored how risk-based nonclinical strategies, first-in-human study expectations, and model-informed drug development and AI for dose selection can support efficient, patient-centered development.
-
Friends of Cancer Research reposted
U.S. FDA
@FDA
Today, Acting FDA Commissioner Kyle Diamantas spoke with @CancerResrch about FDA's role in the future of oncology research & development. We're committed to advancing safe, effective & innovative cancer treatments for patients.
Start watching at 9 min ⬇️
www.youtube.com/live/BtfhFNTaXes?t=540 -
Friends of Cancer Research
@CancerResrch
Thank you to everyone who joined us for our 19th Annual Meeting, and to our speakers and panelists for the thoughtful conversations.
Watch the meeting on YouTube: www.youtube.com/watch?v=BtfhFNTaXes
Read the session white papers: friendsofcancerresearch.org/event/friends-of-cancer-resea…
#friendsam26 -
Friends of Cancer Research
@CancerResrch
At our lunch fireside chat, Angelo de Claro, Director of FDA’s Oncology Center of Excellence, joined Jeff Allen to discuss OCE’s recent progress, building on its original vision, and how Operation Trailblazer is working to modernize clinical trials. #friendsam26
-
Friends of Cancer Research
@CancerResrch
“A patient’s yes is real and it deserves respect, but it is also shaped by fear and running out of options. That means the oncology team has a responsibility to ensure the consent is truly informed.” - Arnoldo Rodriguez, Friends of Cancer Research Advisory Advocate #friendsam26
-
Friends of Cancer Research
@CancerResrch
"The challenge is bringing that flexibility into everyday practice. What residual risk is okay for that patient population? How can this be streamlined with global regulators so sponsors don’t run a study for each country?” – Amy Pointon, @AstraZeneca
#friendsam26 -
Friends of Cancer Research
@CancerResrch
"The streamlined approach is unrelated to the number of studies or the amount of data generated. It needs to define the safety questions that must be addressed before embarking on a clinical trial." - Carole Harbison, @TakedaPharma #friendsam26
-
Friends of Cancer Research
@CancerResrch
Our 19th Annual Meeting is live! Today’s sessions explore risk-based nonclinical strategies, fit-for-purpose first-in-human studies, and model-informed dose optimization. Watch on our YouTube channel: www.youtube.com/watch?v=BtfhFNTaXes
#friendsam26 -
Friends of Cancer Research
@CancerResrch
Patient advocates! Join us November 17 for a webinar unpacking key discussions from our Annual Meeting on early-phase #cancer drug development and what they mean for patients. Submit your questions for the live Q&A! #patientadvocacy
Register: friendsofcancerresearch.org/event/advocates-webinar-annua…. -
Friends of Cancer Research
@CancerResrch
More than a decade after its creation, the BQP remains unpredictable and underused. With only 12 of the 107 projects reaching full qualification, Congress has the opportunity to help modernize the BQP. Explore our solutions and what it means for patients: friendsofcancerresearch.org/bqp/.
-
Friends of Cancer Research
@CancerResrch
Our Annual Meeting white papers take an in-depth look at each session: nonclinical strategies, first-in-human studies, and MIDD and AI for dosing in early-phase oncology development. Read the white papers and register for the meeting on 11/10. friendsofcancerresearch.org/event/friends-of-cancer-resea… #friendsam26
-
Friends of Cancer Research
@CancerResrch
To close out our Annual Meeting, @RepMGriffith and @RepAuchincloss senior congressional staff will discuss a bipartisan legislative proposal addressing challenges and support a federal approach to improve U.S. clinical trials. Register today: friendsofcancerresearch.org/event/friends-of-cancer-resea….
-
Friends of Cancer Research
@CancerResrch
Read the @GoHealio article featuring our landscape assessment of 150+ studies finding that #ctdna reductions are associated with improved OS across solid cancer types, despite differences in assays, time points, and definitions of molecular response: www.healio.com/news/hematology-oncology/20261013/remarkab….
-
Friends of Cancer Research
@CancerResrch
During the Lunch Fireside at our Annual Meeting, @FDA Oncology Center of Excellence Director Angelo de Claro will join President and CEO Jeff Allen for a conversation on priorities shaping oncology innovation and regulatory policy. Register today: friendsofcancerresearch.org/event/friends-of-cancer-resea….
-
Friends of Cancer Research
@CancerResrch
Acting @FDA Commissioner Kyle Diamantas and @NCIDirector Anthony Letai will join an opening keynote fireside chat at our Annual Meeting on Nov 10, 2026. Discussions will focus on innovation, U.S. competitiveness, and FDA modernization. Register today: friendsofcancerresearch.org/event/friends-of-cancer-resea….
-
Friends of Cancer Research
@CancerResrch
For 30 years, Friends of Cancer Research has had a partner and champion in Janet Woodcock—former Acting FDA Commissioner, now a member of our Board. Her perspective from both sides of drug development has helped shape our mission.
#friends30
www.youtube.com/watch?v=jvzVNlmHz1w -
Friends of Cancer Research
@CancerResrch
Panelists announced! Join us for our 19th Annual Meeting on November 10. Experts will explore risk-based nonclinical strategies, first-in-human study expectations, and AI-enabled oncology dosing. Register in-person or virtually: friendsofcancerresearch.org/event/friends-of-cancer-resea…. #friendsam2026
-
Friends of Cancer Research
@CancerResrch
On Friday, October 23, Jeff Allen will join the "PDUFA VIII Demystified" session at @IAmBiotech's Patient Advocacy Changemakers Event to discuss why PDUFA reauthorization matters to patient advocates and how they can help shape the process. #biopace26 #patientadvocacy
-
Friends of Cancer Research
@CancerResrch
Since Ellen Sigal and Marlene Malek founded Friends of Cancer Research, our mission has stayed the same: making sure every scientific breakthrough reaches the patients who need it. Thank you to our partners, collaborators, and supporters. #friends30
-
Friends of Cancer Research
@CancerResrch
On October 19, Bernat Navarro will present at @DrugInfoAssn's 2026 Real-World Evidence Conference, sharing lessons from our ECA Pilot on applying a common analytical framework across external data sources and informing future regulatory use. #rwe
-
Friends of Cancer Research
@CancerResrch
Our collaborative work has helped drive everything from breakthrough therapy designation to advances in ctDNA, making clinical development faster and more efficient for patients. Thank you to partners like @susanmgalbraith and @AstraZenecaUS for 30 years of progress.
#friends30This media couldn't be displayed. See it on the original post. -
Friends of Cancer Research
@CancerResrch
Regulatory uncertainty, a stage-based structure, extended timelines, and limited incentives have constrained biomarker qualification through the FDA's BQP. Our white paper outlines how the BQP can be modernized to better support drug development: friendsofcancerresearch.org/wp-content/uploads/Modernizin….
-
Friends of Cancer Research
@CancerResrch
Join us on November 10 for our 2026 Annual Meeting! Sessions will explore modernizing nonclinical strategies, first-in-human trial expectations, and model-informed approaches to oncology dosing.
Register to attend in person or virtually: friendsofcancerresearch.org/event/friends-of-cancer-resea….
#friendsam26 -
Friends of Cancer Research
@CancerResrch
For 30 years, Friends of Cancer Research has brought together experts across fields to advance cancer research and care.
Dr. Crystal Mackall, @StanfordMed professor, highlights our unique role connecting leaders to generate evidence and advance solutions for patients.
#friends30This media couldn't be displayed. See it on the original post. -
Friends of Cancer Research
@CancerResrch
Jeff Allen will join the Alliance for a Stronger FDA 2026 Summit on Sep 30, speaking on the "FDA Priorities for 2027" panel, and #gcris on Oct 6, where he'll moderate two sessions on cancer research and regulatory pathways. We look forward to connecting with colleagues. #avbcc
-
Friends of Cancer Research
@CancerResrch
An FDA panel voted in favor of a multi-cancer screening test's safety, effectiveness, and benefit-risk profile but urged use as an adjunct to guideline-recommended screening, with post-market data to build confidence. Read our Stakeholder Connect: friendsofcancerresearch.org/blog/stakeholder-connect-insi….
-
Friends of Cancer Research
@CancerResrch
How can RPT dosage optimization support effective treatment while maintaining patient safety? RPT development should generate sufficient evidence to support dosage selection while minimizing unnecessary burden on patients. Watch the full webinar: www.youtube.com/watch?v=eMUnVSgoltY.
-
Friends of Cancer Research
@CancerResrch
We thank the @FDA for the opportunity to comment on their draft guidance on demonstrating substantial evidence of effectiveness. We offer three considerations for the guidance's application in oncology development. Read our full comments: friendsofcancerresearch.org/wp-content/uploads/Demonstrat….
-
Friends of Cancer Research
@CancerResrch
Mark Stewart will join a panel at the @DrugInfoAssn Oligonucleotide-Based Therapeutics Conference on Sept 24, exploring recent FDA CMC programs and strategies for applying them to oligonucleotide therapeutics. Register today: www.diaglobal.org/en/conference-listing/meetings/2026/09/….
-
Friends of Cancer Research
@CancerResrch
Mark Stewart will join the "Future Vision for Patient-Centered Drug Development" panel at ACRO 2026 Global Clinical Trials Regulatory Summit on Sept 23, highlighting our work modernizing clinical trial eligibility criteria. Learn about this work: friendsofcancerresearch.org/clinical-trial-eligibility-cr….
-
Friends of Cancer Research
@CancerResrch
Our Q3 Advocacy Newsletter is out! Catch up on our RPT dosing webinar, an advocate’s perspective on AI in oncology from Donna Short, and what will be explored at our Annual Meeting. Read the latest issue: friendsofcancerresearch.org/blog/quarterly-advocacy-newsl….
#patientadvocacy -
Friends of Cancer Research
@CancerResrch
For Board Member Margaret Anderson, our mission is personal. After losing her father to leukemia, she now supports her husband through lung cancer, seeing firsthand how science advances can change lives.
As we celebrate #friends30, we thank Margaret for sharing her story.This media couldn't be displayed. See it on the original post. -
Friends of Cancer Research
@CancerResrch
The PDUFA Agreement Letter for reauthorization funds key processes but does not enhance the BQP. Jeff Allen spoke at today's @FDA public meeting; we hope PDUFA VIII addresses this so the BQP can function as intended. Learn more about strengthening the BQP: friendsofcancerresearch.org/wp-content/uploads/Modernizin…
-
Friends of Cancer Research
@CancerResrch
In June 2026, HHS launched Operation TrialBlazer, under which FDA will lead efforts to speed up early- and late-stage clinical trials. While this offers sponsors new flexibilities, the challenge will be applying it in practice. Learn more: friendsofcancerresearch.org/blog/stakeholder-connect-from…. #healthpolicy
-
Friends of Cancer Research
@CancerResrch
Starting now! Eileen Sneeden kicks off our “Optimizing Dosing for Radiopharmaceutical Therapies” webinar, highlighting the unique characteristics of RPTs, and the opportunities and challenges they present for drug development. Watch now or on-demand later. www.youtube.com/watch?v=eMUnVSgoltY
-
Friends of Cancer Research
@CancerResrch
Hillary Andrews will be a panelist at the ASA RISW 2026 on 9/18, presenting the ai.RECIST and Digital PATH Projects, which explore how AI-enabled tools can support imaging assessments in oncology clinical trials. Learn more about these projects: friendsofcancerresearch.org/projects/.
-
Friends of Cancer Research
@CancerResrch
Last chance to register for our "Optimizing Dosing for Radiopharmaceutical Therapies" webinar on September 15 at 1PM. Panelists will examine strategies for dose escalation and dosimetry-informed development to support regulatory decision-making: friendsofcancerresearch.org/event/optimizing-dosing-for-r…. #oncology
-
Friends of Cancer Research
@CancerResrch
Join us for our Annual Meeting on 11/10. This year’s meeting will focus on early-phase clinical trial development, exploring risk-based and modern quantitative approaches that support efficient drug development while prioritizing patient safety: friendsofcancerresearch.org/event/friends-of-cancer-resea….
-
Friends of Cancer Research
@CancerResrch
A @Bloomberg article featured a recent @CancerResrch manuscript: China approved more novel oncology drugs than the FDA between 2020 and 2025, though the US still leads in first-in-class approvals, with FDA reviews completed faster overall. Read more: www.bloomberg.com/news/articles/2026-07-20/cancer-drug-ap…
-
Friends of Cancer Research
@CancerResrch
Sponsors in rare disease drug development often have one shot. At our April 7 meeting on external control arms, panelists made the case: infeasibility cannot end the conversation, it has to be a design challenge. FDA's Amy Comstock Rick explains: www.youtube.com/live/fh7y3J2xyYY?cbrd=1&ucbcb=1.
-
Friends of Cancer Research
@CancerResrch
For 30 years, Friends of Cancer Research has brought diverse voices together to advance cancer care and put patients at the center. As @sudipsparikh, CEO of @aaas, reflects, regulatory policy can have a profound impact on patients. #friends30
www.youtube.com/watch?v=KWf4YEZYJH0 -
Friends of Cancer Research reposted
The ASCO Post
@ASCOPost
2️⃣ new analyses add to evidence supporting on-treatment ctDNA reductions as a potential early endpoint in #cancerresearch.
➡️ Further research and greater standardization are still needed
▪️@HillStirSci & Elena Levi-D’Ancona, PhD of @CancerResrch
🔗 ascopost.com/news/september-2026/two-studies-build-eviden… -
Friends of Cancer Research
@CancerResrch
Jeff Allen, President & CEO, is keynoting the 2026 Technology Showcase, hosted by @theNCI and the Frederick National Laboratory for Cancer Research on Sept. 9. He will address innovation, challenges, and the power of collaboration in oncology.
Register: frederick.cancer.gov/events/2026-technology-showcase -
Friends of Cancer Research
@CancerResrch
RPTs are an expanding area of oncology drug development, and optimizing dosing remains a key challenge. Our new white paper proposes a fit-for-purpose approach to dosage optimization, anchored in clinical, dosimetry, and imaging evidence: friendsofcancerresearch.org/wp-content/uploads/Optimizing….
-
Friends of Cancer Research
@CancerResrch
We submitted comments to @FDA's draft guidance on leveraging prior knowledge in cell and gene therapy development. The concepts build on a risk-based framework from our 2023 cell therapy meeting, where panelists described challenges sponsors experience: friendsofcancerresearch.org/wp-content/uploads/Final_Leve….
-
Friends of Cancer Research
@CancerResrch
Mark Stewart will join the Sept. 1 panel "Bringing CAR-T and TCE Care Closer to Home", discussing patient access barriers and opportunities for regulatory flexibility and emerging technologies to safely bring care closer to patients. Register today: zoom.us/webinar/register/WN_zBBTHLn6SbC6ee61emwQOg!
-
Friends of Cancer Research
@CancerResrch
We submitted comments on @FDA's proposed Expedited IND Pilot Program, supporting the effort, with considerations on Qualified Research Institution designations, rolling review logistics, and how pilot success should be measured. friendsofcancerresearch.org/wp-content/uploads/Final_Expe… #healthpolicy
-
Friends of Cancer Research
@CancerResrch
For three decades, we have brought together leaders across fields to advance science-based solutions that improve cancer care. Explore reflections from those who have helped shape our journey and learn about our 30th Anniversary celebration: friendsofcancerresearch.org/30th/.
#friends30 -
Friends of Cancer Research
@CancerResrch
Early reductions in #ctdna levels predict improved survival for patients with advanced cancer across cancer type, treatment, and molecular response definitions. Read our new landscape assessment synthesizing findings from 162 studies in @JCOOA_ASCO: ascopubs.org/doi/10.1200/OA-26-00005.
-
Friends of Cancer Research
@CancerResrch
Join us on 9/15 for a public webinar examining approaches to optimize dosing strategies for radiopharmaceutical therapies as their use continues to expand across oncology, including examining fit-for-purpose strategies and dosimetry-informed development: friendsofcancerresearch.org/event/optimizing-dosing-for-r….
-
Friends of Cancer Research
@CancerResrch
See our comments to the Senate Finance Committee's RFI, "Commonsense Policy Options to Lower Drug Prices for Patients," outlining that U.S. innovation and biomedical leadership depends on targeted investment and reduced friction across drug development. friendsofcancerresearch.org/wp-content/uploads/20260813_-…
-
Friends of Cancer Research
@CancerResrch
Twitter/X isn't the only way to follow us! Sign up for our emails or connect on LinkedIn for our latest research, register for upcoming meetings, and updates in cancer research and policy.
📩 focr.app.neoncrm.com/forms/subscription-preferences-form
🔗 www.linkedin.com/company/friends-of-cancer-research -
Friends of Cancer Research
@CancerResrch
New analysis: From 2020-2025, China approved more novel oncology drugs overall than the FDA. Yet of 36 first-in-class drugs in the study, the FDA approved 30 first. The U.S. still leads in innovation, but that edge may be narrowing. Read the publication: academic.oup.com/healthaffairsscholar/advance-article/doi….
-
Friends of Cancer Research
@CancerResrch
Friends of Cancer Research works to modernize regulatory frameworks and advance policies for safe, effective therapies, spanning drug development tools, responsible AI use, cell and gene therapies, and inclusive clinical research. Explore our priorities: friendsofcancerresearch.org/policy-portfolio/.
-
Friends of Cancer Research
@CancerResrch
What does it take to move a biomarker from exploratory measure to approval endpoint? At our recent meeting on modernizing oncology endpoints that question was addressed in every session. @realrickpazdur on why the answer depends on the context of use. www.youtube.com/live/3Wy4H4jlNcY?cbrd=1&ucbcb=1
-
Friends of Cancer Research
@CancerResrch
For three decades, we've helped transform bold ideas into policy solutions that accelerate innovation and improve patient outcomes. As we look to the future, that commitment remains as strong as ever. Hear from the leaders who've helped shape our journey: friendsofcancerresearch.org/30th/.
-
Friends of Cancer Research
@CancerResrch
The @FDA's recent CTGTAC meeting considered data supporting a novel intratumoral immunotherapy and raised broader questions for the evaluation of these novel therapies. Read our Stakeholder Connect blog for more: friendsofcancerresearch.org/blog/stakeholder-connect-insi…
-
Friends of Cancer Research
@CancerResrch
Radiopharmaceutical therapies (RPTs) offer significant therapeutic potential but determining appropriate dosing is complex. Join us 9/15 for a webinar to examine approaches to optimizing RPT dosing strategies as their use continues to expand in oncology. friendsofcancerresearch.org/event/optimizing-dosing-for-r…
-
Friends of Cancer Research
@CancerResrch
Fast to open the first clinical trial site. Slow to scale. Prolonged budget talks, redundant IRB reviews, and site resource limits are holding U.S. trials back. Here's what's driving the gap and where things can improve in our recent blog: friendsofcancerresearch.org/blog/data-driven-insights-fas…. #clinicaltrials
-
Friends of Cancer Research
@CancerResrch
Advancing HHS's Operation TrialBlazer, the @US_FDA's Oncology Center of Excellence has issued three final guidances aimed at increasing patient participation in oncology trials, developed through workshops with Friends of Cancer Research and @ASCO: www.fda.gov/about-fda/oncology-center-excellence/oncology….
-
Friends of Cancer Research
@CancerResrch
Patient voices are essential to shaping drug development. progressforpatients.org is a free education course on the FDA's role, clinical trials, drug approval and advocacy, and has been taken by 1,700+ advocates and early-career professional advocates. Take the course today.
-
Friends of Cancer Research
@CancerResrch
From peer-reviewed papers to guidance comments, our publications reflect the work across our research projects and initiatives. Browse the library and learn about the research that has helped shape policy and informed industry standards: friendsofcancerresearch.org/publications/. #cancerresearch
-
Friends of Cancer Research
@CancerResrch
The @US_FDA's Expedited Pathways give special consideration to innovative therapies treating serious diseases or offering significant patient benefits. See how Fast Track, Breakthrough Therapy, RMAT, Priority Review, and Accelerated Approval differ: friendsofcancerresearch.org/glossary-term/expedited-progr….
-
Friends of Cancer Research
@CancerResrch
There is no one-size-fits-all approach to interim OS data. At our recent webinar, experts discussed how timing, harm definitions, and cross-disciplinary alignment all shape how these results should be interpreted. Watch the full webinar: www.youtube.com/watch?v=sYK2fYm4ipc.
-
Friends of Cancer Research
@CancerResrch
A @Bloomberg article featured our analysis: from 2020-2025, China approved 94 novel oncology drugs vs. the FDA's 87, overtaking the US in 2023. The US still leads in innovation, with 30 of 36 first-in-class therapies approved here first. www.bloomberg.com/news/articles/2026-07-20/cancer-drug-ap…
-
Friends of Cancer Research
@CancerResrch
A new manuscript from the @CancerResrch ctMoniTR Project, published in @jlb_islb, showed early #ctdna decreases were significantly associated with improved OS and PFS. Methodological work is still needed to advance it toward regulatory qualification. www.journalofliquidbiopsy.com/article/S2950-1954(26)00027…
-
Friends of Cancer Research
@CancerResrch
Topics announced! Join us for our 19th Annual Meeting on Nov. 10, 2026, as we bring together leaders from across the field to drive forward unique, evidence-based solutions to current challenges in drug development. Register in-person or virtually: friendsofcancerresearch.org/event/friends-of-cancer-resea….
-
Friends of Cancer Research
@CancerResrch
China has outpaced the U.S. in novel cancer drug approvals since 2023, yet the @US_FDA still reviews drugs a median of 182 days faster and approves 5x as many global first-in-class therapies. Read our new analysis in @Health_Affairs Scholar: academic.oup.com/healthaffairsscholar/advance-article/doi….
-
Friends of Cancer Research
@CancerResrch
Ever missed a Friends of Cancer Research meeting and did not have time to watch the full recording? Our meeting recaps break down the key discussions and link to white papers, slides, and full YouTube recordings — everything you need, on your schedule. friendsofcancerresearch.org/blog-engaging-innovation/?_sf…
-
Friends of Cancer Research
@CancerResrch
Our webinar on interpreting interim overall survival (OS) for decision-making is live! Névine Zariffa opens the webinar by setting the stage for why rigorous interpretation of interim OS data is critical for patients. Watch now or on-demand later: www.youtube.com/watch?v=sYK2fYm4ipc.
-
Friends of Cancer Research
@CancerResrch
Register for our 7/15 webinar on interpreting interim OS for decision-making. Experts will present a simulation-informed framework for improving how interim OS analyses are designed and interpreted, focusing on assessing potential treatment-related harm: friendsofcancerresearch.org/event/interpreting-interim-ov…
-
Friends of Cancer Research
@CancerResrch
For 30 years, Friends of Cancer Research has shown what is possible when patients, scientists, regulators, policymakers, and industry come together around a shared purpose: accelerating progress for people facing cancer. Learn more: friendsofcancerresearch.org/30th/
#friends30 -
Friends of Cancer Research
@CancerResrch
The Biomarker Qualification Program has not consistently delivered on its promise. Friends of Cancer Research outlined three recommendations to modernize the program and improve regulatory clarity. Read the full white paper: friendsofcancerresearch.org/wp-content/uploads/Modernizin….
-
Friends of Cancer Research
@CancerResrch
Early OS data in #oncology trials can be difficult to interpret and misinterpretation can occur without thoughtful planning. Join us July 15th for a simulation-informed framework for designing and interpreting interim OS analyses. Register today: friendsofcancerresearch.org/event/interpreting-interim-ov….
-
Friends of Cancer Research
@CancerResrch
Baby KJ received a custom CRISPR therapy in six months. Bringing that same innovation to cell therapies in oncology will require more than science — it requires policy, infrastructure, and collaboration. Read the full blog: friendsofcancerresearch.org/blog/from-innovation-to-imple….
#celltherapy #genetherapy -
Friends of Cancer Research
@CancerResrch
Consistency in diagnostic test outputs is critical for patient care. Hillary Andrews will join the @theNCI Precision in Practice Workshop on July 2 to discuss our Diagnostic Harmonization Project and share key takeaways from our work. Register today: events.cancer.gov/OD/functional-medicine/registration!
-
Friends of Cancer Research
@CancerResrch
What does it take for a patient to enroll in a cell and gene therapy trial and where do the biggest practical barriers arise? Watch our advocates webinar to hear what make these therapies more accessible: www.youtube.com/watch?v=JTNBp8xZNmg #patientadvocacy
-
Friends of Cancer Research
@CancerResrch
Friends of Cancer Research advances science and policy to speed life-saving treatments to patients through three core areas of work: Research Partnerships, Policy Initiatives, and Data-Driven Insights & Analysis. Learn more: friendsofcancerresearch.org/projects/.
#cancerresearch -
Friends of Cancer Research
@CancerResrch
Our new manuscript, published in @OncJournal, outlines four evidence categories that can support demonstrating contribution of effect when a full factorial design is not practical in combination drug development: academic.oup.com/oncolo/advance-article/doi/10.1093/oncol…. #cancerresearch
-
Friends of Cancer Research
@CancerResrch
Jeff Allen will be joining "Crisis Can Be Opportunity: FDA Reform for the Good of Patients" at @IAmBiotech #bio2026, discussing the FDA's Biomarker Qualification Program and why strengthening it is critical for trial efficiency and U.S. competitiveness. We hope to see you there!
-
Friends of Cancer Research
@CancerResrch
Interim OS analyses are often based on immature data yet can influence critical clinical and regulatory decisions. Register for “Interpreting Interim OS for Decision-Making" webinar to explore a simulation-informed framework for interpreting these results. friendsofcancerresearch.org/event/interpreting-interim-ov…
-
Friends of Cancer Research
@CancerResrch
Jeff Allen, President and CEO, joined @Medidata's Anthony Costello and Ruthie Davi to discuss the ECA Pilot and how external control arms can be a credible tool in oncology drug development, especially for rare cancers. Watch the full podcast: www.medidata.com/en/from-dreamers-to-disruptors-podcast/.
-
Friends of Cancer Research
@CancerResrch
Grace Collins will be presenting a poster at @DrugInfoAssn 2026 Global Annual Meeting, evaluating how PMCs can provide timely access to novel therapies while ensuring IVDs intended to be used as CDx continue to be developed to inform labeling. friendsofcancerresearch.org/wp-content/uploads/Companion-… #dia2026
-
Friends of Cancer Research
@CancerResrch
Read our Q2 2026 Advocate Newsletter to catch up on our recent meetings and webinars, findings from a recent analysis of companion diagnostic PMCs, key regulatory updates, and Misha Mehta's patient advocate story: friendsofcancerresearch.org/blog/quarterly-advocacy-newsl….
#patientadvocacy -
Friends of Cancer Research
@CancerResrch
Hillary Andrews will chair a session on AI Tools in Clinical Trials at @DrugInfoAssn #dia2026. Join panelists as they examine how AI tools may improve consistency in radiology and pathology assessments, and the regulatory and methodological considerations they raise.
-
Friends of Cancer Research
@CancerResrch
Our free Advocates Webinar on cell and gene therapy development is happening now! Experts will discuss topics such as what it means for a trial to be ready for patients and how sponsors and regulators balance urgency with safety. Join now or watch later. www.youtube.com/watch?v=JTNBp8xZNmg
-
Friends of Cancer Research
@CancerResrch
Jeff Allen will be speaking at the @theNCI Frederick National Laboratory and @hood_college Reproducibility in Science Symposium on June 17, to discuss the ctMoniTR Project and the role of #ctdna as an early endpoint in clinical trials. Register today: frederick.cancer.gov/events/reproducibility-science-2026.
-
Friends of Cancer Research
@CancerResrch
The FDA's Biomarker Qualification Program takes a one-size-fits-all approach but not all biomarkers are created equal. Hear panelists discuss how a tiered framework matching evidence requirements to the science can lead to more efficient drug development. www.youtube.com/watch?v=EsRy8u8UIC0
-
Friends of Cancer Research
@CancerResrch
Starting now! Watch Senator @timkaine open our virtual Hill briefing on strengthening the FDA's Biomarker Qualification Program. Congress must act - more predictable biomarker development means faster therapies for patients who cannot wait. www.youtube.com/watch?v=EsRy8u8UIC0
-
Friends of Cancer Research reposted
The ASCO Post
@ASCOPost
🌟 For more than 2 decades, Richard Pazdur, MD, helped transform cancer drug development and regulatory science at the #fda.
Now, he joins the Friends of Cancer Research (@CancerResrch) Board of Directors as the organization marks its 30th anniversary.
🔗 ascopost.com/news/june-2026/friends-of-cancer-research-na… -
Friends of Cancer Research reposted
The Cancer Letter
@TheCancerLetter
Richard Pazdur joins @CancerResrch board
cancerletter.com/cancer-policy/20260605_7b/ -
Friends of Cancer Research
@CancerResrch
Last chance to register! Join us June 11 at 1:00PM ET for our free Advocates Webinar on cell and gene therapy development — translating complex scientific and regulatory concepts into clear, actionable takeaways for patient advocates.
Register today: friendsofcancerresearch.org/event/advocates-webinar-unloc…! -
Friends of Cancer Research
@CancerResrch
How can FDA’s BQP provide a more predictable pathway for qualified biomarkers across drug development programs?
Our new white paper outlines recommendations to strengthen the program and support more consistent regulatory use.
Read the white paper: friendsofcancerresearch.org/wp-content/uploads/Modernizin…. -
Friends of Cancer Research reposted
Medidata
@Medidata
In cancer research, settling for the status quo isn’t an option. External Control Arms are rewriting the rules.
To mark 30 years of oncology innovation, @CancerResrch President and CEO Jeff Allen joined Medidata’s Anthony Costello and Ruthie Davi on our "from Dreamers to Disruptors" podcast to explore how ECAs use AI and cutting-edge tech to solve data gaps, accelerate clinical trials, and deliver life-saving treatments to patients faster.
🎧 Stream it and subscribe now: mdso.io/8az
#aiforimpact #medidata -
Friends of Cancer Research
@CancerResrch
Join us for "Advocates Webinar: Unlocking Next-Generation Therapies" on 6/11: friendsofcancerresearch.org/event/advocates-webinar-unloc…. This webinar will build on discussions from our public meeting on cell therapy and highlight key themes, clarify outstanding questions, and emphasize patient-focused next steps.
-
Friends of Cancer Research reposted
Lung-MAP
@LungMAP
.@LungMAP investigators present 4 posters at #asco26. 1 is an analysis led by Dr. Diane Tseng of how the severity of immune-related adverse events (irAEs) in patients getting ICIs is associated with clinical outcomes: www.asco.org/abstracts-presentations/265964 @FNIH_Org @CancerResrch @theNCI @SWOG
-
Friends of Cancer Research
@CancerResrch
In a recent interview with @TheEviBase, Bernat Navarro discusses findings from the ECA Pilot Project, highlighting that ECAs can be feasible, but their credibility depends on careful design, fit-for-purpose data, and transparent operationalization. becarispublishing.com/digital-content/blog-post/examining…
-
Friends of Cancer Research
@CancerResrch
Friends of Cancer Research welcomes Dr. Richard Pazdur to the Board of Directors. A pioneer in cancer drug development and founding director of the FDA's Oncology Center of Excellence, he now brings that invaluable expertise to our mission. Learn more: friendsofcancerresearch.org/news/dr-richard-pazdur-joins-….
-
Friends of Cancer Research
@CancerResrch
Mark your calendars. Friends of Cancer Research has a full lineup for the second half of 2026! From biomarker qualification to interim OS decision-making, and radiopharmaceutical dosing to our flagship Annual Meeting. Register today: friendsofcancerresearch.org/events/! #cancerresearch
-
Friends of Cancer Research
@CancerResrch
Ryan Hohman will moderate "Hot Topics: A Look at What to Watch for Patient Advocates" at @foodanddruglaw's Essentials of Working with the FDA for Patient Organizations on June 16-17. The panel will cover FDA budget updates, drug shortages, and more. Apply: www.fdli.org/2026/06/2026-essentials-of-working-with-fda-…
-
Friends of Cancer Research reposted
Medidata
@Medidata
Clinical trials have been many patients' only lifeline. The External Control Arm is changing that.
@CancerResrch President and CEO Jeff Allen joins our CEO Anthony Costello and SVP, Statistics and Regulatory Science Innovation Ruthie Davi for the latest episode of our "from Dreamers to Disruptors" podcast. Tune in as they explore over 30 years of life-saving breakthroughs, and the tech driving a new standard of care in cancer research.
🎧 Stream it and subscribe now: mdso.io/t65
#medidata -
Friends of Cancer Research reposted
OVAC
@OVACInfo
30 years ago, the outlook for cancer patients looked very different. Thanks to organizations like @CancerResrch, the death rate has decreased 34%.🩺That’s millions of lives saved & proof of what sustained research & advocacy can do. Let’s keep going. #nationalcancerresearchmonth
-
Friends of Cancer Research
@CancerResrch
We are heading to @ASCO! From immunotherapy combinations to radiopharmaceuticals to ctDNA-guided decision-making — these conversations are at the heart of our mission to accelerate cutting-edge cancer care for patients.
If you're there, we hope to see you. #asco26 #cancerresearch -
Friends of Cancer Research
@CancerResrch
Senator @timkaine will deliver the opening keynote for our Virtual Hill Briefing examining how a stronger @US_FDA biomarker qualification program can support more consistent use of biomarkers in clinical trials and regulatory-decision making. Register: friendsofcancerresearch.org/event/virtual-hill-briefing-s….
-
Friends of Cancer Research
@CancerResrch
What is necessary to bring cell-based therapies to more patients? Join us June 11 for the Advocates Webinar: Unlocking Next-Generation Therapies, exploring challenges and solutions across trial design, manufacturing, and regulatory flexibility: friendsofcancerresearch.org/event/advocates-webinar-unloc….
-
Friends of Cancer Research
@CancerResrch
Cell-based therapies are advancing quickly but patient access has not kept pace. Read our 2025 Scientific Report to explore how we are working to close that gap: innovative manufacturing models, risk-adjusted development, and public-private partnerships. friendsofcancerresearch.org/wp-content/uploads/Friends-Sc…
-
Friends of Cancer Research
@CancerResrch
Jeff Allen will deliver the opening keynote and join a fireside chat at @KidneyHealthIn's Kidney Innovation Conference on May 20. He will explore how the research partnerships and innovative policy that have driven progress in oncology can be expanded to other therapeutic areas.
-
Friends of Cancer Research
@CancerResrch
Bernat Navarro, Senior Science Policy Analyst, will present findings from our ECA Pilot at @ISPORorg on 5/20. Across nine data partners, we evaluated whether ECAs can be constructed across heterogeneous external data sources using a shared analysis plan: www.ispor.org/heor-resources/presentations-database/prese….
-
Friends of Cancer Research reposted
Lung-MAP
@LungMAP
"You might have been on osimertinib and found you have a resistance mechanism called MET amplification," says MET Crusaders chair Marcia Horn, JD. Patients with #nsclc that grows resistant to osimertinib may be eligible for @LungMAP S1900G. @FNIH_Org @CancerResrch @metcrusaders
-
Friends of Cancer Research
@CancerResrch
As cell-based therapies expand to treat different cancers, it brings new challenges. Our "Unlocking Next-Generation Therapies" meeting explored what it takes to move these therapies forward.
➡️Read the recap: friendsofcancerresearch.org/blog/meeting-recap-unlocking-…
➡️Watch the meeting: www.youtube.com/live/vjW1NqLXJKs?cbrd=1&ucbcb=1 -
Friends of Cancer Research
@CancerResrch
The @foodanddruglaw is hosting a free two-day virtual training for patient organizations on working with the FDA on June 16–17. Topics include FDA engagement, Hill advocacy, clinical trial design, AI, and more. Apply today: www.fdli.org/2026/06/2026-essentials-of-working-with-fda-…!
-
Friends of Cancer Research
@CancerResrch
Thank you to everyone who attended the @CancerResrch and @parkerici “Unlocking Next-Generation Therapies" meeting. We hope you enjoyed the discussions.
➡️Watch the meeting: www.youtube.com/live/vjW1NqLXJKs?cbrd=1&ucbcb=1
➡️Register for future meetings: friendsofcancerresearch.org/events/ -
Friends of Cancer Research reposted
Parker Institute
@parkerici
Thanks to @CancerResrch for co-hosting “Unlocking Next-Generation Therapies” this week in Washington, DC, convening leaders from academia, regulatory agencies, and patient advocacy to discuss how to accelerate the development and delivery of next-generation cell-based therapies.
A key highlight from the program was PICI Chief Scientific Officer @John_E_Connolly moderating a session on operationalizing risk-based flexibility in CMC across the product lifecycle, a critical lever for enabling faster, more adaptive development pathways without compromising rigor.
Learn more about the meeting and panelists here: friendsofcancerresearch.org/event/unlocking-next-generati… -
Friends of Cancer Research reposted
METCrusaders
@metcrusaders
We are so grateful for Lung-MAP at the MET Crusaders. Ask your oncologist about whether you qualify for one of the Lung-MAP arms that target MET. And thank you @CancerResrch and @SWOG
Dr. Estela Rodriguez
@Latinamd
#eaonc26 @LealTiciana @WinshipAtEmory provides an update on @LungMAP - a biomarker driven trial platform that has been opened for 10 years via the cooperative groups and continues to advance the science #lcsm @eaonc
-
Friends of Cancer Research
@CancerResrch
Register for our free "Advocates Webinar: Unlocking Next-Generation Therapies" on June 11 at 1PM ET: friendsofcancerresearch.org/event/advocates-webinar-unloc…. Experts will translate complex cell and gene therapy scientific, manufacturing, and regulatory topics into clear, actionable takeaways for advocates.
-
Friends of Cancer Research
@CancerResrch
Thank you to everyone who attended our "Unlocking Next-Generation Therapies" meeting. Learn more about this meeting and panelists on our website, friendsofcancerresearch.org/event/unlocking-next-generati…, and register for our upcoming meetings at friendsofcancerresearch.org/events/.
-
Friends of Cancer Research
@CancerResrch
"The US ecosystem is unique in the incredible network of relationships we have built. Another defining feature is our tolerance for risk — we have built an ecosystem where risk-taking is possible.” – David Kaufman, Third Rock Ventures #friendscgt26
-
Friends of Cancer Research reposted
John Connolly
@John_E_Connolly
Honored to moderate a fantastic panel on a key bottleneck in #celltherapy @parkerici @US_FDA @AllogeneTx @AstraZeneca @IovanceBio
Friends of Cancer Research
@CancerResrch
Sometimes split starting material equivalence testing is not easy, or is simply impractical — whether due to limitations on starting material that make split studies at scale impossible, or because the original sending site is no longer available. - Marc Better, Pharmefex
-
Friends of Cancer Research
@CancerResrch
Sometimes split starting material equivalence testing is not easy, or is simply impractical — whether due to limitations on starting material that make split studies at scale impossible, or because the original sending site is no longer available. - Marc Better, Pharmefex
-
Friends of Cancer Research
@CancerResrch
A patient wants to hear from another patient, straight from the horse's mouth, but the rules prevent that. It's better to talk to someone who has been through it so they can walk you through it. Regulatory frameworks need to make that happen. - @MucosalMelanoma #friendscgt26
-
Friends of Cancer Research
@CancerResrch
Our "Unlocking Next Generation Therapies" public meeting has started!
➡️Watch live or on-demand: www.youtube.com/live/vjW1NqLXJKs?cbrd=1&ucbcb=1
➡️Learn more about the meeting and panelists: friendsofcancerresearch.org/event/unlocking-next-generati… -
Friends of Cancer Research
@CancerResrch
Jeff Allen joined a panel of experts to discuss the Prescription Drug User Fee Act (PDUFA), highlighting the importance of the FDA bringing the patient and caregiver voice into clinical development and the regulatory process.
Explore our policy priorities: friendsofcancerresearch.org/policy-portfolio/ -
Friends of Cancer Research reposted
Chris White
@MucosalMelanoma
Join myself and my fellow panelist from the @FDA @theNCI @bmsnews @KeloniaTx at “Unlocking Next-Generation Therapies” in person or virtually on May 6th, hosted by @CancerResrch & @parkerici Click here to register at friendsofcancerresearch.org/event/unlocking-next-generati… #yourtilspeaker #friendscgt26
-
Friends of Cancer Research
@CancerResrch
The @US_FDA's ODAC met April 30 to consider two cancer treatment regimens. The votes raised critical questions about trial design, biomarker validation, and what it means to demonstrate clinically meaningful benefit. Read the recap: friendsofcancerresearch.org/blog/stakeholder-connect-insi….
-
Friends of Cancer Research
@CancerResrch
Last chance to register! Join us Wednesday in DC or virtually for our "Unlocking Next-Generation Therapies" meeting: friendsofcancerresearch.org/event/unlocking-next-generati…. This free event will bring together experts across industries to explore innovative approaches in cell therapy development.
-
Friends of Cancer Research reposted
Allogene Therapeutics
@AllogeneTx
Looking forward to having Allogene's CTO Ben Beneski join the discussion on advancing next-generation cell-based therapies. @CancerResrch #friendscgt26 #allogeneic #celltherapy $ALLO
Join Us: friendsofcancerresearch.org/event/unlocking-next-generati… -
Friends of Cancer Research
@CancerResrch
Join us for a virtual Hill Briefing on June 9 at 1PM ET exploring opportunities to strengthen the FDA's Biomarker Qualification Program. Experts will discuss improving efficiency, consistency, and regulatory alignment for biomarker-driven drug development. friendsofcancerresearch.org/event/virtual-hill-briefing-s…
-
Friends of Cancer Research reposted
Flatiron Health
@flatironhealth
#friendseca26 is a pilot project exploring how ECAs can accelerate drug development, strengthen decision-making, & expand patient access to treatments.
Read the @CancerResrch meeting recap & join us at #isporannual to see the impact of this collaboration: friendsofcancerresearch.org/blog/meeting-recap-applicatio… -
Friends of Cancer Research
@CancerResrch
Don't miss our 1:00 PM ET Fireside Chat at our May 6 Next-Generation Therapies meeting, "Predictability in Drug Development in an Evolving Policy Environment": friendsofcancerresearch.org/event/unlocking-next-generati…. Conversations will explore how policy dynamics are shaping drug development and investment.
-
Friends of Cancer Research
@CancerResrch
Join us in one week for our “Unlocking Next-Generation Therapies” meeting. Read our issue brief highlighting areas where targeted dialogue and greater clarity could enhance development efficiency and regulatory predictability. Register today: friendsofcancerresearch.org/event/unlocking-next-generati….
-
Friends of Cancer Research reposted
Oncology Times
@OncologyTimes
“Today's discussion is about one thing above all: patients,” said Ellen V. Sigal, PhD, Founder and Chairperson, at a Friends of Cancer Research conference in Washington, DC, to focus on new findings from two of its research projects. journals.lww.com/oncology-times/fulltext/2026/04000/promi…
-
Friends of Cancer Research reposted
Christopher Heery MD
@ChrisHeery
I am looking forward to joining this public meeting, hosted by Friends of Cancer Research on Wednesday May 6th, "Unlocking Next-Generation Therapies." I hope you will consider joining us. Should be a very insightful program. #friendscgt26
friendsofcancerresearch.org/event/unlocking-next-generati… -
Friends of Cancer Research
@CancerResrch
We submitted comments to @US_FDA on the Plausible Mechanism Framework, urging clarity on CMC expectations beyond the IND stage, defining "well-characterized" natural history data, and post-marketing evidence requirements for n=1 therapies. friendsofcancerresearch.org/wp-content/uploads/Final-plau…
-
Friends of Cancer Research reposted
Ankit kansagra
@kansagraMD
Clinical trials tell us what can work. Real-world data shows us what's actually happening when those therapies reach the patients sitting across from us every day. Both matter. And increasingly, they have to travel together.
In my practice, the challenge is that the comparator arm, which was used in regulatory practices, might be different in clinical practice: a dose that was approved 5 years ago for a drug is no longer used, and the treatment schedule is now completely different! We look forward to discussing the challenges and how RWD can help bridge answer some of them.
On May 7, I'm joining C.K. Wang @VeronaHealth , MD, Donna Rivera @CanalRowAdvisor , and Jeff Allen @CancerResrch for a conversation hosted by Verana Health on what real-world evidence is actually telling us about oncology today — treatment patterns, outcomes, unmet need, and where limitations still require caution.
If you're a clinician, researcher, industry scientist, or policy leader thinking about how trials and real-world data fit together we are going to have a fun debate and ready to ask TOUGH questions! -
Friends of Cancer Research
@CancerResrch
When Friends of Cancer Research was founded in 1996, 63% of cancer patients survived 5 years past their diagnosis. Today, that number stands at 70%. Previously untreatable cancers now have options that are saving lives. Help ensure this work continues: friendsofcancerresearch.org/donate-friends-of-cancer-rese….
-
Friends of Cancer Research
@CancerResrch
Cell and gene therapies are transforming cancer treatment, but manufacturing complexity, evolving regulatory frameworks, and prohibitive costs limit patient access. Join us and @parkerici on May 6 as we explore opportunities to advance solutions: friendsofcancerresearch.org/event/unlocking-next-generati…
-
Friends of Cancer Research
@CancerResrch
Happening Now! Our free “Advocates Webinar: Application of External Control Arms (ECAs) in Oncology Drug Development” is live on YouTube: www.youtube.com/watch?v=7FKUr0cLLH8. Join now or watch on-demand to learn what ECAs mean for patients, drug development, and regulatory decision making.
-
Friends of Cancer Research
@CancerResrch
That is a wrap! Thank you @AACR for another great Annual Meeting. We enjoyed connecting with colleagues and the warm San Diego weather. We hope you enjoyed our session on oncology trial ecosystem. Learn more about our work in this space: friendsofcancerresearch.org/wp-content/uploads/Multi-Regi…. #aacr26
-
Friends of Cancer Research reposted
The Cancer Letter
@TheCancerLetter
At @CancerResrch meeting, data quality, modern evidence generation, and early regulatory alignment top the list of “next steps” for external control arms
cancerletter.com/cancer-policy/20260417_6c/ -
Friends of Cancer Research
@CancerResrch
The FDA approved the first CAR-T #celltherapy in 2017. Since then, the science has advanced, but the infrastructure supporting it has not evolved in parallel. Join us and @parkerici on 5/6 for a meeting on advancing next-generation therapies. friendsofcancerresearch.org/event/unlocking-next-generati…!
-
Friends of Cancer Research
@CancerResrch
How can clinical trials work better for patients when traditional designs are not feasible? Register for our 4/23 webinar for patient advocates, exploring external control arms and how they can strengthen evidence generation in oncology drug development: friendsofcancerresearch.org/event/advocates-webinar-exter….
-
Friends of Cancer Research
@CancerResrch
Multi-regional oncology trials bring real challenges for data interpretability and regulatory decision-making. Join us at @AACR Annual Meeting as we discuss practical and policy-driven approaches to improve trial efficiency. We hope to see you there on Monday, April 20! #aacr26
-
Friends of Cancer Research
@CancerResrch
External control arms offer new ways to generate evidence in oncology, but depend on data completeness, comparability, and thoughtful design.
Our meeting explored what that means in practice.
➡️Read the recap: friendsofcancerresearch.org/blog/meeting-recap-applicatio…
➡️Watch the meeting: www.youtube.com/live/fh7y3J2xyYY?cbrd=1&ucbcb=1 -
Friends of Cancer Research
@CancerResrch
Ellen Sigal founded Friends of Cancer Research after losing her sister to breast cancer. 30 years later, she continues her mission to ensure patients are never powerless in the face of science and policy. Help us keep that work going. Donate today: friendsofcancerresearch.org/donate-friends-of-cancer-rese….
-
Friends of Cancer Research
@CancerResrch
We will be at the @AACR Annual Meeting! This year's theme reflects continuous innovation in cancer science—from AI-driven discovery and early detection to cell therapies, radiopharmaceuticals, and evolving regulatory frameworks. We hope to see you there. #aacr26
-
Friends of Cancer Research reposted
PanCAN
@PanCAN
Earlier this week, Cassadie Moravek, Senior Director of Clinical Trial Portfolio and Program Management at PanCAN, participated in a Friends of Cancer Research meeting as part of the “Application of External Control Arms in Oncology Drug Development” panel.
External control arms (ECAs) are constructed using existing data sources, such as prior clinical trials or real-world data, and can offer an important alternative when traditional randomized trials are not feasible. When developed with rigorous methodology, ECAs have the potential to improve trial efficiency, reduce the number of patients assigned to control arms and help inform regulatory decision-making.
PanCAN is proud to serve as a data partner in the Friends of @CancerResrch ECA Pilot, a multi-stakeholder research initiative focused on evaluating and advancing methodological approaches for building external control arms from historical clinical trial and real-world data sources. 💜 -
Friends of Cancer Research
@CancerResrch
Join us for an Advocates Webinar on External Control Arms in Oncology Drug Development on April 23. Watch our ECA public meeting on YouTube, LINK, and submit your questions to our experts ahead of the webinar. Register today: friendsofcancerresearch.org/event/advocates-webinar-exter…! #patientadvocacy
-
Friends of Cancer Research
@CancerResrch
Join us 5/6 for Unlocking Next-Generation Therapies, a public meeting hosted in partnership with @parkerici exploring IND readiness, risk-based CMC flexibility, and longer-term policy opportunities to strengthen the cell therapy ecosystem. Register today! friendsofcancerresearch.org/event/unlocking-next-generati…
-
Friends of Cancer Research
@CancerResrch
Thank you to everyone who attended our "Application of External Control Arms in Oncology Drug Development” meeting! We hope to see you again!
➡️Watch the meeting on-demand: friendsofcancerresearch.org/events/.
➡️Explore our future meetings: friendsofcancerresearch.org/events/.
#friendseca26 -
Friends of Cancer Research
@CancerResrch
There are operational barriers, data barriers, and methodological barriers. On the operational side, do not underestimate the contracting phase — that alone is one of the most time-consuming parts of conducting an ECA. – Jaclyn Bosco, @IQVIA_global #friendseca26
-
Friends of Cancer Research
@CancerResrch
Can we apply these learnings to later lines or different endpoints to develop more pragmatic clinical trials — ones where fewer patients need to be placed on control arms so that patients don't fall off?" – Cassadie Moravek, @PanCAN #friendseca26 #realworlddata
-
Friends of Cancer Research
@CancerResrch
The variability in data sources — the fact that they were different and had different levels of compatibility in terms of trial fit-for-purpose — is real. But the insights we gain are still greater because we can look across that range of studies. – Jennifer Rider, @ConcertAI
-
Friends of Cancer Research
@CancerResrch
Our "Application of External Control Arms in Oncology Drug Development" meeting has started! Watch live or later on-demand on our YouTube page: www.youtube.com/live/fh7y3J2xyYY?cbrd=1&ucbcb=1. #friendseca26 #realworlddata
-
Friends of Cancer Research
@CancerResrch
Last chance to register! Join us tomorrow for our meeting on the Application of External Control Arms in Oncology Drug Development. Explore how ECAs can support regulatory decision-making, enhance drug development, and expand patient access to treatments. friendsofcancerresearch.org/event/application-of-external…
-
Friends of Cancer Research
@CancerResrch
In 1999, Kelly Cuvar was diagnosed with a rare sarcoma affecting fewer than 900 people a year. Without organizations like Friends of Cancer Research, she would not be here today. Support the work that turns rare diagnoses into survivable ones. Donate today—friendsofcancerresearch.org/donate-friends-of-cancer-rese…
-
Friends of Cancer Research
@CancerResrch
Join us in one week for our "Application of External Control Arms in Oncology Drug Development" meeting on April 7 in DC or virtually: friendsofcancerresearch.org/event/application-of-external…! We will present new findings from our ECA Pilot Project and discuss how ECAs can strengthen regulatory decision-making.
-
Friends of Cancer Research
@CancerResrch
OS remains the gold standard in clinical trials, but the time to observe OS outcomes can delay patient access to promising therapies. Our 2025 Scientific Report examines early endpoints and the FDA's BQP to support more efficient drug development: friendsofcancerresearch.org/wp-content/uploads/Friends-Sc….
-
Friends of Cancer Research
@CancerResrch
Mark Stewart will join experts at @BioCanRx’s Summit for Cancer Immunotherapy to explore how different countries are working to expand patient access to immunotherapies, sharing insights from our cell and gene therapy initiative. Learn more: friendsofcancerresearch.org/cell-gene-therapies/.
-
Friends of Cancer Research
@CancerResrch
Join us on April 23 for an advocate-focused webinar on external control arms (ECAs) in oncology drug development. Learn what reliable ECAs mean for patients and how they can support evidence generation and access to promising therapies: friendsofcancerresearch.org/event/advocates-webinar-exter… #patientadvocacy
-
Friends of Cancer Research
@CancerResrch
Jeff Allen will join experts at the @ACGTFoundation Summit's keynote panel, sharing insights from our cell and gene therapy initiative, including global regulatory alignment and the FDA's Plausible Mechanism Framework. Learn more: friendsofcancerresearch.org/cell-gene-therapies/.
-
Friends of Cancer Research
@CancerResrch
Join Mark Stewart and experts from PAQ Therapeutics and MMS Holdings for a webinar exploring how sponsors can make better decisions in early oncology development when the data is still incomplete. Hosted by MMS Holdings and @Citeline. Register today: discover.pharmaignite.com/data-interpretation-in-early-on…!
-
Friends of Cancer Research
@CancerResrch
.@CancerResrch and @parkerici are hosting a public meeting on May 6 to explore opportunities to advance next-generation therapies, including innovative approaches in cell development. Register for in person in Washington, DC or virtually: friendsofcancerresearch.org/event/unlocking-next-generati…! #celltherapy
-
Friends of Cancer Research
@CancerResrch
ECAs offer a complementary approach for generating comparative evidence, but their credibility depends on data quality, population alignment, and analytic rigor. Join our April 7 meeting to explore findings from our ECA Pilot Project. Register today: friendsofcancerresearch.org/event/application-of-external…!
-
Friends of Cancer Research reposted
Elad Sharon
@EladSharonMD
Nice posting from @CancerResrch from my panel at the annual meeting: www.linkedin.com/posts/elad-sharon-speaking-at-the-friend…
-
Friends of Cancer Research reposted
Jennifer R Rider, ScD, MPH
@jenniferrrider
Thrilled to participate in the upcoming Applications of External Control Arms (ECA) in Oncology Drug Development event. We'll share insights on methodogy and data source selection from FOCR's cross-sector collaborative ECA pilot project. Join us April 7! friendsofcancerresearch.org/event/application-of-external…
-
Friends of Cancer Research
@CancerResrch
30 years young and still no time for cake.
Ellen Sigal founded Friends of Cancer Research in 1996 because patients deserved better.
The mission hasn't changed. And neither has the urgency.
Happy 30th to us. Now back to work!
Join us. Donate Today: friendsofcancerresearch.org/donate-friends-of-cancer-rese…! -
Friends of Cancer Research
@CancerResrch
How do we demonstrate each drug in a combination therapy benefits patients without adding unnecessary toxicity? Our white paper builds on FDA draft guidance on COE in novel oncology combinations, outlining design considerations for registrational trials. friendsofcancerresearch.org/wp-content/uploads/Assessing-…
-
Friends of Cancer Research reposted
The ASCO Post
@ASCOPost
🖥️ #ascoai: In a comparative analysis of #ai pathology tools:
• Highest agreement for HER2 3+ (88% agreement)
• Lower agreement in borderline categories (eg, 1+ vs 2+)
➡️ Insights into where AI tools may need refinement.
@ModernPathology @CancerResrch
ascoai.org/articles/2026/03/her2-scoring-interpretation-c… -
Friends of Cancer Research
@CancerResrch
Our latest Advocate Newsletter is out now! This issue covers highlights from our Modernizing Oncology Endpoints meeting and Advocates Webinar, the launch of progresoparapacientes.org, and key takeaways on the Biomarker Qualification Program. friendsofcancerresearch.org/blog/quarterly-advocacy-newsl…
#patientadvocacy -
Friends of Cancer Research
@CancerResrch
Read our 2025 Scientific Report, featuring publications advancing flexible, aligned approaches for developing and validating companion diagnostics and proposing best practices for AI-enabled tools in digital pathology: friendsofcancerresearch.org/wp-content/uploads/Friends-Sc…. #diagnostics
-
Friends of Cancer Research
@CancerResrch
Amy Abernethy, Co-Founder of Highlander Health, will join Michael McCaughan of Prevision Policy for a Fireside Chat at our upcoming “Application of ECAs in Oncology Drug Development" meeting on April 7. Register today to join in-person or virtually: friendsofcancerresearch.org/event/application-of-external….
-
Friends of Cancer Research
@CancerResrch
Thank you for joining "Advancing Patient Advocacy for Spanish-Speaking Communities Through Accessible Education." Learn more about the FDA, drug development, and patient advocacy through the free courses at progresoparapacientes.org (Spanish) and progressforpatients.org (English).
-
Friends of Cancer Research
@CancerResrch
Accessible, culturally and linguistically appropriate education shaped progresoparapacientes.org. Yadira speaks to how strong family bonds, a cornerstone of Latino and Hispanic culture, make family caregivers an essential part of medical decision-making. www.youtube.com/watch?v=KAZQhVxC7a0
-
Friends of Cancer Research
@CancerResrch
Hear Debbie Denardi speak on how progresoparapacientes.org can provide Spanish-speaking communities with accessible education on drug development, helping advocates engage more effectively in research, clinical, and policy conversations. Watch now: www.youtube.com/watch?v=KAZQhVxC7a0.
-
Friends of Cancer Research
@CancerResrch
Starting now! Join the free webinar "Advancing Patient Advocacy for Spanish-Speaking Communities Through Accessible Education," marking the launch of progresoparapacientes.org, a new patient advocacy education program for Spanish-speaking communities. www.youtube.com/watch?v=KAZQhVxC7a0
-
Friends of Cancer Research
@CancerResrch
#ai-enabled tumor assessment tools are transforming how we evaluate treatment response in #oncology trials. Our new white paper outlines how different AI-enabled approaches have the potential to improve current assessments. Read the full paper: friendsofcancerresearch.org/wp-content/uploads/Leveraging….
-
Friends of Cancer Research
@CancerResrch
Jeff Allen attended @FNIH_Org’s Biomarkers Consortium Symposium, where he spoke on the role of industry partnerships with tool developers in evaluating emerging technologies, addressing alignment challenges, and advancing regulatory frameworks needed to keep pace with innovation.
-
Friends of Cancer Research
@CancerResrch
Our 2025 Scientific Report features our publications that focus on adapting or modernizing traditional #clinicaltrial approaches and regulatory frameworks to meet evolving scientific and patient needs. Read the full report to learn more: friendsofcancerresearch.org/wp-content/uploads/Friends-Sc….
-
Friends of Cancer Research
@CancerResrch
External control arms (ECAs) are helping advance evidence generation in oncology. Join us on April 7 to hear new findings from our ongoing ECA research project and discuss how ECAs can inform drug development and regulatory decision-making. Register today! friendsofcancerresearch.org/event/application-of-external…
-
Friends of Cancer Research
@CancerResrch
ICYMI: Last week's Endpoints Advocates Webinar explored how circulating tumor DNA (#ctdna) and artificial intelligence (AI)-enabled tumor assessment tools are reshaping cancer drug development and what this means for patients. Watch the full webinar: www.youtube.com/watch?v=1Mf7yH0irKc.
-
Friends of Cancer Research
@CancerResrch
Our interactive drug development dashboards provide comprehensive, data-driven insights into #oncology drug development and FDA approvals. Using publicly available sources and updated regularly, they track regulatory trends and approval patterns. friendsofcancerresearch.org/drug-development-dashboard/
-
Friends of Cancer Research
@CancerResrch
How do promising liquid biopsy technologies move from validation to sustainable coverage?
Mark Stewart, VP of Science Policy, will explore this as he moderates the panel “From Validation to Payment: Coverage Pathways That Work” at @PMWCintl on Thursday, March 5, 2026. -
Friends of Cancer Research
@CancerResrch
#ai-enabled tumor assessment tools could lead to more precise endpoints, potentially shortening trials and accelerating patient access to effective therapies. Read our blog, which explores the white paper featured at last week's endpoints meeting: friendsofcancerresearch.org/blog/meeting-recap-endpoints-….
-
Friends of Cancer Research
@CancerResrch
Happening Now! Our free Advocates Webinar is live, building on conversations from our Modernizing Oncology Endpoints meeting. Join now or watch on-demand: www.youtube.com/watch?v=1Mf7yH0irKc. #patientadvocacy
-
Friends of Cancer Research
@CancerResrch
At our Modernizing Oncology Endpoints meeting, Lia Ridout emphasized how patients would prefer maintaining human involvement in AI-enabled imaging to ensure patient trust. Our Advocates Webinar on 2/19 will build on these conversations. Register today: friendsofcancerresearch.org/event/advocates-webinar-moder….
-
Friends of Cancer Research
@CancerResrch
Our October 2025 analysis in @DrugInfoAssn TIRS called for stronger resources and collaboration in the Biomarker Qualification Program. The @US_FDA responded, acknowledging challenges and highlighting process improvements. Read their full response: link.springer.com/article/10.1007/s43441-025-00911-x.
-
Friends of Cancer Research
@CancerResrch
How can external control arms support regulatory decision-making in oncology? Join us April 7, 10AM-2PM ET, for insights from our ECA research partnership and discussion of best practices for generating rigorous, decision-grade evidence. friendsofcancerresearch.org/event/application-of-external… #realworlddata
-
Friends of Cancer Research
@CancerResrch
Our latest blog breaks down our white paper on AI-enabled tools used to evaluate radiological images in evaluating treatment and clinical trial endpoints. It is perfect for #patientadvocates preparing for our upcoming Advocates Webinar on early endpoints.
friendsofcancerresearch.org/blog/project-pulse-modernizin… -
Friends of Cancer Research
@CancerResrch
Patient Advocates! Join us for our free Advocates Webinar on February 19 at 12pm ET to explore early endpoints in cancer drug development. Register here: friendsofcancerresearch.org/event/advocates-webinar-moder…. We recommend watching the Modernizing Oncology Endpoints meeting to get the most out of the webinar.
-
Friends of Cancer Research
@CancerResrch
Jeff Allen will attend the @FNIH_Org Biomarker Consortium Symposium, highlighting the Digital PATH and ai.RECIST projects and the need for regulatory policy to ensure AI-enabled tool alignment.
Learn more about the projects: friendsofcancerresearch.org/digital-pathology/, friendsofcancerresearch.org/ai-recist/. -
Friends of Cancer Research
@CancerResrch
Thank you for attending our “Modernizing Oncology Endpoints” meeting. Missed a session or would like to revisit the discussions? The complete meeting is now available on-demand on our YouTube channel: www.youtube.com/live/3Wy4H4jlNcY?cbrd=1&ucbcb=1. We look forward to seeing you at our future meetings.
-
Friends of Cancer Research
@CancerResrch
The final session of our Modernizing Oncology Endpoints meeting explored regulatory and policy implications of integrating novel measurement tools and endpoints into clinical development programs.
Thank you to everyone who attended the meeting. We hope to see you at the next one. -
Friends of Cancer Research
@CancerResrch
Some AI tools may be not human guided. You may not have a user that is guiding that test. But all radiology AI, all oncology AI, should be human centered. – Nate Braman, @PictureHealthAI #friendsendpoints26
-
Friends of Cancer Research
@CancerResrch
From a regulatory perspective, the FDA is open minded in using endpoints. To continue that, there needs to be transparency and trust. Alain Silk, @TempusAI #friendsendpoints26
-
Friends of Cancer Research
@CancerResrch
We can combine trial data effectively, but we need to ensure there isn't too much heterogeneity in the data. We need to clearly define what that clinical endpoint timepoint is for #ctdna and we need to harmonize across those trials and timepoints. - Jon Baden @FriendsEndpoints26
-
Friends of Cancer Research
@CancerResrch
We don't want to subject patients to unnecessary biopsies, but we understand there is value in understanding endpoints. There has to be a strong rationale and patients are well consented and understand how often they will need tissue biopsies. - Paz Vellanki #friendsendpoints26
-
Friends of Cancer Research
@CancerResrch
The Honorable @RepDianaDeGette kicks off our "Modernizing Oncology Endpoints" meeting by emphasizing the vital need for cancer research and continued investment in its future. #friendsendpoints26
-
Friends of Cancer Research
@CancerResrch
Starting now: the Friends of Cancer Research "Modernizing Oncology Endpoints" meeting!
Watch live, www.youtube.com/watch?v=3Wy4H4jlNcY, and join the conversation using the hashtag #friendsendpoints26. -
Friends of Cancer Research
@CancerResrch
Last chance to register! Join us Thursday, Feb. 5 in Washington, DC or virtually for our "Modernizing Oncology Endpoints: Pathways for Evidence and Policy" meeting: friendsofcancerresearch.org/event/modernizing-oncology-en…. Visit our website to register, explore panel topics, and read the meeting white paper.
-
Friends of Cancer Research
@CancerResrch
Every 5 years, the FDA enters a new user fee cycle—directly impacting how quickly treatments reach patients. Ryan Hohman of Friends of Cancer Research breaks down how FDA user fees work, why they matter, and what’s at stake for patients and innovation. youtu.be/R-RFS_N3b3c
-
Friends of Cancer Research
@CancerResrch
Prepare for our “Modernizing Oncology Endpoints” public meeting on February 5 by reading our white paper (friendsofcancerresearch.org/wp-content/uploads/Leveraging…) that examines how to validate and integrate novel AI-imaging endpoints to improve trial precision and accelerate drug development. #cancerresearch
-
Friends of Cancer Research
@CancerResrch
As science advances, policy and regulatory frameworks must evolve with it. At our meeting, Modernizing Oncology Endpoints, policy experts will explore how regulatory frameworks can adapt to support innovation and maintain public trust. Register today: friendsofcancerresearch.org/event/modernizing-oncology-en…!
-
Friends of Cancer Research
@CancerResrch
We support the @US_FDA's proposed CDx reclassification and submitted comments recommending clarity on alternative sample sources, opportunities for reference datasets, examples of successful approaches, and applying principles to other diagnostics. friendsofcancerresearch.org/wp-content/uploads/Reclassifi…
-
Friends of Cancer Research
@CancerResrch
As we enter our 30th year, we continue transforming oncology drug development through partnerships that make an impact.
Read our 2025 Scientific Report featuring 13 publications addressing critical challenges in cancer research: friendsofcancerresearch.org/wp-content/uploads/Friends-Sc…. #cancerresearch -
Friends of Cancer Research
@CancerResrch
We are joining @UnitedforCures1 for the Jan 21 Day of Action to urge swift passage of FY26 medical research funding.
Join us and contact your congressional representative today: unitedforcures.org/day-of-action.
#supportcures #fundmedicalresearch #curescantwait -
Friends of Cancer Research
@CancerResrch
Join us on February 19 at 12pm for a free, advocates-focused webinar to explore two emerging tools in cancer drug development, #ctdna and AI-based tumor assessment tools, that can improve trial efficacy and help increase access to life-saving treatments: friendsofcancerresearch.org/event/advocates-webinar-moder….
-
Friends of Cancer Research
@CancerResrch
Read our latest blog on the recent Digital PATH Project. Explore how our study aids alignment among AI-enabled digital pathology tools while proposing key questions that will shape the future direction of AI in #pathology: friendsofcancerresearch.org/blog/project-pulse-evaluating….
-
Friends of Cancer Research
@CancerResrch
Can #ai streamline #oncology clinical trials without compromising patient safety? Join our Feb. 5 meeting to explore insights from our ai.RECIST Project on AI-enabled tumor assessment and its potential to accelerate patient access to treatments: friendsofcancerresearch.org/event/modernizing-oncology-en….
-
Friends of Cancer Research
@CancerResrch
As #pdufa discussions continue to spotlight modernizing evidence generation, our new analysis sheds light on how biomarkers are being qualified today. Read our blog to review findings from a recent study of the FDA’s Biomarker Qualification Program: friendsofcancerresearch.org/blog/data-driven-insights-the….
-
Friends of Cancer Research
@CancerResrch
Just announced! Rep. Diana DeGette and Dr. Janet Woodcock will be keynote speakers at our Modernizing Oncology Endpoints meeting on February 5. The meeting will review the current landscape and application of evolving early endpoints. Register today: friendsofcancerresearch.org/event/modernizing-oncology-en…!
-
Friends of Cancer Research
@CancerResrch
Our just released calendar of public meetings will feature new project results and discuss topics shaping the future of cancer research and policy, including early endpoints, external control arms, and next-generation therapies: friendsofcancerresearch.org/events/.
-
Friends of Cancer Research
@CancerResrch
We launched the ctMoniTR Project to accelerate ctDNA use in clinical trials through coordinated, multi-stakeholder collaboration. Join our February 5 meeting where we will present new findings and examine how #ctdna functions as an early endpoint: friendsofcancerresearch.org/event/modernizing-oncology-en….
-
Friends of Cancer Research
@CancerResrch
Our ctMoniTR Project unites pharma companies, diagnostic labs, government agencies, patient advocates, and researchers to aggregate data across multiple clinical trials to support #ctdna as an early endpoint. Read more in @thecancerletter: cancerletter.com/regulatory-news/20251024_1/.
-
Friends of Cancer Research
@CancerResrch
Read our 2025 Scientific Report: friendsofcancerresearch.org/wp-content/uploads/Friends-Sc…. The report highlights progress from our research partnerships in 2025 and presents evidence-based strategies, insights, and collaborative solutions to advance oncology drug development for patients.
-
Friends of Cancer Research
@CancerResrch
A new manuscript from our Digital PATH Project in @ModernPathology establishes a foundation for advancing alignment in novel #ai tools—building trust, ensuring consistency, and unlocking AI's potential in #oncology drug development and patient care. doi.org/10.1016/j.modpat.2025.100944
-
Friends of Cancer Research
@CancerResrch
Next year marks our 30th anniversary. As we approach this milestone, our work continues with new opportunities to accelerate scientific progress and transform patient care. Please consider making a year-end gift to fuel our mission: friendsofcancerresearch.org/donate-friends-of-cancer-rese….
-
Friends of Cancer Research
@CancerResrch
How can global #cancer trials be designed when the standard of care (SOC) differs in every region? Our White Paper explores a 7-step structured "funnel approach" to comparator selection that progressively filters the broad landscape of potential SOCs. friendsofcancerresearch.org/wp-content/uploads/Multi-Regi…
-
Friends of Cancer Research
@CancerResrch
At Friends of Cancer Research, our mission is clear: accelerate the development of innovative therapies to bring lifesaving treatments to patients nationwide. Every contribution makes a meaningful difference in this critical work. Give today: friendsofcancerresearch.org/donate-friends-of-cancer-rese….
-
Friends of Cancer Research
@CancerResrch
Have you seen the latest manuscript from our ctMoniTR Project but aren’t sure what #ctdna is, why later time points matter, or how to interpret the findings? Read our companion blog to walk you through the science and what it means for cancer research: friendsofcancerresearch.org/blog/project-pulse-friends-ne….
-
Friends of Cancer Research
@CancerResrch
Next year, over two million Americans will face a cancer diagnosis. Ensuring they have access to cutting-edge treatments isn't just important—it's critical. Donate today and support our mission to speed lifesaving treatments to patients: friendsofcancerresearch.org/donate-friends-of-cancer-rese…. #cancerresearch
-
Friends of Cancer Research
@CancerResrch
How do we demonstrate each drug's meaningful benefit in combination therapy? Alternative trial designs—such as adaptive and 3-arm designs—can provide robust evidence for COE when factorial designs are not feasible. Learn more in our white paper: friendsofcancerresearch.org/wp-content/uploads/Assessing-….
-
Friends of Cancer Research
@CancerResrch
Read our latest quarterly Advocate Newsletter! Catch up on important developments in #cancerresearch, new projects from Friends of Cancer Research, take a look back at our 2025 Year in Review, and learn about the upcoming Spanish-language version of PfP: friendsofcancerresearch.org/blog/quarterly-advocacy-newsl….
-
Friends of Cancer Research
@CancerResrch
How can we accelerate drug development in #rarecancers while maximizing insights from every patient? Our new white paper explores seamless trial designs that are scientifically rigorous, operationally viable, and prioritize patient safety: friendsofcancerresearch.org/wp-content/uploads/Seamless-C…. #cancerresearch
-
Friends of Cancer Research
@CancerResrch
Want a meaningful way to use holiday downtime? Learn how drugs move from lab to FDA review, how patient voices have sparked real change, and how to effectively communicate with drug developers. Take the free advocacy education course at progressforpatients.org. #patientadvocacy
-
Friends of Cancer Research
@CancerResrch
Friends of Cancer Research is hosting a public meeting, Modernizing Oncology Endpoints: Pathways for Evidence and Policy, to review the current landscape and application of evolving early endpoints. View our agenda and register now to secure your spot: bit.ly/487Mv9B/.
-
Friends of Cancer Research
@CancerResrch
On behalf of everyone at Friends of Cancer Research, thank you for your continued partnership and support. As we approach 2026, please consider donating to support our mission of speeding life-saving treatments to patients: friendsofcancerresearch.org/donate-friends-of-cancer-rese….
#givingtuesday -
Friends of Cancer Research
@CancerResrch
How do patient perspectives strengthen #cancerresearch? During our Advocates Webinar, Advisory Advocates shared how their lived experiences as patients, survivors, and caregivers helped shape key discussions at the 2025 Annual Meeting. Read the recap: friendsofcancerresearch.org/blog/meeting-recap-advocates-….
-
Friends of Cancer Research
@CancerResrch
Have you seen the latest manuscript from our ctMoniTR Project but aren’t sure what #ctdna is, why later time points matter, or how to interpret the findings? Read our companion blog to walk you through the science and what it means for cancer research: friendsofcancerresearch.org/blog/project-pulse-friends-ne….
-
Friends of Cancer Research
@CancerResrch
Thank you to all who joined. You can watch this Advocate Webinar on-demand on our YouTube Channel: www.youtube.com/watch?v=AGp6LtUSK_w. Visit our events pages for information on our upcoming meetings: friendsofcancerresearch.org/events/.
-
Friends of Cancer Research
@CancerResrch
I learned about clinical equipoise—the idea that if evidence shows one trial arm is clearly ineffective or harmful, we do not enroll patients. - Carol Vallett, Advisory Advocate.
Watch the Advocate Webinar happening now on our YouTube: www.youtube.com/watch?v=AGp6LtUSK_w. -
Friends of Cancer Research
@CancerResrch
Every patient is precious and every data point is valuable. - Misha Mehta, Friends of Cancer Research Advisory Advocate, explains the value of seamless trials for rare cancer patients.
Watch our Advocate Webinar happening now on our YouTube channel: www.youtube.com/watch?v=AGp6LtUSK_w. -
Friends of Cancer Research
@CancerResrch
At our Annual Meeting, Kristin McJunkins highlighted the importance of the physician-patient relationship in clinical trials. Watch our Advocate Webinar, happening now, to learn about the real-world impact of the evolving treatment landscape on patients: www.youtube.com/watch?v=AGp6LtUSK_w.
-
Friends of Cancer Research
@CancerResrch
At our Annual Meeting, Carol Vallett emphasized the need to reduce burdens on patients participating in clinical trials. Learn more about how clinical trial design impacts patients and caregivers at our upcoming Advocate Webinar. Register here: friendsofcancerresearch.org/event/advocates-webinar-annua….
This media couldn't be displayed. See it on the original post. -
Friends of Cancer Research
@CancerResrch
Our ctMoniTR Project unites stakeholders to develop data supporting the use of #ctdna as an early endpoint, streamlining evidence generation and helping get safe treatments to patients faster. Read more in @TheCancerLetter: cancerletter.com/regulatory-news/20251024_1/.
-
Friends of Cancer Research
@CancerResrch
Missed our Annual Meeting? Watch it and our other meetings anytime on our YouTube page. Since 2020, we've been recording all our sessions, from our meeting on the future use of complex biomarkers to our most recent session on next-generation therapies: www.youtube.com/@FriendsofCancerResearch.
-
Friends of Cancer Research
@CancerResrch
What if we could predict cancer treatment success in weeks instead of months? Recent findings published in @jitcancer demonstrate that ctDNA reduction measured as early as 7 weeks post-treatment can indicate long-term survival benefits in aNSCLC patients: jitc.bmj.com/lookup/doi/10.1136/jitc-2025-012454.
-
Friends of Cancer Research
@CancerResrch
Our 2025 Annual Meeting showcased the power of collaboration, innovation, and patient partnership in advancing clinical research. Read the blog to explore seamless trial designs, evaluating combination therapies, and strengthening global studies designs: friendsofcancerresearch.org/blog/recap-friends-of-cancer-….
-
Friends of Cancer Research
@CancerResrch
Yesterday's Annual Meeting brought together industry leaders tackling the most pressing challenges in cancer research and drug development. #patientadvocates: Join us Monday, November 17, where we will dive deeper into these discussions! Register today: friendsofcancerresearch.org/event/advocates-webinar-annua….
-
Friends of Cancer Research reposted
The Cancer Letter
@TheCancerLetter
“Seamless trial designs can streamline rare cancer drug development by integrating multiple phases into a single, continuous framework. This approach ensures that every patient contributes meaningfully to evidence generation," says Bernat Navarro, science policy analyst @CancerResrch
cancerletter.com/the-cancer-letter/20251031_3/ -
Friends of Cancer Research
@CancerResrch
Thank you all for joining our 18th Annual Meeting! Learn more about our speakers, friendsofcancerresearch.org/2025-annual-meeting-speaker-b…, and read the white papers on our website: friendsofcancerresearch.org/event/friends-of-cancer-resea…. #friendsam25
-
Friends of Cancer Research
@CancerResrch
The worst clinical trials are those that don’t complete themselves. - Raymond Osarogiagbon (@BaptistOnline) speaking on our "Control Arm Selection for Multi-Regional Clinical Trials" panel #friendsam25
-
Friends of Cancer Research
@CancerResrch
Patterns of enrollment are a surrogate for applicability - Harpreet Singh (Precision for Medicine) speaking on our "Control Arm Selection for Multi-Regional Clinical Trials" panels. #friendsam25
-
Friends of Cancer Research reposted
Elad Sharon
@EladSharonMD
Final panel of the @CancerResrch Annual Meeting (#friendsam25) here in DC! Exciting discussion on control arm selection for multi-regional trials! You can watch live and even ask questions: friendsofcancerresearch.org/event/friends-of-cancer-resea…
-
Friends of Cancer Research
@CancerResrch
The US is positioned to continue leading biomedical innovation, but we can't take for granted the dynamics that enabled this. Research, discovery, commercialization, IP—all of these can be touched and impacted by policy changes. - Anna Abram (@akin_gump) #friendsam25
-
Friends of Cancer Research reposted
Elad Sharon
@EladSharonMD
Continuing to discuss some future policy perspectives for the @CancerResrch Annual Meeting (#friendsam25). You can still join live (or watch later): friendsofcancerresearch.org/event/friends-of-cancer-resea…
-
Friends of Cancer Research
@CancerResrch
We are close to figuring out how to move data efficiently, cutting down on expenses and reducing patient travel to trial sites. The goal will be to treat patients at their primary oncologist's site and get that data to health authorities. - Amy McKee (@AstraZeneca) #friendsam25
-
Friends of Cancer Research
@CancerResrch
With budget cuts hitting health and research sectors, public-private partnerships are essential to maintain innovation. - Roy Herbst (@YaleCancer) speaking on our Future Policy Perspectives Lunch Discussion #friendsam25
-
Friends of Cancer Research
@CancerResrch
We are taking a 35-minute lunch break. Stay connected or rejoin us at 1:20 PM ET for our Lunch Discussion – Future Policy Perspectives with Jeff Allen, Anna Abram, Remy Brim, Roy Herbst, and Amy McKee: www.youtube.com/watch?v=CDPGQniPj4o #friendsam25
-
Friends of Cancer Research
@CancerResrch
Every patient is unique. We need to work closely with patients and be transparent when inviting them to join trials. Reducing patient burden is essential, even seemingly small things like number of blood draws matter. - Carol Vallett, Advisory Advocate #friendsam25
-
Friends of Cancer Research
@CancerResrch
I would argue we need to bring more of these innovative oncology clinical trials to the community. You will see how drugs perform in the same environment where they will be administered post-approval. - Elad Sharon (@DanaFarber) #friendsam25
-
Friends of Cancer Research reposted
Chris White
@MucosalMelanoma
If your not currently watching this, #friendsam25 #focr
@CancerResrch Annual Meeting, register and log on. friendsofcancerresearch.org/event/friends-of-cancer-resea…
The 2nd session just started, “Trial Designs for Combination Drug Development”.
Link to White Paper 👇
friendsofcancerresearch.org/wp-content/uploads/Assessing-… -
Friends of Cancer Research
@CancerResrch
We need to view COE at a program level and not a single study output. The totality of data is not in itself sufficient, but it can still be valuable. - Gary Doherty (@AstraZeneca) speaking on our "Trial Designs for Combination Drug Development" panel #friendsam25
-
Friends of Cancer Research
@CancerResrch
Session 2: "Trial Designs for Combination Drug Development" starts at 11:40 AM. Watch on YouTube (www.youtube.com/watch?v=CDPGQniPj4o) and stay connected to the conversation using the hashtag #friendsam25
-
Friends of Cancer Research
@CancerResrch
"In the rare cancer space, there's constant pressure to deliver products quickly. However, it's crucial to pause and develop a comprehensive strategy. Early engagement with regulatory bodies is critical." - Lola Fashoyin-Aje (@Parexel) #friendsam25
-
Friends of Cancer Research
@CancerResrch
If you are limiting the number of trial sites, you have to consider that you may not receive enough patient enrollment for specific cancer subtypes. - Harindra Ranil Abeysinghe (@JNJNews) on our "Seamless Trial Designs for Rare Cancer Drug Development" panel #friendsam25
-
Friends of Cancer Research
@CancerResrch
"In this rare population more so than any other trial, every single patient is critical. You have to make every single patient count." - Christopher Turner (@nuvalent) speaking on our "Seamless Trial Designs for Rare Cancer Drug Development" panel #friendsam25
-
Friends of Cancer Research reposted
Elad Sharon
@EladSharonMD
Excellent opening panel at the @CancerResrch annual meeting (#friendsam25) here in #dc on Seamless Trial Designs for #rarecancers! Very exciting to think of these issues with broad policy implications! You can still watch live! secure-web.cisco.com/1-aSs6clrewX3E06VDfk44Zl1VLul-RmmZGX…
-
Friends of Cancer Research
@CancerResrch
Our 18th Annual Meeting has begun! Follow the conversation using the hashtag #friendsam25 and watch online on our YouTube channel: www.youtube.com/watch?v=CDPGQniPj4o
-
Friends of Cancer Research
@CancerResrch
Last chance to register! Join us tomorrow for our Annual Meeting to hear discussions on challenges and solutions in cancer research and drug development. Visit our website to register, explore panel topics, read white papers, and watch explainer videos: friendsofcancerresearch.org/event/friends-of-cancer-resea….
-
Friends of Cancer Research
@CancerResrch
New findings in @DrugInfoAssn TIRS show limited use of FDA’s Biomarker Qualification Program. Enhancements would support novel biomarker development, especially surrogate endpoints critical for bringing effective drugs to patients faster.
link.springer.com/article/10.1007/s43441-025-00889-6 -
Friends of Cancer Research
@CancerResrch
One week until our Annual Meeting. Register for this free event on 11/4 in-person in Washington, DC or virtually: friendsofcancerresearch.org/event/friends-of-cancer-resea…. Read the white papers to learn more about each panel and prepare for deeper discussions. #friendsam25
-
Friends of Cancer Research
@CancerResrch
Mark Stewart explores the third session of our Annual Meeting, “Control Arm Selection for Multi-Regional Clinical Trials,” focusing on practical, science-based strategies to guide control arm decisions that are regionally relevant and globally credible: www.youtube.com/watch?v=xO6Amsc_SLE.
-
Friends of Cancer Research
@CancerResrch
We submitted comments on @US_FDA's draft guidance for assessing overall survival (OS) in oncology trials—supporting clearer interpretation of interim OS analyses in benefit-risk evaluations. This work aligns with our Interim Overall Survival Project. friendsofcancerresearch.org/wp-content/uploads/Interim-OS….
-
Friends of Cancer Research
@CancerResrch
Watch as Hillary Andrews explains key concepts from our Annual Meeting session, "Trial Designs for Combination Drug Development,” which will focus on strategies for efficiently demonstrating each drug's contribution to oncologic combination therapies: www.youtube.com/watch?v=68WocyN1Cx0.
-
Friends of Cancer Research
@CancerResrch
Our Annual Meeting is just around the corner, and the conversations will not stop there. Join us on 11/17 for a free #patientadvocate webinar to explore key topics from the meeting on #cancerresearch, clinical trials, and regulation. Register today: friendsofcancerresearch.org/event/advocates-webinar-annua….
-
Friends of Cancer Research
@CancerResrch
Bernat Navarro delves into key topics from our Annual Meeting session, "Seamless Trial Designs for Rare Cancer Drug Development," exploring how to design scientifically rigorous and operationally viable seamless trials for rare disease: www.youtube.com/watch?v=o2MHv6dxMxo. #friendsam25
-
Friends of Cancer Research
@CancerResrch
RPT dosage optimization poses unique challenges. Our @US_FDA draft guidance comments support evidence-based strategies to maximize therapeutic benefit while ensuring patient safety. We commend FDA's leadership and look forward to continued collaboration: friendsofcancerresearch.org/wp-content/uploads/101525_Onc….
-
Friends of Cancer Research
@CancerResrch
Why conduct cancer clinical trials in community healthcare settings? Hear Dr. Bryan Faller from @MissouriBaptist explain how @LungMAP's success has benefited rural communities. Learn more about Lung-MAP's recent success: friendsofcancerresearch.org/event/lung-map-webinar-advoca…. #lcsm
-
Friends of Cancer Research
@CancerResrch
Congrats to our Advisory Advocate Judy Fitzgerald on being named a 2026 FORD Warrior in Pink. Learn about her work: bit.ly/3VUxJxl. Congrats to all the 2026 FORD Warriors in Pink. #patientadvocacy
-
Friends of Cancer Research reposted
Bernat Navarro
@bnserer
🚨 @CancerResrch is looking for a 2026 Science Policy Fellow to turn cutting-edge research into real-world impact for people with cancer.
Join our team to help shape policies that accelerate cancer research and improve patient care.
Apply here 👇
friendsofcancerresearch.org/job/2026-science-policy-fello… -
Friends of Cancer Research
@CancerResrch
We published a manuscript about our recent findings from the ctMoniTR Project. Read our companion blog that breaks down the concepts: friendsofcancerresearch.org/blog/project-pulse-friends-ne…. #cancerresearch #ctdna
-
Friends of Cancer Research
@CancerResrch
How can we speed up access to lifesaving #cellandgenetherapies? @US_FDA CBER held a virtual public listening session on using prior knowledge and platform approaches to accelerate development and approval of CGTS. Read our blog about the event: friendsofcancerresearch.org/blog/stakeholder-connect-insi….
-
Friends of Cancer Research reposted
Janice Cowden
@JaniceTNBCmets
Appreciate projects like this, thanks to @CancerResrch, & project partners, for moving the needle forward in clinical trial design that will ultimately benefit people diagnosed with #cancer!
#ecapilotproject
#bcsm
friendsofcancerresearch.org/eca/ -
Friends of Cancer Research
@CancerResrch
The External Control Arm (ECA) Project will identify best practices for using clinical trial data and #realworlddata to construct ECAs, which can aid in evaluating treatments for patients with rare or hard-to-treat disease: friendsofcancerresearch.org/eca/.
-
Friends of Cancer Research
@CancerResrch
Explore the breadth of work, access white papers, and watch full video recordings from previous Annual Meetings: friendsofcancerresearch.org/friends-of-cancer-research-an…. Dive into topics like pragmatic clinical trial designs, updating drug labels, and optimizing the use of Accelerated Approval. #cancerresearch
-
Friends of Cancer Research
@CancerResrch
This year’s Ellen V. Sigal Advocacy Award went to Peter Marks for his steadfast commitment to advancing public health through scientific integrity and regulatory excellence. Watch the award video on our YouTube channel: www.youtube.com/watch?v=5ZmoVliIMjE.
-
Friends of Cancer Research
@CancerResrch
This year’s Marlene A. Malek Public Service Award was awarded to Mark McClellan for his exceptional leadership and enduring contributions to public health. Watch the video on our YouTube channel: www.youtube.com/watch?v=KIHW0agwDDI
-
Friends of Cancer Research
@CancerResrch
Through collaborations with federal health agencies, academia, industry, and patient advocates, Friends of Cancer Research generates scientific evidence to shape public policy, speeding life-saving treatments to patients. Learn more: friendsofcancerresearch.org/policy-priorities/.
-
Friends of Cancer Research
@CancerResrch
Mark Stewart, VP, Science Policy, will be speaking at @HansonWade’s 15th World Clinical Biomarkers & Companion Diagnostics Summit, presenting findings from the Digital PATH project and be on panel discussions on H&E-Based Molecular Profiling and companion diagnostics. #worldcdx
-
Friends of Cancer Research
@CancerResrch
New ctMoniTR Project research published in @jitcancer shows that reductions in #ctdna levels on treatment are strongly associated with improved overall survival (OS) in patients with advanced non-small cell lung #cancer (aNSCLC): jitc.bmj.com/lookup/doi/10.1136/jitc-2025-012454.
-
Friends of Cancer Research
@CancerResrch
Thank you to everyone who joined our 29th Annual Cancer Leadership Awards Celebration! It was truly such a fun evening hosting a visionary group of people dedicated to advancing oncology for all patients. Thank you to the sponsors who made the evening possible!
-
Friends of Cancer Research
@CancerResrch
How can patients access safe, effective #cellandgenetherapies earlier? Ahead of today’s @US_FDA CBER OTP Public Listening Meeting, we submitted recommendations to leverage prior regulatory knowledge, streamline development, and expand patient access: friendsofcancerresearch.org/publication/public-comments-f….
-
Friends of Cancer Research
@CancerResrch
Research funded by the NIH is the cornerstone of new advances against the toughest diseases we face, and it fuels jobs and economic growth across the United States. Join the 13th Annual #rallymedres by participating in the National Day of Action at rallyformedicalresearch.org.
-
Friends of Cancer Research
@CancerResrch
Just released! Our Q3 2025 Advocacy Newsletter highlights the ai.RECIST project and recent blog posts on the July 17 ODAC hearing and PDUFA reauthorization. Read the latest issue and subscribe today! friendsofcancerresearch.org/blog/quarterly-advocacy-newsl… #patientadvocacy
-
Friends of Cancer Research reposted
Lung-MAP
@LungMAP
A recording of the May 14th @LungMAP Advocacy Webinar is online at www.youtube.com/watch?v=sFQh17pS64Y.
Featuring a panel discussion with @CancerResrch's Ryan Hohman, @LUNGevity's @aesfCEO, Marcia Horn of @METCrusaders, and @lcfamerica's Kim Norris. #lcsm #lungcancer @SWOG @FNIH_Org -
Friends of Cancer Research
@CancerResrch
We submitted comments on the @US_FDA draft guidance, “Development of Cancer Drugs for Use in Novel Combination.” This guidance represents an important step toward addressing the challenges of evaluating contribution of effect in combination therapies: www.regulations.gov/comment/FDA-2025-D-1071-0007
-
Friends of Cancer Research
@CancerResrch
Mark Stewart will join the @US_FDA-@AACR Workshop: Approach to Novel Oncology Endpoint Development, highlighting learnings and opportunities for endpoint development, emphasizing the need for deliberate collaboration and standardization to speed the acceptance of ctDNA endpoints.
-
Friends of Cancer Research
@CancerResrch
Katherine Cheng is lacing up her gloves in support of @CancerResrch. Her commitment to cancer research, both professionally and as part of this amazing charity event, are advancing the fight for the cure that we’re all in together.
Support here: haymakersforhope.org/events/boxing/belles-of-the-brawl-20… -
Friends of Cancer Research
@CancerResrch
Our progressforpatients.org course is a free, online educational program designed to empower patients, advocates, and caregivers with the tools to effectively engage with researchers, developers, and regulators. Sign-up today! #patientadvocacy
-
Friends of Cancer Research
@CancerResrch
47 leading patient orgs are calling on House appropriators to protect robust federal funding for medical research in FY26, because cures can’t wait.
Read the coalition letter + details: unitedforcures.org/47-leading-patient-advocacy-organizati…
#medicalresearch #cures #appropriations -
Friends of Cancer Research
@CancerResrch
Register for our Annual Meeting on November 4th to hear experts discuss challenges in combination drug development and solutions, such as adaptive trial designs and strategies for evaluating each agent’s contribution of effect: friendsofcancerresearch.org/event/friends-of-cancer-resea…. #friendsam25 #oncology
-
Friends of Cancer Research
@CancerResrch
Our 2025 Annual Meeting will tackle key challenges in oncology drug development. Experts will discuss trial design for rare diseases, combination therapies, and control arm selection in multi-regional trials. Register for this free event: friendsofcancerresearch.org/event/friends-of-cancer-resea…. #friendsam25
-
Friends of Cancer Research
@CancerResrch
The @US_FDA and @ASCO released principles on dose optimization and tolerability. Expanding on Project Optimus, which our work supports, they urged modern trial designs, stronger tolerability data, and broader eligibility. Read the story at @RAPSorg: bit.ly/4oM9A9d.
-
Friends of Cancer Research
@CancerResrch
Friends of Cancer Research and @MMSHoldings are partnering to improve interpretation of interim OS data in oncology trials. This effort will support decision-making around immature OS data and strengthen confidence in the Accelerated Approval pathway: friendsofcancerresearch.org/news/friends-of-cancer-resear….
-
Friends of Cancer Research
@CancerResrch
Jeff Allen will be presenting at @CHI_Healthtech #ngdx on 8/20. “Biomarker Harmonization and Use of AI-Enabled Digital Pathology Tools” and “ctDNA as Early Response Indicator” will explore the future of precision medicine in cancer research and treatment. www.nextgenerationdx.com
-
Friends of Cancer Research
@CancerResrch
Cancer drug development has never been more complex. Join us on Nov. 4 at our Annual Meeting. Industry leaders will discuss trial designs for rare diseases, combination drug development, and multi-regional clinical trials. Register today: friendsofcancerresearch.org/event/friends-of-cancer-resea…!
#friendsam25 -
Friends of Cancer Research
@CancerResrch
Tumor measurements are critical for #cancer therapy efficacy, but RECIST assessments can be biased and inconsistent. Our ai.RECIST Project explores how AI tools could provide consistent measurements and reduce review times, while maintaining standards. friendsofcancerresearch.org/ai-recist/
-
Friends of Cancer Research
@CancerResrch
The success of early PD(L)1 trials relied on multiple expansion cohorts leading to FDA approval in a few #cancer types. At our Annual Meeting, we will discuss single-arm designs that prioritize patient access and regulatory confidence: Register here: friendsofcancerresearch.org/event/friends-of-cancer-resea….
-
Friends of Cancer Research
@CancerResrch
While early endpoints in #oncology trials enable faster approvals, challenges arise when interim OS data conflicts with positive signals. Our #2024am white paper explores recent learnings and proposes frameworks and strategies for interpreting interim OS: friendsofcancerresearch.org/wp-content/uploads/Enhancing-…
-
Friends of Cancer Research
@CancerResrch
Our ctMoniTR Project manuscript in @CCR_AACR demonstrated that #ctdna clearance is associated with improved overall survival in patients with aNSCLC treated with TKIs. These findings are a foundational step toward using ctDNA as an intermediate endpoint. friendsofcancerresearch.org/news/new-findings-from-the-fr….
-
Friends of Cancer Research
@CancerResrch
Register for our Annual Meeting in-person or virtual on November 4 at 10AM. Hear experts explore this year’s topics in single-arm trial designs, trial designs for combination drug development, and control arm selection for multi-regional clinical trials. friendsofcancerresearch.org/event/friends-of-cancer-resea….
-
Friends of Cancer Research
@CancerResrch
Building trust in #ai for #cancercare requires benchmarks that capture real-world representativeness and clinical realities. In our response to @theNCI, we outline key priorities to help AI tools meet regulatory standards and deliver reliable results: friendsofcancerresearch.org/wp-content/uploads/Friends-of….
-
Friends of Cancer Research
@CancerResrch
FDA-approved cancer drugs frequently require additional postmarketing studies to address outstanding safety and efficacy questions. Our PMR/Cs dashboard analyzes novel #oncology therapies approved from 2012-2024, revealing postmarketing landscape trends: friendsofcancerresearch.org/pmr-cs-for-novel-oncology-the….
-
Friends of Cancer Research
@CancerResrch
Lost in the language of drug development? Our progressforpatients.org course explains key regulatory terms like "Breakthrough Therapy designation" in plain language. Empower your advocacy with knowledge. #patientadvocacy
-
Friends of Cancer Research
@CancerResrch
.@US_FDA’s ODAC voted the benefit-risk profile of 2 #multiplemyeloma combination therapies is not favorable due to concerns around high-rates of toxicity at the proposed dosages, inadequate dose optimization, and poor representation of U.S. patients.
friendsofcancerresearch.org/blog/stakeholder-connect-insi… -
Friends of Cancer Research
@CancerResrch
Many promising #celltherapies for rare diseases stall due to regulatory, manufacturing and access barriers. Our white paper proposes fit-for-purpose CMC frameworks, alternative manufacturing models and cost recovery approaches to expand access. friendsofcancerresearch.org/wp-content/uploads/Regulatory…
-
Friends of Cancer Research
@CancerResrch
A @CancerResrch and @ASCO task force found that #clinicaltrial flexibilities can be implemented without compromising data quality, suggesting decentralized elements maintain standards while improving access and increasing enrollment: ascopubs.org/doi/full/10.1200/OA-25-00021.
-
Friends of Cancer Research
@CancerResrch
Stay informed on the latest developments in #cancerresearch, policy, and regulatory science. Sign up for our newsletter for research updates, event announcements, and opportunities to engage in patient advocacy efforts that drive change: focr.app.neoncrm.com/forms/sign-up-form.
-
Friends of Cancer Research
@CancerResrch
We are encouraged by the news that the @US_FDA and @NIH released a glossary of RWD/#rwe terms to help standardize definitions to strengthen communication across studies using innovative trial designs and data sources. Read the full story at @RAPSorg: www.raps.org/News-and-Articles/News-Articles/2025/6/FDA,-….
-
Friends of Cancer Research
@CancerResrch
Pragmatic #clinicaltrial elements (i.e. broadening eligibility criteria, utilizing real-world evidence, and embedding trials in routine care) can reduce patient burden, enhance generalizability, and maintain scientific rigor. Read more: www.esmorwd.org/article/S2949-8201(24)00043-2/fulltext.
-
Friends of Cancer Research
@CancerResrch
Using publicly available data from review documents on Drugs@FDA, we created a dashboard to assess how four of @US_FDA’s expedited programs impact the time it takes for new cancer therapies to be approved. Explore the dashboard: friendsofcancerresearch.org/expedited-programs-and-new-ap…. #acceleratedapproval
-
Friends of Cancer Research
@CancerResrch
.@balasubramaniac, @Path_AI, on how advancing AI/ML-enabled #digitalpathology tools requires collaboration to enhance accuracy & reproducibility. Our discussion guide explores how use of reference datasets can be an efficient approach toward validation: friendsofcancerresearch.org/wp-content/uploads/Considerat….
-
Friends of Cancer Research
@CancerResrch
#patientadvocates, your Q2 Advocate Newsletter is here! Get highlights from our recent conference, trends in Accelerated Approval and breaking news in cancer research. Read the latest issue and subscribe to stay up to date on cancer advocacy and research: friendsofcancerresearch.org/blog/quarterly-advocacy-newsl….
-
Friends of Cancer Research
@CancerResrch
Attending @IAmBiotech International Convention? Jeff Allen will discuss recent trends in Accelerated Approvals and how the mechanism continues to support timely patient access to treatments for serious illness. #bio2025
-
Friends of Cancer Research
@CancerResrch
New framework developed in partnership with @parkerici highlights the need for flexible approaches to efficiently characterize & advance cell therapies. This will enable rapid prioritization of enhanced T-cell constructs.
Read @jitcancer manuscript here: jitc.bmj.com/content/13/6/e011301 -
Friends of Cancer Research
@CancerResrch
Attending #dia2025? Hillary Andrews chairs a panel on validation approaches and regulatory flexibilities for rare biomarker diagnostics, which will discuss strategies for leveraging alternative data sources. Learn more about this work: friendsofcancerresearch.org/news/new-analysis-describes-f….
-
Friends of Cancer Research
@CancerResrch
Mark Stewart, VP of Science Policy, will join a panel at @DrugInfoAssn's Annual Meeting to discuss AI/ML-enabled diagnostic tools, exploring key challenges, opportunities, and regulatory considerations. Learn more about this work: friendsofcancerresearch.org/digital-pathology/.
#dia2025 -
Friends of Cancer Research
@CancerResrch
A new analysis published in @ASCO #jcooa finds that flexibilities implemented in cancer clinical trials during the COVID-19 pandemic did not compromise data quality, supporting the broader adoption of decentralized trial elements.
Read the full analysis: ascopubs.org/doi/full/10.1200/OA-25-00021 -
Friends of Cancer Research
@CancerResrch
Jeff Allen will join two panels at @DrugInfoAssn's Annual Meeting to discuss novel approaches for testing and manufacturing cell and gene therapies and the accelerated approval program's role in delivering treatments for serious illnesses. See you at #dia2025!
-
Friends of Cancer Research
@CancerResrch
In 2020, we released a blueprint for strengthening the #acceleratedapproval pathway while preserving scientific rigor. Recognizing its critical importance, Congress codified these priorities in the 2023 Consolidated Appropriations Act. Learn more: friendsofcancerresearch.org/blog/30-years-of-accelerated-….
-
Friends of Cancer Research
@CancerResrch
Yesterday, Jeff Allen, President and CEO, participated in a Cell and Gene Therapy Roundtable hosted by @US_FDA Leadership to discuss enhanced regulatory support to advance novel treatments. Watch the full roundtable at www.youtube.com/live/0qDhRtnHXdU.
-
Friends of Cancer Research
@CancerResrch
#precisionmedicine enables biomarker-specific cancer therapies, but rare biomarkers pose CDx validation challenges due to limited samples.
Our @DrugInfoAssn article proposes FDA guidance on alternative sample use to help developers overcome these hurdles: idp.springer.com/transit?redirect_uri=https%3A%2F%2Flink.…. -
Friends of Cancer Research
@CancerResrch
Tomorrow, Jeff Allen, President and CEO, will be attending the @US_FDA Cell and Gene Therapy Roundtable. We look forward to working with newly appointment FDA leadership and discussing the evolving regulatory landscape for cell and gene therapies.
www.fda.gov/vaccines-blood-biologics/workshops-meetings-c… -
Friends of Cancer Research
@CancerResrch
We had a great time at @ASCO Annual Meeting! From groundbreaking research to connecting with colleagues, this meeting reinforced the power of uniting research efforts and working together to advance cancer treatments. We are already looking forward to next year! #asco2025
-
Friends of Cancer Research reposted
Stephen V Liu, MD
@StephenVLiu
Results from SWOG Pragmatica-Lung study at #asco25. Previously treated NSCLC randomized to pembrolizumab + ramucirumab vs SOC. Pragmatic design with simple protocol and ICF improved accrual, diversity in demographics. But no OS difference here with OS HR 0.99.
-
Friends of Cancer Research reposted
SWOG Cancer Research Network
@SWOG
Results of the @SWOG S2000 phase 2 trial in patients with symptomatic #melanoma brain metastases are reported today at #asco25 in an oral presentation. Late-breaking abstract LBA9507: meetings.asco.org/abstracts-presentations/244151
-
Friends of Cancer Research reposted
Astellas Pharma US
@AstellasUS
Patient Advocacy Organization (PAO) Action Week returns next week for its second year! This collaborative initiative is dedicated to raising awareness and connecting patients to relevant PAOs.
Follow #paoactionweek and visit www.paoactionweek.com for more info. -
Friends of Cancer Research
@CancerResrch
Pragmatica-Lung has effectively reduced barriers to clinical trial participation and decreased clinical trial staff burden, showing its efficacy as a potential model for future studies.
New findings announced at #asco25: www.asco.org/abstracts-presentations/ABSTRACT513098 -
Friends of Cancer Research
@CancerResrch
Our latest study shows that within early RECIST categories (i.e., SD, PR at first RECIST), ctDNA clearance associates with improved OS in aNSCLC TKI treatment.
Read the study here: aacrjournals.org/clincancerres/article/doi/10.1158/1078-0…. -
Friends of Cancer Research reposted
Lung-MAP
@LungMAP
Results from @LungMAP sub-study S1900E will be presented as a rapid oral abstract (8515) at #asco25 on Mon, June 2, 9:00am CT, by @SukiPaddaMD. Abstract is at meetings.asco.org/abstracts-presentations/246551. #lcsm
@CancerResrch @FNIH_Org @ReckampK @drgandara
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
#asco25 @ASCO #nsclc #lcsm
S1900E (Abstract 8518): Sotorasib efficacy by co-mutations in previously treated KRAS G12C-mut NSCLC:
• 🎯 ORR: 35% (TP53 co-mut) vs 16% (STK11 co-mut)
• 📊 Disease control rate: 78% vs 60%
• ⏳ Median PFS: 5.7 vs 4.1 months
• 🕒 Median OS: 18.2 vs 8.0 months
• ⚠️ STK11 co-mutation may reduce sotorasib efficacy
• ✅ Safety profile consistent with prior reports
Important insights into biomarker-driven KRAS G12C therapy!
@SukiPadda @SWOG @HosseinBorghaei @JulieBrahmer -
Friends of Cancer Research
@CancerResrch
How can AI enhance cancer trials? Join Mark Stewart at #asco25 for "Accelerating Cancer Trials with AI" to explore how AI can improve trial design and representativeness. Gain practical insights on how to implement AI responsibly.
-
Friends of Cancer Research
@CancerResrch
Attending @ASCO's Annual Meeting? Say hi if you see us there! We are excited to join this year’s meeting and look forward to connecting with colleagues and sharing insights! #asco25
-
Friends of Cancer Research
@CancerResrch
Read the recap of our #patientadvocate webinar of the "Next Generation Therapies" meeting to learn policy opportunities that overcome current barriers and ensure that patients can access the potentially transformative benefits of #celltherapies: friendsofcancerresearch.org/blog/meeting-recap-unlocking-….
-
Friends of Cancer Research reposted
International Alliance for Personalised Medicine
@united4cancer
🧪 MRD testing is a game-changer—so why are most patients still waiting?
At #icpc2025, Session 3 brings global experts to tackle MRD equity, regulation & access.
🗓️ May 30 | 2 PM
📍 Chicago
🔗 Register here: forms.office.com/r/DkPpNuDdYW
#ctdna #oncology -
Friends of Cancer Research
@CancerResrch
Is the @US_FDA Accelerated Approval pathway working as intended? Our analysis of all 344 approvals shows most treatments are verified, confirmatory trials progress on track, and clinical benefit is confirmed within four years. Explore our full analysis friendsofcancerresearch.org/blog/30-years-of-accelerated-…
-
Friends of Cancer Research
@CancerResrch
And that's a wrap! Unlocking Next-Generation Therapies Meeting Recap will be available on demand on our YouTube channel: www.youtube.com/live/Yf4u04__U-Y?cbrd=1&ucbcb=1. Thanks for joining!
-
Friends of Cancer Research
@CancerResrch
The fact that the media continues to cover cell-based therapies is an indication that people are interested and intrigued about these innovative treatments.
#cartcelltherapy #cgtfriends -
Friends of Cancer Research
@CancerResrch
To expand CAR T-cell therapies to rural areas, we must develop robust infrastructure, include more telemedicine options, and partner with oncology experts in urban areas. www.youtube.com/live/Yf4u04__U-Y
#cgtfriends #cartcelltherapy -
Friends of Cancer Research
@CancerResrch
Bringing CAR T-cell therapies to community and rural hospitals can increase access to more patients. Join the conversation: www.youtube.com/live/Yf4u04__U-Y.
#cgtfriends #celltherapy -
Friends of Cancer Research
@CancerResrch
Starting now! Our advocate-focused webinar recapping the Unlocking Next-Generation Therapies meeting. Join the live webinar: www.youtube.com/watch?v=Yf4u04__U-Y. #cgtfriends #cellandgenetherapy
-
Friends of Cancer Research
@CancerResrch
Rare #cancer biomarkers make CDx validation challenging due to limited samples. Our new @DrugInfoAssn article proposes FDA guidance recommendations to clarify appropriate use of alternative samples—ensuring patient access to safe and effective treatments: idp.springer.com/transit?redirect_uri=https%3A%2F%2Flink.…
-
Friends of Cancer Research reposted
Joan Mancuso
@JoanMancusoMBC
Advocacy community - Learn more about cell and gene therapies and how we can support research and policy for these innovative therapies to reach patients? Join
@CancerResrch on 5/21 Register here:
friendsofcancerresearch.org/event/unlocking-next-generati…
#cgtfriends -
Friends of Cancer Research
@CancerResrch
Join our May 21 advocate-focused webinar "Unlocking Next-Generation Therapies Meeting Recap" to hear experts discuss key takeaways and challenges limiting cell-based therapies for rare diseases: friendsofcancerresearch.org/event/unlocking-next-generati…. Submit your questions during registration for the live Q&A!
-
Friends of Cancer Research
@CancerResrch
We are deeply saddened to learn of Former President @JoeBiden's cancer diagnosis. Our thoughts are with him and his family as they navigate the road ahead. His lifetime of service and determination remain an example to all of us.
-
Friends of Cancer Research
@CancerResrch
Our joint meeting with @parkerici addressed industry challenges in #celltherapy manufacturing and highlighted key solutions: regulatory flexibility, cross-sector collaboration, and alternative business models.
Watch the full meeting: www.youtube.com/live/hkQfiGWks54?cbrd=1&ucbcb=1
#cgtfriends -
Friends of Cancer Research
@CancerResrch
Join us on May 21 for “Unlocking Next-Generation Therapies Meeting Recap: Sharing Next Steps and Opportunities with Advocates.” This webinar will explore unique challenges facing cell-based therapies and opportunities for #patientadvocacy: friendsofcancerresearch.org/event/unlocking-next-generati….
#cgtfriends -
Friends of Cancer Research
@CancerResrch
Increasing access to #clinicaltrials can include decentralized study designs, developing just-in-time clinical trials, and offering financial incentives or removing financial barriers.
Thank you for attending the @LungMAP Webinar. Watch live or on-demand: www.youtube.com/watch?v=sFQh17pS64Y -
Friends of Cancer Research
@CancerResrch
Many states, such as Louisiana and Illinois, are requiring insurance companies to cover cancer biomarker testing. Watch the Advocacy Webinar live and on-demand for @LungMAP updates: www.youtube.com/watch?v=sFQh17pS64Y #lcsm #biomarkertesting
-
Friends of Cancer Research
@CancerResrch
Advancements in clinical trials have enabled therapies to become first-line treatments. In the last 15 years, clinical trials have been the gold standard. Watch the @LungMAP Advocacy Webinar live at www.youtube.com/watch?v=sFQh17pS64Y. #lcsm #lungcancer
-
Friends of Cancer Research
@CancerResrch
.@LungMAP allows patients to be enrolled in clinical trials conducted at small sites, which leads to better outcomes. Watch the webinar live and on-demand: www.youtube.com/watch?v=sFQh17pS64Y
#lcsm #luncancer -
Friends of Cancer Research
@CancerResrch
Starting now! @LungMAP Advocacy Webinar: Advocating, Accelerating, and Amplifying Lung Cancer Discovery. Join the live webinar: friendsofcancerresearch.org/event/lung-map-webinar-advoca…. #lcsm #lungcancer
-
Friends of Cancer Research
@CancerResrch
Only two days left to register for “Advocating, Accelerating, and Amplifying Lung Cancer Discovery!" Hear from expert and patient advocates on @LungMAP trial updates, challenges in traditional clinical trial, and opportunities for patient engagement. friendsofcancerresearch.org/event/lung-map-webinar-advoca….
-
Friends of Cancer Research
@CancerResrch
That's a wrap! Thank you to our speakers, our partner, @parkerici, and all of our in-person and virtual attendees. The meeting will be available on-demand via our YouTube channel: youtube.com/live/hkQfiGWks54. #cgtfriends
-
Friends of Cancer Research
@CancerResrch
Session 2: 'Manufacturing Strategies to Support Access to Cell-Based Therapies' is now underway. Whether joining us in person or via livestream, submit your questions at app.sli.do/event/9gfcCxw8wXQ2B5ek7vVyXt.
#cgtfriends #celltherapy -
Friends of Cancer Research
@CancerResrch
You have to be thoughtful on striking a balance between speed and rigor so that you can meet the goal of helping as many patients as possible.
#cgtfriends #celltherapy -
Friends of Cancer Research
@CancerResrch
We are back from break with a lunch keynote. As a reminder, you can watch virtually at bit.ly/4iXowgx. #cgtfriends #celltherapy
-
Friends of Cancer Research
@CancerResrch
Given our current cost structure, how can we sustain innovation, particularly in #raredisease with limited patient populations? We must evolve our models to address these unique challenges. #cgtfriends
-
Friends of Cancer Research
@CancerResrch
We must explore alternative private-sector business models that accept more modest—yet still positive—returns to maintain #celltherapy development cycles...and this requires tapping into diverse capital sources beyond traditional investment channels. #cgtfriends
-
Friends of Cancer Research
@CancerResrch
How can we create incentives for alternative development pathways for #celltherapy when profitability is absent? What mechanisms might enable earlier cost recovery to make these innovations viable? - Kristen Hege #cgtfriends
-
Friends of Cancer Research
@CancerResrch
Despite their effectiveness, #celltherapies remain prohibitively expensive to develop—often costing hundreds of millions of dollars—creating significant barriers to patient access.
Crystal Mackall, @Stanford, kicks off the first session with a presentation. #cgtfriends -
Friends of Cancer Research
@CancerResrch
Session 1, Advancing Regulatory Frameworks for Cell-Based Therapies, has begun! Watch virtually at bit.ly/4iXowgx! #cgtfriends
-
Friends of Cancer Research
@CancerResrch
One hour until our joint meeting with @parkerici: "Unlocking Next-Generation Therapies." Join virtually at bit.ly/4iXowgx and follow live coverage using #cgtfriends.
-
Friends of Cancer Research reposted
Allogene Therapeutics
@AllogeneTx
Excited to have our CTO Ben Beneski speaking on a panel at the @CancerResrch Cell Therapy Meeting on May 9! Looking forward to discussing manufacturing strategies to support access to cell-based therapies and adaptable manufacturing models. #cancerresearch #cart #cgtfriends $ALLO
Register For the Event: friendsofcancerresearch.org/event/unlocking-next-generati… -
Friends of Cancer Research
@CancerResrch
Only 3 days left until "Unlocking Next-Generation Therapies," our joint meeting with @parkerici on 5/9! Ahead of the event, read our White Paper outlining regulatory, manufacturing, and cost recovery strategies to expand access for cell-based therapies: friendsofcancerresearch.org/wp-content/uploads/Regulatory…
-
Friends of Cancer Research
@CancerResrch
Register for “Advocating, Accelerating, and Amplifying #lungcancer Discovery!" Join us on May 14 for a @LungMAP webinar featuring recent trial updates, challenges to the traditional clinical trial landscape, and opportunities for patient engagement. friendsofcancerresearch.org/event/lung-map-webinar-advoca…
-
Friends of Cancer Research
@CancerResrch
We are proud to support @bremfoundation's Annual Luncheon Empower Hour, celebrating their work and honoring Impact and Leadership Awards recipients for expanding cancer screening access.
#bremempowerhour2025 -
Friends of Cancer Research
@CancerResrch
Manufacturing is a critical hurdle for advancing #celltherapies. Our 2nd panel at “Unlocking Next-Generation Therapies” will explore solutions for reducing production costs and supporting scalable, adaptable manufacturing models. Register: friendsofcancerresearch.org/event/unlocking-next-generati…
-
Friends of Cancer Research
@CancerResrch
#patientadvocates: Curious about cell-based therapies? Hear from experts on May 21 as they discuss the future of cell-based therapies , including challenges impeding progress, clinical implications, and opportunities for patient advocacy. Register today: friendsofcancerresearch.org/event/unlocking-next-generati….
-
Friends of Cancer Research
@CancerResrch
The first “Unlocking Next-Generation Therapies” panel will explore challenges in developing cell-based therapies for rare patient populations and identify potential solutions to address gaps in development and access. Register today: friendsofcancerresearch.org/event/unlocking-next-generati… #celltherapy
-
Friends of Cancer Research reposted
Brem Foundation
@bremfoundation
We’re incredibly grateful to @CancerResrch for standing with us as an Emerald Sponsor for Empower Hour 2025. Their support strengthens our ability to champion the critical education, access programs, and advocacy needed for early detection of breast cancer.
-
Friends of Cancer Research
@CancerResrch
Friends of Cancer Research study in @CCR_AACR assessed the relationship between #ctdna clearance with overall survival; findings indicate ctDNA's potential as an intermediate endpoint in drug development. aacrjournals.org/clincancerres/article/doi/10.1158/1078-0…
#ctdnafriends -
Friends of Cancer Research
@CancerResrch
The @AACR Annual Meeting has kicked off! We are excited to see sessions focused on ctDNA-based early endpoints and optimizing regulatory approaches. It is a powerful reminder of the research community's shared commitment to accelerating research and advancing treatments. #aacr25
-
Friends of Cancer Research
@CancerResrch
At our upcoming “Unlocking Next-Generation Therapies” meeting on Friday, May 9, a lunch keynote will feature discussion on anticipated cell-based therapy breakthroughs and address critical bottlenecks. Register to join in-person or virtual: friendsofcancerresearch.org/event/unlocking-next-generati… #celltherapy
-
Friends of Cancer Research reposted
Guardant Health
@GuardantHealth
Findings in @CCR_AACR assessed the relationship between #ctdna change and early RECIST measurements with overall survival and progression-free survival.
Access the manuscript: aacrjournals.org/clincancerres/article/doi/10.1158/1078-0…
#ctdnafriends
Friends of Cancer Research
@CancerResrch
New @CancerReserch findings in @CCR_AACR aggregating and assessing 8 clinical trials of patients with #ansclc treated with TKI indicate circulating tumor DNA (#ctdna) clearance on treatment is associated with improved overall survival.
Learn more: aacrjournals.org/clincancerres/article/doi/10.1158/1078-0… -
Friends of Cancer Research reposted
Alex Yu
@JAlexYu
The next leap of faith in cell therapies. Look forward to a productive meeting in DC @cancerresrch @parkerici friendsofcancerresearch.org/event/unlocking-next-generati…
-
Friends of Cancer Research
@CancerResrch
#biomarkertesting is crucial for guiding #cancer treatment decisions. Through our HRD Harmonization and Digital PATH Projects, our 2024 Scientific Report highlights the need for standardization as diagnostic technologies become increasingly sophisticated. friendsofcancerresearch.org/wp-content/uploads/Friends-Sc…
-
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
So excited to see this work published!!
Friends of Cancer Research
@CancerResrch
New @CancerReserch findings in @CCR_AACR aggregating and assessing 8 clinical trials of patients with #ansclc treated with TKI indicate circulating tumor DNA (#ctdna) clearance on treatment is associated with improved overall survival.
Learn more: aacrjournals.org/clincancerres/article/doi/10.1158/1078-0… -
Friends of Cancer Research
@CancerResrch
New @CancerReserch findings in @CCR_AACR aggregating and assessing 8 clinical trials of patients with #ansclc treated with TKI indicate circulating tumor DNA (#ctdna) clearance on treatment is associated with improved overall survival.
Learn more: aacrjournals.org/clincancerres/article/doi/10.1158/1078-0… -
Friends of Cancer Research
@CancerResrch
The @LungMAP Accrual Enhancement Committee is hosting the "Advocating, Accelerating, and Amplifying Lung Cancer Discovery" webinar on May 14. Learn about clinical trial updates, Lung-MAP's advantages, and patient engagement opportunities. Register today: friendsofcancerresearch.org/event/lung-map-webinar-advoca…
-
Friends of Cancer Research
@CancerResrch
Using engineered T-cells, scientists have created therapies that better detect and treat #cancer. Watch our video to learn about CAR-T #celltherapies and join fellow patient advocates on May 21 to explore how manufacturing challenges impact patient access. friendsofcancerresearch.org/event/unlocking-next-generati…
This media couldn't be displayed. See it on the original post. -
Friends of Cancer Research reposted
Lung-MAP
@LungMAP
Patients with #lungcancer enrolling to @LungMAP can now be matched to a targeted treatment trial based on past genomic testing, without submitting new tumor or blood samples, making Lung-MAP 3.0 available to more patients at a wider range of clinical sites
www.swog.org/news-events/news/2025/04/16/lung-map-30-expa… -
Friends of Cancer Research
@CancerResrch
Can #ai based imaging tools improve tumor measurements? Our ai.RECIST Project will answer that question, providing a greater understanding of tool performance & establishing validation approaches to support their use in future studies.
Visit: friendsofcancerresearch.org/ai-recist/
#airecist -
Friends of Cancer Research
@CancerResrch
The ctDNA Portfolio develops an aligned strategy for generating evidence to support using changes in #ctdna levels as an intermediate endpoint. Our Step 1 @JCOPO_ASCO manuscript demonstrates the value of ctDNA as an early indicator of treatment benefit.
ascopubs.org/doi/full/10.1200/PO.21.003 -
Friends of Cancer Research
@CancerResrch
At the #sxsw panel, ‘Entrepreneurship at the Speed of Innovation’, Our President & CEO, Jeff Allen, @PatGarciaGonzal, CEO of @themaxfndn, and Mark Lanasa, CMO of Solid Tumors (@BeOneMedicines) explored some of the latest innovations in #diagnostictesting: youtu.be/tfZnMIS5RxI
-
Friends of Cancer Research
@CancerResrch
In response to @US_FDA's draft guidance on #ai to Support Regulatory Decision-Making for Drug and Biological Products, we submitted comments emphasizing the need for standardized, independent reference datasets to ensure AI model reliability across diverse clinical settings.
Friends of Cancer Research
@CancerResrch
We appreciate the opportunity to provide these comments and look forward to continued collaboration with the FDA. Read the full comment: www.regulations.gov/comment/FDA-2024-D-4689-0040.
-
Friends of Cancer Research
@CancerResrch
In our recent Scientific Report, our findings show pandemic-era flexibilities, such as remote monitoring and #telemedicine, and recruitment strategies for diverse patient populations, enhance #cancer treatments and improve patient outcomes. friendsofcancerresearch.org/wp-content/uploads/Friends-Sc…
-
Friends of Cancer Research
@CancerResrch
📢 Speakers Announced! Join us and @parkerici for our public meeting, Unlocking Next-Generation Therapies, on May 9 in DC. Stakeholders from across industry, patient advocacy, and academia will address critical challenges in #celltherapy development: friendsofcancerresearch.org/event/unlocking-next-generati….
-
Friends of Cancer Research
@CancerResrch
Drastic cuts to the @US_FDA & @NIH workforce threaten to undermine scientific leadership and delay the treatments #patients are counting on. Smart investments not capricious cuts are what’s needed to stay at the forefront of innovation.
Read our statement: friendsofcancerresearch.org/news/weakened-fda-nih-will-hu… -
Friends of Cancer Research
@CancerResrch
Friends of Cancer Research's 2024 Scientific Report highlights our advancements in innovative drug development - from strategies to advance #celltherapy cancer treatments to new data informing the use of #ctdna as an early clinical endpoint. Learn more: friendsofcancerresearch.org/wp-content/uploads/Friends-Sc…
-
Friends of Cancer Research
@CancerResrch
In our comment to the White House's Request for Information on the development of an AI Action Plan, we outline key considerations for regulatory oversight and policy development to support the safe and effective integration of #ai/ML technologies into drug development.
Friends of Cancer Research
@CancerResrch
We appreciate the opportunity to contribute to this RFI and look forward to working collaboratively with policymakers to develop a plan that promotes both innovation and patient safety. Read the full comment on our website: friendsofcancerresearch.org/wp-content/uploads/Public-Com…
-
Friends of Cancer Research
@CancerResrch
Launched in late 2024, @LungMAP 3.0 is the third generation of the trial and includes a major expansion of genomic screening options—patients and their physicians can utilize almost any CLIA-certified next-generation sequencing platform.
Learn more: lung-map.org #lcsm -
Friends of Cancer Research
@CancerResrch
At Friends of Cancer Research, we:
-Integrate RWE into drug development & regulatory assessment
-Advance the use of digital pathology & AI-based technologies
-Drive biomarker harmonization to optimize diagnostic tools used to inform treatment decisions
friendsofcancerresearch.org/impact-reports/2024-impact-re… -
Friends of Cancer Research
@CancerResrch
Interested in becoming a certified progressforpatients.org advocate? Take the Advocacy Education Course to learn about drug development and how to effectively add your voice to the process. Sign up at progressforpatients.org/take-the-course/. #patientadvocacy
-
Friends of Cancer Research
@CancerResrch
Join Friends of Cancer Research and @parkerici on May 9th to explore engineered cell-based therapies. Sessions will cover #raredisease therapy development and accessibility challenges and innovative manufacturing models.
Register today! friendsofcancerresearch.org/event/unlocking-next-generati… #celltherapy -
Friends of Cancer Research
@CancerResrch
Our Advocate Newsletter is out now! Catch up on the recent advocate-focused diagnostic webinar, explore FDA/ EMA differences in expediting treatments, and learn about recent policy shifts potentially impacting cancer research and care. bit.ly/4i3TKDf #patientadvocacy
-
Friends of Cancer Research
@CancerResrch
Tissue biopsies in clinical trials are critical, but their use must be carefully considered to balance benefits and risks. Thank you to the @US_FDA for the opportunity to comment on “Considerations for Including Tissue Biopsies in Clinical Trials”: www.regulations.gov/comment/FDA-2024-D-2402-0018
-
Friends of Cancer Research
@CancerResrch
Join us and Prevision Policy for #biopharmacongress: Ready for a New Era on 4/7. Key topics include the future of accelerated approval and how #ai guidance will be implemented in the real world.
Register today: biopharmacongress.com -
Friends of Cancer Research
@CancerResrch
Building on our research portfolio, we recently released findings that show how RWE and pragmatic #clinicaltrials can create more efficient patient-centered drug development. Read our 2024 Scientific Report to learn more about RWE and other research: friendsofcancerresearch.org/wp-content/uploads/Friends-Sc…
-
Friends of Cancer Research
@CancerResrch
Tomorrow, @md_stewart, Vice President of Science Policy, will be speaking at @TriConference to discuss the Digital PATH Project and how lessons learned from this project can inform validation approaches for other AI-driven tools. Learn more: friendsofcancerresearch.org/digital-pathology/. #tricon
-
Friends of Cancer Research
@CancerResrch
How many #oncology drugs granted #acceleratedapproval progress to full approval or face withdrawal? To gain insights into this, we created a dashboard that tracks Accelerated Approvals, confirmatory trials, full approval conversions, and withdrawals: friendsofcancerresearch.org/accelerated-approvals-in-onco…
-
Friends of Cancer Research
@CancerResrch
Our President & CEO Jeff Allen will be at @sxsw to discuss how AI-enabled diagnostics tools can analyze #cancer biopsies, providing biomarker testing and making personalized treatments more widely available. Learn more: friendsofcancerresearch.org/digital-pathology/ #sxsw
-
Friends of Cancer Research
@CancerResrch
The #acceleratedapproval pathway is vital for timely access to promising therapies in areas of unmet need. Its integrity and success rely on a transparent process and timely verification of clinical benefit. Its use continues to expand in #oncology and other disease areas.
Friends of Cancer Research
@CancerResrch
We recently submitted comments on @US_FDA’s draft Guidance Documents on #acceleratedapproval (AA): “Expedited Programs for Serious Conditions” (www.regulations.gov/comment/FDA-2024-D-2033-0029) and “AA and Considerations for Determining Whether a Confirmatory Trial is Underway” (www.regulations.gov/comment/FDA-2024-D-3334-0004).
-
Friends of Cancer Research
@CancerResrch
Our 2024 Impact Report highlights key efforts and advancements in #cancer research & policy: from integrating RWE into regulatory frameworks to advancing the use of digital pathology and driving diagnostic tools harmonization to inform treatment decisions: friendsofcancerresearch.org/impact-reports/2024-impact-re…
-
Friends of Cancer Research
@CancerResrch
Friends welcomes Dr. Monica Bertagnolli its Board of Directors! Dr. Bertagnolli has built her career around improving the lives of patients, and we are fortunate to add a member with experience as a physician scientist and patient: friendsofcancerresearch.org/news/dr-monica-bertagnolli-jo….
-
Friends of Cancer Research
@CancerResrch
Join us and @parkerici on May 9th for our public meeting, Unlocking Next-Generation Therapies: Exploring Innovative Development and Manufacturing Models for Cell Therapies. We will explore innovative engineered cell-based therapies and their challenges. friendsofcancerresearch.org/event/unlocking-next-generati…
-
Friends of Cancer Research
@CancerResrch
Last week, we hosted a webinar for #patientadvocates on the Future of #diagnostics. The meeting delved into the promises and challenges of AI-enabled digital pathology in oncology and the ways advocates can drive solutions to challenges: friendsofcancerresearch.org/blog/meeting-recap-advancing-…
-
Friends of Cancer Research reposted
Lung-MAP
@LungMAP
Now in @ASCOPost: @LungMAP 3.0: Simplifying the Process to Meet Patients’ Needs, by @ReckampK.
With advances in next-gen sequencing, the trial has expanded screening thru a range of commercial & academic NGS platforms.
ascopost.com/issues/february-25-2025/lung-map-30-simplify… @FNIH_Org @CancerResrch @theNCI @SWOG -
Friends of Cancer Research
@CancerResrch
Missed our advocate-focused webinar on Advancing #diagnostics & Regulatory Innovations? Watch on-demand to hear from experts as they delve into digital pathology, CDx validation for rare biomarkers, and emerging #ai-enabled diagnostic tools. #friendsdx
youtu.be/4ub7ZXiWfEs -
Friends of Cancer Research
@CancerResrch
Join our advocate-focused webinar on #diagnostics and regulatory innovations today at 1pm. You’ll hear from experts on digital pathology and #ai, rare biomarker testing strategies, and emerging diagnostic tools. Don't miss these vital insights: friendsofcancerresearch.org/event/advancing-the-future-of…
-
Friends of Cancer Research
@CancerResrch
#patientadvocates, join us 2/19 for our patient-focused webinar on diagnostics & regulatory innovation? Submit your questions around AI, #digitalpathology and rare biomarker diagnostics. Experts will discuss how these impact patient care and advocacy: bit.ly/42xpifP
-
Friends of Cancer Research
@CancerResrch
New Study: @US_FDA leads the world in approving novel #oncology drugs, reviewing almost twice as fast as the EMA and ensuring faster #patientaccess to lifesaving treatments. Read our latest blog post for the full findings: friendsofcancerresearch.org/blog/20-years-of-fda-leadersh…
-
Friends of Cancer Research
@CancerResrch
As AI evolves in healthcare, regulatory science has to guide responsible adoption. #friendsdx explored how oversight shapes #ai, digital pathology, & CDx for rare biomarkers, ensuring innovation expands access while ensuring patient safety. Read the recap: friendsofcancerresearch.org/blog/meeting-recap-advancing-…
-
Friends of Cancer Research
@CancerResrch
Thanks to all who joined the Advancing the Future of Diagnostics and Regulatory Innovations meeting. The full meeting is available to watch anytime on YouTube: www.youtube.com/live/wFHolEBYx48. And don't forget to register for our advocate-focused webinar on 2/19: friendsofcancerresearch.org/event/advancing-the-future-of….
-
Friends of Cancer Research
@CancerResrch
Interested in learning more about AI, diagnostics, and regulatory science as discussed in Session 3? Explore our newly launched Policy Priorities Page: friendsofcancerresearch.org/policy-priorities/. #frienddx
-
Friends of Cancer Research
@CancerResrch
There's going to be spaces where regulatory bodies are more conformable regulating [AI in healthcare], such as pathology and imaging. But there are other tools where there's more caution. We don’t want to be wrong if someone is diagnosed with cancer. - @RohiniKos, @FusionFundVC
-
Friends of Cancer Research
@CancerResrch
When it comes to risk with AI tools, there's more clear regulation on the medical device side. But the challenge with AI drug development...AI isn't a static tool. Regulatory teams must ensure that guidance evolves with it over time. - Joe Franklin from @CovingtonLLP #frienddx
-
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
It was so incredible to work with such a great group of experts to align on the output of this white paper. Regulatory flexibilities for companion diagnostics with limited clinical samples are important to support patients receiving access to novel targeted therapy in oncology.
Friends of Cancer Research
@CancerResrch
Read more about the Innovative Validation and Regulatory Processes for Companion Diagnostic Tests for Rare Biomarkers or Indications white paper discussed in Session 2: friendsofcancerresearch.org/wp-content/uploads/Innovative… #frienddx
-
Friends of Cancer Research reposted
Kelly Mercier, Ph.D
@KellyMercierPh1
The second discussion at the @CancerResrch was on the validation of diagnostic tests for rare biomarkers. The panel described updates needed to a white paper that was initially written in 2021.
-
Friends of Cancer Research
@CancerResrch
Read more about the Innovative Validation and Regulatory Processes for Companion Diagnostic Tests for Rare Biomarkers or Indications white paper discussed in Session 2: friendsofcancerresearch.org/wp-content/uploads/Innovative… #frienddx
-
Friends of Cancer Research reposted
Kelly Mercier, Ph.D
@KellyMercierPh1
In the first discussion, we discussed the digital pathology and harmonization project led by @CancerResrch in HER2 IHC.
-
Friends of Cancer Research
@CancerResrch
At the end of the day, patients deserve high quality tests especially when the test determines the drug that will prolong their life. - Elizabeth Mansfield from @FoundationATCG #frienddx
-
Friends of Cancer Research
@CancerResrch
How do we define when something is rare? 1% is a starting point, not a magical number. There are other considerations and it's important to discuss with the agency to determine when and what flexibility can be applied. - Alain Silk from @TempusAI #frienddx
-
Friends of Cancer Research
@CancerResrch
As we move to Session 2, reminder that our Advancing the Future of Diagnostics and Regulatory Innovations meeting is available to watch live and on-demand on YouTube: youtube.com/live/wFHolEBYx48 #friendsdx
-
Friends of Cancer Research
@CancerResrch
Learn more about the Session 1 findings in the digital pathology discussion document (friendsofcancerresearch.org/wp-content/uploads/Considerat…) and explore our Digital PATH Project research (friendsofcancerresearch.org/digital-pathology/). #friendsdx
-
Friends of Cancer Research
@CancerResrch
The opportunity to standardize the way we construct data sets is important...If we try to build a data set for every use case, we can set ourselves up to fail. We don't want to build a large reference data set that doesn't get used - @balasubramaniac from @Path_AI #frienddx
-
Friends of Cancer Research
@CancerResrch
AI will not replace pathologists, but it can help supplement their work for a more accurate diagnostic result - Joe Lennerz from @BostonGeneCorp #friendsdx
-
Friends of Cancer Research
@CancerResrch
The Advancing the Future of Diagnostics and Regulatory Innovations meeting is live! Stream on YouTube now or later on-demand: youtube.com/live/wFHolEBYx48. #frienddx
-
Friends of Cancer Research
@CancerResrch
Last chance to register for tomorrow’s Advancing the Future of Diagnostics Meeting! Expert panels will explore #ai #diagnostic reference sets, validation for rare biomarker tests, and regulatory frameworks. Register for in-person or virtual: friendsofcancerresearch.org/event/advancing-the-future-of….
-
Friends of Cancer Research reposted
FDLI
@foodanddruglaw
Just two months to go! Join us for the Essentials of Working with FDA course on March 4–5💥
This course will bring together experts to equip patient advocates with the legal tools and strategies for engaging with the agency.
Register now at www.fdli.org/2025/03/2025-essentials-of-working-with-fda-… -
Friends of Cancer Research
@CancerResrch
Read about how Friends’ efforts to enhance clinical trial design, optimize diagnostic test development, and construct innovative data analyses have advanced how new therapies are developed, evaluated, and delivered.
Read Friends' 2024 Scientific Report: friendsofcancerresearch.org/wp-content/uploads/Friends-Sc… -
Friends of Cancer Research reposted
Bernat Navarro
@bnserer
thrilled to start my new role as a science policy analyst at @CancerResrch! excited to help drive healthcare collaboration and advance science, policy, and regulation to accelerate life-saving treatments for patients!
follow us for more! 😀🤝 -
Friends of Cancer Research
@CancerResrch
At the Advancing the Future of Diagnostics meeting on 2/4, a panel will discuss Friends’ whitepaper on innovative validation processes for companion #diagnostictests in rare disease settings. Read the full paper before the meeting: friendsofcancerresearch.org/wp-content/uploads/Innovative….
-
Friends of Cancer Research
@CancerResrch
Read Friends' new discussion document, "Considerations for Developing Reference Data Sets for Digital Pathology Biomarkers," on standardized data for biomarker analysis: friendsofcancerresearch.org/wp-content/uploads/Considerat…. Join us 2/4 at the Advancing the Future of Diagnostics Meeting for expert insights.
-
Friends of Cancer Research reposted
BostonGeneCorp
@BostonGeneCorp
BostonGene's Chief Scientific Officer, Joe Lennerz, MD, PhD, will discuss the importance of high-quality data, ground truth and integrating new diagnostic technologies into patient care at the @CancerResrch meeting, Advancing the Future of Diagnostics and Regulatory Innovations, on Feb 4 in DC! #ai #cancerresearch #diagnostics
Read more: bostongene.com/news-and-publications/news/bostongene-to-p… -
Friends of Cancer Research
@CancerResrch
In 2024, Friends’ made pivotal strides in advancing #oncology drug development, regulatory policy and promoting innovative trial designs, contributing to advancements in therapy development, evaluation, and delivery.
Read Friends' 2024 Scientific Report: friendsofcancerresearch.org/wp-content/uploads/Friends-Sc… -
Friends of Cancer Research
@CancerResrch
Patient Advocates: Join our patient-focused webinar on 2/19 that will dive into discussions, topics, and implications from the Advancing the Future of Diagnostics and Regulatory Innovations meeting. Register today: friendsofcancerresearch.org/event/advancing-the-future-of…
-
Friends of Cancer Research reposted
Joan Mancuso
@JoanMancusoMBC
I’ll be a panelist during session 1 during a Friends of Cancer Research meeting to discuss the current and future use of digital pathology tools and #ai in oncology. Join in-person or online here: friendsofcancerresearch.org/event/advancing-the-future-of…
#aioncology @CancerResrch -
Friends of Cancer Research
@CancerResrch
Friends welcomes Paul Kim to its Board of Directors. Kim brings a wealth of knowledge in federal life sciences and public health policy and has been integral in informing and shaping public health in the US. friendsofcancerresearch.org/news/friends-announces-janet-…
-
Friends of Cancer Research
@CancerResrch
Friends welcomes Dr. Janet Woodcock to its Board of Directors. During her 35+ years at the FDA, she has made a profound impact on patient care, regulatory science, as well as being a key advocate and ally for patients. friendsofcancerresearch.org/news/friends-announces-janet-…
-
Friends of Cancer Research
@CancerResrch
Session 2 of Friends’ Feb. 4 meeting, “Validating Diagnostic Tests for Rare Biomarkers,” will discuss regulatory flexibility for rare biomarker tests in addition to types and sources of data for diagnostic validation.
Register here: friendsofcancerresearch.org/event/advancing-the-future-of… -
Friends of Cancer Research
@CancerResrch
Thank you @NCIDirector for highlighting #pragmaticalung trial in @theNCI’s “The year in #cancer: 24 advances in 2024.” Pragmatica-Lung is a phase 3 trial designed to remove many of the barriers that prevent people from joining clinical trials.
Learn more: www.cancer.gov/types/lung/research/pragmatica-lung-cancer… -
Friends of Cancer Research
@CancerResrch
Session 1 of Friends' “Advancing the Future of #diagnostics and Regulatory Innovations” meeting will feature a panel that discusses the current and future use of digital pathology tools and #ai in oncology.
Register today: friendsofcancerresearch.org/event/advancing-the-future-of…. -
Friends of Cancer Research
@CancerResrch
Friends is hosting a meeting on February 4 focused on driving innovation in diagnostic tests and #regulatory policy. Discussions will include evidence generation for AI tech and Dx, with the release of new data from the Digital PATH Project.
Register: friendsofcancerresearch.org/event/advancing-the-future-of… -
Friends of Cancer Research
@CancerResrch
Meet our Advisory Advocate, Judy Fitzgerald @breast_teacher! Hear her story about how she champions patient quality of life through dose optimization projects and ensures patient perspectives are represented in #clinicaltrials.
www.youtube.com/watch?v=iCPuhRPjiLQ -
Friends of Cancer Research
@CancerResrch
Meet #advisoryadvocate Ken Billett! Ken is a melanoma survivor, patient advocate, and a progressforpatients.org graduate. He’s focused on making sure patient voices are heard in drug development.
Watch Ken's story: youtu.be/2Y3deSJKKog
#progressforpatients -
Friends of Cancer Research
@CancerResrch
Thank you @US_FDA for sharing guidance to integrate RCTs into routine care. Our comments highlight the importance of encouraging efficient & accessible trials that support enrollment of representative populations to generate more generalizable results. www.regulations.gov/comment/FDA-2024-D-2052-0009
-
Friends of Cancer Research
@CancerResrch
Friends founder Ellen Sigal has been diagnosed with a non-aggressive form of #kidneycancer. Read Ellen's @ASCOPost article sharing her perspective on efforts to achieve patient centered care and to overcome future challenges in #oncology.
ascopost.com/news/december-2024/my-cancer-diagnosis-and-r… -
Friends of Cancer Research
@CancerResrch
Friends is hosting a meeting, “Advancing the Future of Diagnostics and Regulatory Innovations,” focused on driving innovation in diagnostics and regulatory policy, featuring a keynote from Michelle Tarver, Director of CDRH.
- Register today: friendsofcancerresearch.org/event/advancing-the-future-of…
#aioncology -
Friends of Cancer Research reposted
Joan Mancuso
@JoanMancusoMBC
Brittany McKelvey of @CancerResrch for digital path project for HER2 breast cancer. Honored to be a part of this effort after 2 wildly disparate results when early stage. We deserve accuracy to help improve outcomes. @SABCSSanAntonio
-
Friends of Cancer Research reposted
Pedro Torres-Saavedra, PhD
@PTorresSaavedra
New Digital PATH findings presented at #sabcs24 evaluate the level of agreement in HER2 biomarker assessment across different AI models, building on efforts to improve reproducibility and accuracy in AI-driven biomarker evaluations. friendsofcancerresearch.org/wp-content/uploads/SABCS-Post…
-
Friends of Cancer Research reposted
Nucleai
@nucleai_ai
New Digital PATH findings presented at #sabcs24 evaluate #her2 biomarker agreement across #ai models, advancing efforts to improve reproducibility in AI-driven #biomarker assessments. Proud to contribute to this transformative project! friendsofcancerresearch.org/wp-content/uploads/SABCS-Post… @CancerResrch
-
Friends of Cancer Research
@CancerResrch
New Digital PATH findings at #sabcs24 demonstrate a similar level of agreement in HER2 biomarker assessment across different AI models compared to pathologists, building on efforts to improve reproducibility and accuracy in AI-driven biomarker evaluations. friendsofcancerresearch.org/wp-content/uploads/SABCS-Post…
Friends of Cancer Research
@CancerResrch
Our partnership aims to inform the development of best practices for measuring and reporting AI-driven biomarker assessments in drug development to better understand variability across AI models. Full findings will be presented at our Feb 4th meeting. friendsofcancerresearch.org/event/advancing-the-future-of…
-
Friends of Cancer Research
@CancerResrch
At the #friendsam24 advocates recap event, Carol Vallett & Alex Wyatt discussed Friends' collaborative efforts in advancing #ctdna as an intermediate endpoint & highlighted the role of patient advocates in research. Watch the highlight below.
#patientadvocacy #oncologyThis media couldn't be displayed. See it on the original post. -
Friends of Cancer Research
@CancerResrch
Thank you for joining “Friends Annual Meeting 2024 Recap: Sharing Next Steps and Opportunities with Advocates.” We deeply appreciate everyone's engagement during the webinar and look forward to you joining us in the future! Missed the webinar? Click here: www.youtube.com/live/gGa4eAg4T5c
-
Friends of Cancer Research
@CancerResrch
"What we wanted to define with this white paper and this working group effort is what do we need to do as a community to prove that ctDNA is an early endpoint that can give us all of that information. " Alexander Wyatt at #friendsam24 Recap. Watch here: www.youtube.com/live/gGa4eAg4T5c
-
Friends of Cancer Research
@CancerResrch
“Patients are desperate for new effective and safe drugs to treat all cancers and anything that we can do to bring those treatments to market sooner is something that we really need.” Carol Vallett discussing the promise of ctDNA at #friendsam24 Recap: friendsofcancerresearch.org/event/friends-annual-meeting-…
-
Friends of Cancer Research
@CancerResrch
Starting now! @CancerResrch's webinar providing an overview of the 3 topics from the recent #friends’ Annual Meeting 2024 and offering #advocates the opportunity to engage directly with experts. #friendsam24. focr-org.zoom.us/w/89437554960?tk=7QT52XFk5Zz9CXLegImf3O6…
-
Friends of Cancer Research
@CancerResrch
Just a day away! Register for @CancerResrch's webinar providing an overview of the 3 topics from our recent Annual Meeting. This meeting will be an opportunity for #advocates to engage directly with experts and learn about our latest projects. friendsofcancerresearch.org/event/friends-annual-meeting-…
#friendsam24 -
Friends of Cancer Research
@CancerResrch
Session 3 of #friendsam24 focused on the Friends white paper “Framework for Integrating Change in ctDNA Levels in Advanced Cancer Clinical Trials to Support Meta-analyses for Intermediate Endpoint Validation”.
Access the Session 3 white paper here: friendsofcancerresearch.org/publication/white-paper-frame… -
Friends of Cancer Research
@CancerResrch
Session 2 of #friendsam24 focused on the Friends white paper “Pragmatism in Postmarket Trials”.
To access the Session 2 white paper, click here: friendsofcancerresearch.org/publication/white-paper-pragm… -
Friends of Cancer Research
@CancerResrch
Session 1 of #friendsam24 focused on the Friends white paper “Enhancing Study Designs and Interpretation of Interim Overall Survival Data in Oncology Trials”.
To access the Session 1 white paper, click here: friendsofcancerresearch.org/publication/white-paper-enhan… -
Friends of Cancer Research
@CancerResrch
Thank you to the @US_FDA for putting forth guidance to ensure multiregional oncology trials meet high standards of diversity, integrity, and applicability to the U.S. population.
Read our public comments here: www.regulations.gov/comment/FDA-2024-D-3163-0008 -
Friends of Cancer Research
@CancerResrch
Thank you @NCIDirector for joining us! #friendsam24
Dr. Anthony Letai
@NCIDirector
I was delighted to join the Friends of Cancer Research annual meeting this week. Thanks to @CancerResrch President and CEO Dr. Jeff Allen for hosting a great fireside chat with me to discuss modernizing clinical trials for the new era of cancer research.
Friends of Cancer Research
@CancerResrch
"If we limit our knowledge to only those who have access today we miss out. We miss out on bringing these discoveries as far and as wide as they can get, but we also miss out on the data as well." @theNCI's @KimrynRathmell at #friendsam24
Watch here: www.youtube.com/watch?v=hQ7rYiJTcmU -
Friends of Cancer Research
@CancerResrch
Join @CancerResrch's webinar providing an overview of the 3 topics from the recent #friends’ Annual Meeting 2024 and offering #advocates the opportunity to engage directly with experts. #friendsam24. friendsofcancerresearch.org/event/friends-annual-meeting-…
-
Friends of Cancer Research
@CancerResrch
"The technologies are moving at a pace that is quite remarkable, with incredible new modalities that are able to target cancer in new ways. That is going to continue no matter the political environment." @CancerResrch's Jeff Allen speaking @MilkenInstitute's #mihealthsummit
-
Friends of Cancer Research
@CancerResrch
Thank you to the hundreds of people who joined us from across the country in person and virtually for this year's Friend of Cancer Research Annual Meeting!
Missed the meeting? watch the full #friendsam24 here: youtube.com/live/hQ7rYiJTcmU -
Friends of Cancer Research
@CancerResrch
And that's a wrap! Thank you for joining us in person and virtually at #friendsam24. We have a number of upcoming public meetings, to learn more visit: friendsofcancerresearch.org/events/
-
Friends of Cancer Research
@CancerResrch
"As patients give their informed consent it needs to be clear to them what is being asked of them and what the outcome will be." Carol Vallett live at #friendsam24
friendsofcancerresearch.org/wp-content/uploads/Framework-… -
Friends of Cancer Research
@CancerResrch
Thanks @JoanMancusoMBC! #friendsam24 Session 3 White Paper can be found here: friendsofcancerresearch.org/wp-content/uploads/Framework-…
Joan Mancuso
@JoanMancusoMBC
@HillStirSci with an excellent presentation on using change in ctDNA as an intermediate endpoint in CTs, with many stakeholders involved for a comprehensive approach, at Friends of Cancer Research annual meeting @CancerResrch. White paper available online. #friendsam24
-
Friends of Cancer Research reposted
Joan Mancuso
@JoanMancusoMBC
@HillStirSci with an excellent presentation on using change in ctDNA as an intermediate endpoint in CTs, with many stakeholders involved for a comprehensive approach, at Friends of Cancer Research annual meeting @CancerResrch. White paper available online. #friendsam24
-
Friends of Cancer Research reposted
Flatiron Health
@flatironhealth
Flatiron’s Neal Meropol spoke on a panel at the @CancerResrch Annual Meeting revealing a few key insights on incorporating pragmatic elements into #clinicaltrial designs to enhance generalizability & efficiency.
Read the full white paper to learn more: friendsofcancerresearch.org/event/friends-of-cancer-resea… -
Friends of Cancer Research
@CancerResrch
#friendsam24 Session 3 is starting now! Watch @HillStirSci discuss, "A Common Strategy for Using ctDNA as an Intermediate Endpoint in Prospectively Designed Trials." www.youtube.com/watch?v=hQ7rYiJTcmU
Access the White Paper here: friendsofcancerresearch.org/wp-content/uploads/Framework-… -
Friends of Cancer Research
@CancerResrch
"If we limit our knowledge to only those who have access today we miss out. We miss out on bringing these discoveries as far and as wide as they can get, but we also miss out on the data as well." @theNCI's @KimrynRathmell at #friendsam24
Watch here: www.youtube.com/watch?v=hQ7rYiJTcmU -
Friends of Cancer Research
@CancerResrch
Thank you @pkluetz for joining us! #friendsam24
-
Friends of Cancer Research
@CancerResrch
"Tech is now gaining traction for the automated transfer of electric healthcare data to clinical trials, reducing site burden and potentially reducing errors because you are not moving the transcription from one source of data to another -Neal Meropol @flatironhealth #friendsam24
-
Friends of Cancer Research reposted
Joan Mancuso
@JoanMancusoMBC
Dr. Richard Schilsky moderating a session on post-marketing studies with pragmatism in CTs at Friends of Cancer Research annual meeting. @CancerResrch @rschilsky is the mastermind behind @ASCO TAPUR studies to evaluate whether FDA-approved drugs may be agnostic. #friendsam24
-
Friends of Cancer Research
@CancerResrch
"I like the idea of starting with the post marketing study because it gives us an opportunity to build on patient partnerships." @EvaMay_CRM during #friendsam24 Session 2 - Enhancing Post-Marketing Studies with Pragmatism.
Read the White Paper here: friendsofcancerresearch.org/wp-content/uploads/Pragmatism… -
Friends of Cancer Research reposted
ECOG-ACRIN Cancer Research Group
@eaonc
The Friends' panel on Pragmatism in Postmarket Trials is happening now! Dr. Peter O'Dwyer, @EAonc co-chair, is on stage now. Listen live at the link below!
Friends of Cancer Research
@CancerResrch
Starting now! #friendsam24 Session 1 – Interim Overall Survival Evaluations and Implications for Trial Designs and Analysis Plans.
Join live here: www.youtube.com/watch?v=hQ7rYiJTcmU
@geoff_oxnard @DavidP4AD @MassGeneralNews @US_FDA @EliLillyandCo @GSK -
Friends of Cancer Research reposted
Timil Patel, MD
@timilpatel
@pkluetz giving an @FDAOncology perspective on DCT and pragmatic trials on the heels of recent published FDA guidances @CancerResrch.
Every trial can integrate pragmatic and DCT elements, and the degree would be context dependent on the disease setting & treatments involved. -
Friends of Cancer Research
@CancerResrch
Starting now! @US_FDA's @pkluetz presenting on #friendsam24 Session 2 – Enhancing Post-Marketing Studies with Pragmatism.
Read the Session 2 White Paper here: friendsofcancerresearch.org/wp-content/uploads/Pragmatism… -
Friends of Cancer Research reposted
Joan Mancuso
@JoanMancusoMBC
2/2 Our difficulty as patients with advanced cancer is not being able to wait for mature OS data, and what can be done about this dilemma without causing harm to us. Thank you for this topic.
-
Friends of Cancer Research
@CancerResrch
"We have a lot of knowledge when we are talking about designing a trial that can really help inform proper trial design. Taking advantage of all that information we have is really important." Nicole Gormley @US_FDA during #friendsam24
Watch live: www.youtube.com/watch?v=hQ7rYiJTcmU -
Friends of Cancer Research
@CancerResrch
"The FDA and sponsors have to reach an agreement on whether or not Interim overall survival (OS) data belongs in the picture and it may not, and we shouldn't be drawing conclusions from it." @DavidP4AD live at #friendsam24
Read the Session 1 White Paper: friendsofcancerresearch.org/wp-content/uploads/Enhancing-… -
Friends of Cancer Research
@CancerResrch
Starting now! #friendsam24 Session 1 – Interim Overall Survival Evaluations and Implications for Trial Designs and Analysis Plans.
Join live here: www.youtube.com/watch?v=hQ7rYiJTcmU
@geoff_oxnard @DavidP4AD @MassGeneralNews @US_FDA @EliLillyandCo @GSK -
Friends of Cancer Research
@CancerResrch
"We have no system in place that is producing the evidence that is really needed, and the @US_FDA can't mandate that." @DrCaliff_FDA live at #friendsam24 discussing the current road blocks for evidence generation.
Join live here: www.youtube.com/watch?v=hQ7rYiJTcmU -
Friends of Cancer Research
@CancerResrch
"There is a lot at stake for the cancer community and industry." @DrCaliff_FDA on the future of #cancercare
@PrevisionPolicy @US_FDA @Ramsey_Baghdadi
#friendsam24 -
Friends of Cancer Research
@CancerResrch
Starting now! Join #friendsam24 live: www.youtube.com/watch?v=hQ7rYiJTcmU
Featuring @DrCaliff_FDA in conversation with @Ramsey_Baghdadi @PrevisionPolicy @US_FDA -
Friends of Cancer Research reposted
ECOG-ACRIN Cancer Research Group
@eaonc
Peter O'Dwyer, our @EAonc group co-chair, is in Washington, DC, today, joining @CancerResrch to discuss pragmatic trial designs. Listen in live at the link below.
Friends of Cancer Research
@CancerResrch
Friends’ Annual Meeting 2024 is today! Join us to live to discuss pragmatic trial designs, enhancing interim OS analyses accuracy & reliability, & advancing ctDNA as an intermediate endpoint in oncology drug development.
focr-org.zoom.us/j/84882614021
#friendsam24 -
Friends of Cancer Research
@CancerResrch
Friends’ Annual Meeting 2024 is today! Join us to live to discuss pragmatic trial designs, enhancing interim OS analyses accuracy & reliability, & advancing ctDNA as an intermediate endpoint in oncology drug development.
focr-org.zoom.us/j/84882614021
#friendsam24 -
Friends of Cancer Research
@CancerResrch
Join us tomorrow for #friendsam24! Friends’ Annual Meeting 2024 will dive into pragmatic trial designs, enhancing interim OS analyses accuracy & reliability, & advancing ctDNA as an intermediate endpoint in oncology drug development. friendsofcancerresearch.org/event/friends-of-cancer-resea…
-
Friends of Cancer Research reposted
Qiming Venture Partners
@QimingVC
@AmoyDx (SZSE:300685) supported a project led by @CancerResrch, utilizing its HRD assay to assess HRD in ovarian cancer samples. Published in the Journal of Clinical Oncology, this study highlights the need for standardized, reliable biomarker testing in oncology.
#qmportfolio
Amoy Diagnostics
@AmoyDx
🌐 We are proud to have participated in the project led by @Friends of Cancer Research, utilizing the AmoyDx HRD assay to assess homologous recombination deficiency (HRD) in ovarian cancer samples. Published in the Journal of … amoy-diagnostics-co-ltd.shp.so/a/t5IOgJ
-
Friends of Cancer Research reposted
Richard Schilsky
@rschilsky
I’m excited to be a panelist at #friendsam24 during panel 2, exploring incorporation of
individual pragmatic elements into clinical trials, enhancing their applicability and
efficiency while maintaining regulatory rigor.
Register: friendsofcancerresearch.org/event/friends-of-cancer-resea…
@CancerResrch -
Friends of Cancer Research
@CancerResrch
Watch @CancerResrch’s @HillStirSci preview our upcoming Annual Meeting Session 3, “A Common Strategy for Using #ctdna as an Intermediate Endpoint in Prospectively Designed Trials.” #friendsam24
Learn more and register here: friendsofcancerresearch.org/event/friends-of-cancer-resea…
www.youtube.com/watch?v=zOZd7C5o7w0&t=23s -
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
Excited to share new findings from @CancerResrch’s #ctmonitr project at #sitc24! Come check out poster number 35 to learn more about our aggregate analysis in patients with aNSCLC treated with IO and/or chemo assessing ctDNA associations with OS.
-
Friends of Cancer Research
@CancerResrch
Watch @CancerResrch’s @BrittanyAnne340 preview our upcoming Annual Meeting Session 2, “Enhancing Post-Marketing Studies with Pragmatism.” #friendsam24
Learn more and register here: friendsofcancerresearch.org/event/friends-of-cancer-resea…
www.youtube.com/watch?v=mtG9zDuGyxw -
Friends of Cancer Research
@CancerResrch
Findings published in @JCO_ASCO show variability in HRD results across assays suggesting a need for consistent, aligned strategies in biomarker selection for clinical trials and decision-making in oncology drug development.
Read the manuscript here: ascopubs.org/doi/10.1200/OA-24-00042
#jcooa -
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
Looking forward to sharing exciting new findings from our #ctmonitr project at #sitc24 in Houston this week!
Friends of Cancer Research
@CancerResrch
Friends @HillStirSci is presenting a poster at @sitcancer #sitc24 detailing results from ctMoniTR Module 2, entitled “The Impact of Treatment Modalities on Use of ctDNA as an Early Endpoint in aNSCLC Trials.”
friendsofcancerresearch.org/ctdna/ -
Friends of Cancer Research
@CancerResrch
Friends @HillStirSci is presenting a poster at @sitcancer #sitc24 detailing results from ctMoniTR Module 2, entitled “The Impact of Treatment Modalities on Use of ctDNA as an Early Endpoint in aNSCLC Trials.”
friendsofcancerresearch.org/ctdna/ -
Friends of Cancer Research reposted
ACT Genomics
@actg_global
ACT Genomics is proud to share the collaboration with Friends of Cancer Research on HRD harmonization project.
We are honored to partner with the organization for the second time after the TMB harmonization project.
Friends of Cancer Research
@CancerResrch
New @CancerReserch findings in @JCO_ASCO examine variability in HRD results across assays, suggesting the need for consistent & aligned strategies in biomarker selection for #clinicaltrials & clinical decision-making. #jcooa
Read the manuscript here: ascopubs.org/doi/10.1200/OA-24-00042 -
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
So incredibly proud of this work - we saw some variability of outputs across 20 HRD assays. Patients rely on these tests to make treatment decisions and clinical agreement is of upmost importance. The next step for the field is aligning clinical validation for better consistency.
Friends of Cancer Research
@CancerResrch
New @CancerReserch findings in @JCO_ASCO examine variability in HRD results across assays, suggesting the need for consistent & aligned strategies in biomarker selection for #clinicaltrials & clinical decision-making. #jcooa
Read the manuscript here: ascopubs.org/doi/10.1200/OA-24-00042 -
Friends of Cancer Research
@CancerResrch
New @CancerReserch findings in @JCO_ASCO examine variability in HRD results across assays, suggesting the need for consistent & aligned strategies in biomarker selection for #clinicaltrials & clinical decision-making. #jcooa
Read the manuscript here: ascopubs.org/doi/10.1200/OA-24-00042 -
Friends of Cancer Research
@CancerResrch
Watch @CancerResrch’s @md_stewart preview our upcoming Annual Meeting Session 1, “Interim Overall Survival Evaluations and Implications for Trial Designs and Analysis Plans.” Register: friendsofcancerresearch.org/event/friends-of-cancer-resea…
youtu.be/s0_GP5LSypQ
#friendsam24 -
Friends of Cancer Research reposted
Brittany Avin McKelvey
@BrittanyAnne340
I've enjoyed the deep discussions we've had on balancing risk with opportunity to incorporate pragmatic elements into postmarket trials. Looking forward to the #friendsam24 discussion!
Friends of Cancer Research
@CancerResrch
#friendsam24 Session 2 “Enhancing Post-Marketing Studies with Pragmatism” will explore incorporation of individual pragmatic elements into clinical trials, enhancing their applicability and efficiency while maintaining regulatory rigor.
Click to register: friendsofcancerresearch.org/event/friends-of-cancer-resea… -
Friends of Cancer Research
@CancerResrch
#friendsam24 Session 3 will discuss an aligned approach for assessing ctDNA changes to support reg. decision-making, focused on using ctDNA in NSCLC treated with immunotherapy.
Register here: friendsofcancerresearch.org/event/friends-of-cancer-resea… -
Friends of Cancer Research
@CancerResrch
#friendsam24 Session 2 “Enhancing Post-Marketing Studies with Pragmatism” will explore incorporation of individual pragmatic elements into clinical trials, enhancing their applicability and efficiency while maintaining regulatory rigor.
Click to register: friendsofcancerresearch.org/event/friends-of-cancer-resea… -
Friends of Cancer Research reposted
-
Friends of Cancer Research
@CancerResrch
Jeff Allen is speaking @ACCCBuzz's Clinical Trial Design Summit discussing the evolution of DCTs in oncology, highlighting the role of tech in increasing enrollment, while addressing reg. considerations, operational challenges, & successful case studies www.accc-cancer.org/home/learn/community-oncology-researc…
-
Friends of Cancer Research
@CancerResrch
Jeff Allen is speaking today @united4cancer’s cancer policy discussion, “Tackling the Implementation Gap” a pre-event to a @WhiteHouse discussion on a global cancer fund. Dr. Allen will be stressing the critical role of Public-Private Partnerships.
-
Friends of Cancer Research
@CancerResrch
Friends’ @BrittanyAnne340 is speaking this afternoon @DrugInfoAssn’s Real-World Evidence Conference discussing, “Health Equity in Drug Development: Leveraging RWD to Inform and Improve Diversity.”
Learn about #rwefriends portfolio here: friendsofcancerresearch.org/rwe/ -
Friends of Cancer Research
@CancerResrch
Friends’ @md_stewart is attending @ESGCT Annual Conference in #rome discussing a framework for data extrapolation in cell & gene therapies, showing how innovative approaches can accelerate the development of next-gen #treatments.
Friends #cgt portfolio: friendsofcancerresearch.org/cell-gene-therapies -
Friends of Cancer Research
@CancerResrch
- #friendsam Session 1 “Interim Overall Survival Evaluations and Implications for Trial Designs and Analysis Plans” will discuss best practices for trial designs & analysis plans for interim OS analyses in cancer #clinicaltrials.
Click to register: friendsofcancerresearch.org/event/friends-of-cancer-resea… -
Friends of Cancer Research
@CancerResrch
Thank you to everyone who has taken progressforpatients.org. Through taking the course, you’ve helped to make drug dev. & #clinicaltrials more inclusive and patient-centered!
Thank you to our project partners from across the #health advocacy community:
progressforpatients.org/take-the-course -
Friends of Cancer Research
@CancerResrch
#friendsam Session 1 “Interim Overall Survival Evaluations and Implications for Trial Designs and Analysis Plans” will discuss best practices for trial designs & analysis plans for interim OS analyses in cancer #clinicaltrials.
Click to register: friendsofcancerresearch.org/event/friends-of-cancer-resea… -
Friends of Cancer Research
@CancerResrch
Congratulations to this year’s Ellen V. Sigal Advocacy honoree @NIHDirector, who has had an immense impact on cancer research & cancer care. We applaud her incredible leadership @NIH & look forward to continuing working with her to advance research for all
www.youtube.com/watch?v=jO3QTC5er1Q -
Friends of Cancer Research reposted
Lung-MAP
@LungMAP
Starting Oct. 15th, @LungMAP 3.0 will greatly simplify the trial’s screening process, making #clinicaltrials of new treatments available to even more patients with #nsclc at a wider range of community treatment sites. @SWOG @FNIH_org @CancerResrch @NCICTEP_ClinRes @lcfamerica
-
Friends of Cancer Research
@CancerResrch
We are honored to award this year’s Marlene A. Malek Public Service Award to @RepGuthrie. Congressman Guthrie has been a staunch advocate for #patients, advancing access and equity through crucial legislation. Thank you for your continued leadership!
www.youtube.com/watch?v=RRhlh6dbpPc -
Friends of Cancer Research reposted
-
Friends of Cancer Research
@CancerResrch
Meet our Advisory Advocate, Judy Fitzgerald @breast_teacher! Hear her story about how she champions patient quality of life through dose optimization projects and ensures patient perspectives are represented in #clinicaltrials. www.youtube.com/watch?v=iCPuhRPjiLQ
-
Friends of Cancer Research
@CancerResrch
Thank you to those of you who joined us at the 28th Cancer Leadership Awards, recognizing our Cancer Leadership Honorees. Through the support of our incredible community, we are leading transformative projects that are shaping the future of cancer care.
friendsofcancerresearch.org/projects -
Friends of Cancer Research
@CancerResrch
Older Americans deserve access to validated screening tools that detect dozens of cancers earlier when they’re more treatable. It’s time to finish the job and pass the Medicare #mced Screening Coverage Act.
-
Friends of Cancer Research
@CancerResrch
Meet @cancerresrch #advisoryadvocate, Ken Billett! He is a melanoma survivor, patient advocate, and a progressforpatients.org graduate. Ken is focused on making sure patient perspectives guide drug development. #progressforpatients
www.youtube.com/watch?v=2Y3deSJKKog -
Friends of Cancer Research reposted
Ibex Medical Analytics
@IbexMedAx
We were thrilled to attend @CancerResrch 28th Annual Cancer Leadership Awards! We share in Friends' commitment to improve the lives of #cancer patients worldwide & proud to support their efforts to advance cancer research and policy. Support their work: friendsofcancerresearch.org?hss_channel=tw-93362167266985…
-
Friends of Cancer Research reposted
Lee Jones
@LeeJonesMBA
This conference is always worthwhile for advocates and others interested in cancer research. Advocates are involved in the research teams and the panel discussions. And, if you're not in the DC area, it's also virtual! @CancerResrch
Friends of Cancer Research
@CancerResrch
Register today! Friends’ Annual Meeting 2024 will dive into pragmatic trial designs, enhancing interim OS analyses accuracy & reliability, & advancing ctDNA as an intermediate endpoint in oncology drug development. friendsofcancerresearch.org/event/friends-of-cancer-resea…
#friendsam24 -
Friends of Cancer Research
@CancerResrch
Friends applauds the recent @FDA DAP guidance. We appreciate the FDA's ongoing efforts to ensure that #clinicaltrials are inclusive and representative and look forward to continued collaboration to achieve these goals. Read our public comment here: www.regulations.gov/comment/FDA-2021-D-0789-0150
-
Friends of Cancer Research
@CancerResrch
Register today! Friends’ Annual Meeting 2024 will dive into pragmatic trial designs, enhancing interim OS analyses accuracy & reliability, & advancing ctDNA as an intermediate endpoint in oncology drug development. friendsofcancerresearch.org/event/friends-of-cancer-resea…
#friendsam24 -
Friends of Cancer Research reposted
Melanoma Research Foundation
@CureMelanoma
We are proud to support Progress for Patients, an incredible resource for educating and preparing patients to actively participate in the drug development process.
The MRF partners with @CancerResrch to offer this free course to our patients and advocates.
Interested in joining? Click through and sign up to take the course - progressforpatients.org #progressforpatients -
Friends of Cancer Research
@CancerResrch
#friendsam will explore 3 topics aimed at enhancing regulatory efficiency & decision-making by addressing challenges impacting cancer clinical trials & drug development, improving the evidence collection process necessary to support drug approvals
Register friendsofcancerresearch.org/event/friends-of-cancer-resea… -
Friends of Cancer Research
@CancerResrch
progressforpatients.org educates patients and advocates about the drug development process provides graduates with a crucial knowledge base before getting involved in the drug development, clinical trial, and #regulatory process.
Take the course: progressforpatients.org -
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
The @CancerResrch Q3 advocate newsletter is out! We highlight recent manuscripts that were published and describe the impacts of Chevron Deference being overturned - in addition to news and upcoming events.
Check it out and share with your network! friendsofcancerresearch.org/blog/quarterly-advocacy-newsl… -
Friends of Cancer Research reposted
The Cancer Letter
@TheCancerLetter
Friends (@CancerResrch) publishes evaluation of RWE in NSCLC.
cancerletter.com/clinical-roundup/20240913_8b/ -
Friends of Cancer Research
@CancerResrch
Join us at Friends Annual Meeting on Nov. 12th! Register today: friendsofcancerresearch.org/event/friends-of-cancer-resea…
#friendsam24
Hillary Andrews, PhD
@HillStirSci
So excited for this work! I’m looking forward to discussions at the @CancerResrch Annual Meeting that will focus on aligning on the approach for measuring ctDNA to understand associations with long-term outcomes to improve clinical trials.
Register here: friendsofcancerresearch.org/event/friends-of-cancer-resea…
Friends of Cancer Research
@CancerResrch
New @CCR_AACR manuscript with @CancerResrch’s @hillstirsci as an author focuses on the promise of using ctDNA to build upon existing response assessments such as RECIST.
Read the manuscript here: aacrjournals.org/clincancerres/article-abstract/doi/10.11… -
Friends of Cancer Research reposted
The Cancer Letter
@TheCancerLetter
Friends of Cancer Research (@CancerResrch) announces publication focused on enhancing clinical trials with pragmatic trial elements.
cancerletter.com/clinical-roundup/20240913_8a/ -
Friends of Cancer Research
@CancerResrch
New @CCR_AACR manuscript with @CancerResrch’s @hillstirsci as an author focuses on the promise of using ctDNA to build upon existing response assessments such as RECIST.
Read the manuscript here: aacrjournals.org/clincancerres/article-abstract/doi/10.11… -
Friends of Cancer Research
@CancerResrch
Overturning of the #chevrondeference by the SCOTUS— what does it all mean? Our VP of public affairs, Ryan Hohman, delves into the implications this ruling has for the @US_FDA and patient access to innovative cancer therapies.
Read the full Q&A with Ryan: friendsofcancerresearch.org/blog/stakeholder-connect-supr… -
Friends of Cancer Research
@CancerResrch
Register today! Friends’ Annual Meeting 2024 will explore three key topics focused on streamlining trial designs, enhancing data collection for #oncology drug approvals, and supporting efficient regulatory processes and decision-making. friendsofcancerresearch.org/event/friends-of-cancer-resea…
#friendsam24 -
Friends of Cancer Research
@CancerResrch
Friends’ @BrittanyAnne340 is speaking today at the 14th World Clinical Biomarkers & Companion Diagnostics Summit, discussing optimizing digital biomarkers.
Learn about Friends #digitalpath work here: friendsofcancerresearch.org/digital-pathology/ -
Friends of Cancer Research reposted
Janice Cowden
@JaniceTNBCmets
Interesting article on integrating pragmatic elements into conventional #clinicaltrials. This hybrid approach appears more patient-centric & reflective of real world practice! A win-win for all stakeholders & participants! Thanks to @CancerResrch!
Conclusion:
“Integrating pragmatic elements into oncology trials to create hybrid PCTs offers a promising avenue for efficient, relevant, and patient-centered drug development. Collaboration with patient advocacy groups, providers, regulators, pharmaceutical companies, and other stakeholders ensures trial designs are patient-centric and reflective of real-world practice. Sharing experiences, challenges, and successes in designing and implementing clinical trials with pragmatic elements will build a knowledge base to guide future trials.”
www.esmorwd.org/article/S2949-8201(24)00043-2/fulltext
#cancerresearch
#bcsm
#patientcentricmedicine
#patientcentereddrugdevelopment
#realworldpractice
#cancer -
Friends of Cancer Research
@CancerResrch
New Friends perspective in @myESMO RWD & Digital Health discusses the potential of incorporating pragmatic elements in oncology clinical trials. #pragmatictrials are a promising way to achieve more efficient, relevant, & patient-centered drug development. linkinghub.elsevier.com/retrieve/pii/S2949820124000432
-
Friends of Cancer Research
@CancerResrch
There is growing interest in using PCTs to bridge the gap between research and practice in oncology, more closely resembling rw-care. Results from a study conducted as part of @LungMAP supported the development of a new pragmatic study (Pragmatica-Lung)
aacrjournals.org/clincancerres/article/30/1/29/732084/Nov… -
Friends of Cancer Research reposted
Tempus
@TempusAI
We're excited to see this work published. At Tempus, we're passionate about partnering with organizations like @CancerResrch to further access the use of real-world data to improve patient outcomes.
Friends of Cancer Research
@CancerResrch
@CancerReserch findings in @JCOCCI_ASCO demonstrate the feasibility of using RWD from EHRs to evaluate tumor response in patients with mNSCLC. This project is part of our RWE Portfolio, establishing methodology for using #rwd to evaluate treatment outcomes ascopubs.org/doi/10.1200/CCI.24.00091
-
Friends of Cancer Research reposted
JCO Clinical Cancer Informatics
@JCOCCI_ASCO
Evaluation of Real-World Tumor Response Derived From Electronic Health Record Data Sources: A Feasibility Analysis in Patients With Metastatic #nsclc Treated With #chemotherapy: ascopubs.org/doi/full/10.1200/CCI.24.00091 @BrittanyAnne340 @CancerResrch #lcsm #ehr
-
Friends of Cancer Research reposted
Flatiron Health
@flatironhealth
For more on this research and why is matters, visit our website: resources.flatiron.com/publications/evaluation-of-real-wo…
-
Friends of Cancer Research
@CancerResrch
Check out our rw-Response @JCOCCI_ASCO publication! This study used a common protocol to assess rw-response in mNSCLC patients across 7 #data sources. ascopubs.org/doi/10.1200/CCI.24.00091 #lungcancer #lcsm
Friends of Cancer Research
@CancerResrch
The study aimed to:
- Assess the availability of core data components in the EHR for measuring response to treatment
- Evaluate the consistency of a measure of rw-response across data sources in an aligned population
friendsofcancerresearch.org/rwe/ -
Friends of Cancer Research reposted
Ontada
@OntadaOncology
Our new study, "Evaluation of real-world tumor response derived from electronic health record data sources," published by @JCOCCI_ASCO and in collaboration with @CancerResrch, is now live!
Read the full study: ascopubs.org/doi/10.1200/CCI.24.00091
#rwe #rwd #rwefriends -
Friends of Cancer Research reposted
Brittany Avin McKelvey
@BrittanyAnne340
Excited for our @CancerResrch publication out in @JCOCCI_ASCO showing the consistency in a measure of response to treatment across 7 RWD sources! #rwefriends
Friends of Cancer Research
@CancerResrch
@CancerReserch findings in @JCOCCI_ASCO demonstrate the feasibility of using RWD from EHRs to evaluate tumor response in patients with mNSCLC. This project is part of our RWE Portfolio, establishing methodology for using #rwd to evaluate treatment outcomes ascopubs.org/doi/10.1200/CCI.24.00091
-
Friends of Cancer Research
@CancerResrch
@CancerReserch findings in @JCOCCI_ASCO demonstrate the feasibility of using RWD from EHRs to evaluate tumor response in patients with mNSCLC. This project is part of our RWE Portfolio, establishing methodology for using #rwd to evaluate treatment outcomes ascopubs.org/doi/10.1200/CCI.24.00091
-
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
So excited to share about @CancerResrch’s ctMoniTR project today at #ngdx!
Friends of Cancer Research
@CancerResrch
On Monday, @CancerResrch’s @HillStirSci will be speaking at #ngdx in #dc about Friends’ work, exploring #ctdna associations with long term outcomes at 10:45 am ET. Learn more here: www.nextgenerationdx.com/liquid-biopsy
-
Friends of Cancer Research
@CancerResrch
On Monday, @CancerResrch’s @HillStirSci will be speaking at #ngdx in #dc about Friends’ work, exploring #ctdna associations with long term outcomes at 10:45 am ET. Learn more here: www.nextgenerationdx.com/liquid-biopsy
Friends of Cancer Research
@CancerResrch
Friends’ #ctmonitr Project aggregates data to address the question, “does change in circulating tumor DNA (#ctdna) levels from baseline to on treatment associate with long term outcomes?” Project findings will be discussed at #ngdx.
friendsofcancerresearch.org/ctdna/ -
Friends of Cancer Research
@CancerResrch
Our policy & regulatory initiatives bring together stakeholders to assess emerging challenges in #oncology drug development and inform policy recommendations for modernizing regulatory frameworks and #clinicaltrials.
Find out what we’re working on here: friendsofcancerresearch.org/projects/ -
Friends of Cancer Research reposted
Penn Medicine
@PennMedicine
.@carlhjune discussed the potential of using #carttherapy to treat #glioblastoma, a rare and aggressive form of brain cancer. “I think about five years down the line, we’re going to have FDA-approved CARs for glioblastoma.” @PennCancer www.forbes.com/sites/juergeneckhardt/2024/08/07/carl-june…
-
Friends of Cancer Research
@CancerResrch
There is growing interest in using pragmatic clinical trials (PCTs) bridge the gap between research and practice in oncology, more closely resembling real-world care.
Results from a recent @LungMAP study supported the development of Pragmatica-Lung. aacrjournals.org/clincancerres/article/30/1/29/732084/Nov… -
Friends of Cancer Research reposted
STAT
@statnews
Jeff Shuren took over FDA's medical device center in 2009, and had to earn back the trust of both the public and the industry. www.statnews.com/2024/08/06/fda-medical-device-center-cdr…
-
Friends of Cancer Research
@CancerResrch
Our Research Partnerships are data-driven collaborations. We generate evidence and alignment to advance the use of innovative measures & approaches in oncology, advancing policy & improving patient outcomes.
Check out our Dx, #ctdna, and #rwe Portfolios: friendsofcancerresearch.org/projects/ -
Friends of Cancer Research
@CancerResrch
Yesterday's @US_FDA ODAC meeting evaluated emerging data from clinical trials in NSCLC in the perioperative setting & asked members to weigh in on the need for additional trials (& designs for those trials). Read our insights from the meeting. friendsofcancerresearch.org/blog/insights-from-july-25-20…
@FDAOncology -
Friends of Cancer Research
@CancerResrch
Real-World Data (RWD) are patient data derived from EHRs or other real-world sources, which are generally reflective of the broad population. Real-World Evidence (RWE) refers to using #rwd to generate evidence, usually on drug safety and effectiveness.
www.youtube.com/watch?v=0izOBTbflDQ -
Friends of Cancer Research
@CancerResrch
Friends Chair & Founder Ellen Sigal on Dr. Jeff Shuren's departure from the @US_FDA after 28 years of service.
-
Friends of Cancer Research
@CancerResrch
“It is very important for patients to have access to as much information as possible in order to understand the risks, the benefits and the tests that help them decide on their treatment options.” Patsy Hinson on the importance of the #hrdfriends project.
www.youtube.com/watch?v=cdVxeF4rga0&t=1s -
Friends of Cancer Research
@CancerResrch
The @FDA's recent draft guidance on #diversityactionplans for clinical trials is an important step towards more inclusive and representative trials. Friends CEO Jeff Allen recently spoke to @RAPSorg about this guidance and its importance. www.raps.org/news-and-articles/news-articles/2024/6/fda-i…
-
Friends of Cancer Research
@CancerResrch
Our friends @FDAOncology are hosting a webinar tomorrow to discuss the founding legislation for the OCE, the #cancermoonshot & all they've been able to accomplish since 2017 as a dedicated center at www.surveymonkey.com/r/MLH7VJZ
-
Friends of Cancer Research
@CancerResrch
We are deeply disappointed by #scotus decision to eliminate #chevron deference, a rule crucial for proper interpretation of healthcare laws. We will continue to work to ensure that laws are implemented in ways that benefit public health. @TheCancerLetter cancerletter.com/judiciary/20240705_1/
-
Friends of Cancer Research
@CancerResrch
Today’s @statnews AI event discussed the impact of AI #diagnostics on drug development and patients. Friends’ Digital Pathology project explores variability in #biomarker assessment across #ai models. friendsofcancerresearch.org/digital-pathology/
-
Friends of Cancer Research
@CancerResrch
Thrilled to see our incredible Board Member @DrEdKim of @cityofhope recognized by @OncLive as a pioneer in cancer care for his leadership in community outreach and education!
OncLive.com
@OncLive
OncLive Honors 15 Cancer Care Pioneers #onoclogy
www.onclive.com/view/onclive-honors-15-cancer-care-pionee… -
Friends of Cancer Research
@CancerResrch
@CancerResrch’s recent study evaluated factors leading to the issuance of PMR/Cs for assessing data in more representative populations (R/E PMR/C), including results of pivotal trial subgroup analyses based on race and ethnicity. aacrjournals.org/clincancerres/article/doi/10.1158/1078-0…
Friends of Cancer Research
@CancerResrch
Subgroup differences were observed for more drugs with an R/E PMR/C compared to drugs without, although these differences may not be clinically meaningful. R/E PMR/Cs may be issued to further evaluate signals observed in pivotal subgroup analyses, particularly for safety.
-
Friends of Cancer Research reposted
The ASCO Post
@ASCOPost
ASCO, Friends of Cancer Research Applaud FDA Draft Guidance ascopost.com/news/july-2024/asco-friends-of-cancer-resear… @ASCO @CancerResrch @US_FDA
-
Friends of Cancer Research
@CancerResrch
Our new Advisory Advocates webpage highlights @CancerResrch advocates who provide invaluable insights on their experiences, ensuring patient perspectives are represented in our work.
Learn more about the Friends’ Advisory Advocates and the program here: friendsofcancerresearch.org/friends-of-cancer-research-ad… -
Friends of Cancer Research
@CancerResrch
New draft guidance released today by @RobCaliff @FDA was part of a recently enacted law requiring manufacturers submit #diversity action plans outlining how they plan to enroll a diverse group of participants for phase 3 & other pivotal #clinicaltrials www.fda.gov/regulatory-information/search-fda-guidance-do…
-
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
Great to see @TheCancerLetter covering @CancerResrch's recent publication in @CCR_AACR highlighting an increase in post marketing requirements and commitments for studies focused on collecting data in underrepresented populations. cancerletter.com/clinical-roundup/20240621_8f/
-
Friends of Cancer Research reposted
Roy Herbst
@DrRoyHerbst
Thrilled to host the lung interSPORE meeting last week @theNCI @YaleCancer @SmilowCancer with my colleagues @politikaterina in New Haven @Yale @YaleWestCampus Over 250 people attended to review progress against lung cancer: 20 years after EGFR mutation discovery @LungMAP @SWOG
-
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
Kicking off the @MetastasisRS meeting in London! Excited to hear about the cutting edge science in this space. #mrs2024
-
Friends of Cancer Research
@CancerResrch
New @CancerResrch manuscript in @CCR_AACR provides key insights into the FDA’s expectations for representation of race and ethnicity in oncology clinical trials.
aacrjournals.org/clincancerres/article/doi/10.1158/1078-0… -
Friends of Cancer Research
@CancerResrch
Recent legislation & FDA policies mandate planning to ensure clinical trials are inclusive and representative of US demographics. Friends’ new study assesses use of PMR/Cs for improving representation. More premarket #diversity plans are needed. aacrjournals.org/clincancerres/article/doi/10.1158/1078-0…
-
Friends of Cancer Research reposted
Indica Labs
@Indica_Labs
We’re delighted to partner with @CancerResrch on their #digitalpath Project & had a great discussion at #asco24 of initial results comparing HER2 assessments from 10 computational #pathology models on over 1000 WSI!
Stay tuned for exciting results.
friendsofcancerresearch.org/digital-pathology/
#pathx -
Friends of Cancer Research
@CancerResrch
Friends' new publication in @CCR_AACR digs further into data from our PMR/C interactive dashboard of oncology PMR/Cs issued 2012-2023 and provides key insights into the FDA’s expectations for representation of race and ethnicity in oncology clinical trials
friendsofcancerresearch.org/pmr-cs-for-novel-oncology-the… -
Friends of Cancer Research
@CancerResrch
Today! Grace Collins is presenting about trends in race and ethnicity PMR/Cs at #dia2024. Stop by at 12:15 pm PT/ 3:15 ET to see the poster entitled “Evaluation of PMR/Cs for Assessing Data in Racial and Ethnic Populations Underrepresented in Pivotal Clinical Trials.”
-
Friends of Cancer Research
@CancerResrch
New publication in @CCR_AACR shows an increase in post-marketing commitments and requirements (PMR/Cs) for race and ethnicity since 2020, which aligns with signals that FDA wants to ensure trials are more representative. aacrjournals.org/clincancerres/article/doi/10.1158/1078-0…
Friends of Cancer Research
@CancerResrch
New congressional & FDA policies mandate increased clinical trial inclusion to reflect US demographics. Results from our analyses can inform efforts to improve premarket clinical trials to ensure they are representative.
Friends of Cancer Research
@CancerResrch
Data included in this publication can be explored using Friends’ PMR/C data dashboard, a public resource for assessing trends in oncology PMR/Cs across different approval years, drug classes, indications, and more friendsofcancerresearch.org/pmr-cs-for-novel-oncology-the…
-
Friends of Cancer Research
@CancerResrch
We, and our fellow advocacy colleagues, unequivocally support @US_FDA's role in safeguarding #patients & urge DOJ to continue to defend their authority. #scotus
Blood Cancer United Advocacy
@bcutd_advocacy
We applaud the Supreme Court’s ruling reversing the Fifth Circuit's decision in Alliance for Hippocratic Medicine et al. v FDA et al. but remain concerned that other plaintiffs will continue challenging FDA authority on drug safety.
Full statement: msg.lls.org/45my5k6 -
Friends of Cancer Research
@CancerResrch
Postmarketing Requirements and Commitments (PMR/Cs) are an additional guardrail placed by the @US_FDA post-approval to ensure safety and efficacy of an approved drug. Check out our dashboard for insights on PMR/Cs for oncology drugs approved in 2012-2023. friendsofcancerresearch.org/pmr-cs-for-novel-oncology-the…
-
Friends of Cancer Research
@CancerResrch
The #ctmonitr Project aggregates data to address the question “does change in circulating tumor DNA (ctDNA) levels from baseline to on treatment associate with long term outcomes?” Key findings from the project will be discussed at #ngdx.
friendsofcancerresearch.org/ctdna/ -
Friends of Cancer Research
@CancerResrch
It was so great to see everyone at #asco24! We had an incredible time connecting with colleagues and meeting with our Digital Pathology Project partners to discuss the latest project developments. View the latest #digitalpath project updates here: friendsofcancerresearch.org/digital-pathology/
-
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
It was a quick one but so glad I made it to #asco24 for a few days to see old and new friends, learn about some incredible research, and even enjoy some of my favorite local food! Can’t wait to see what’s next for this incredible community!
-
Friends of Cancer Research
@CancerResrch
This morning’s #asco24 session, “The State of DNA Repair Targeting: Current Advances and Future Prospects” addresses how germline and somatic aberrations in DNA-repair and DNA damage-response (DDR) genes impact cancer predisposition. meetings.asco.org/2024-asco-annual-meeting/15730?presenta…
Friends of Cancer Research
@CancerResrch
This aligns with our HRD Project, which supports the use of assays measuring the HRD biomarker for treatment decision-making. By evaluating sources of variability in #hrd assays, we aim to standardize and refine these assays, optimizing #patient outcomes. friendsofcancerresearch.org/hrd/
-
Friends of Cancer Research
@CancerResrch
This afternoon’s #asco24 session, “Circulating Biomarkers: Who, What, Where, When, and Why?” Began with a foundational presentation on the session topic to set the stage for the abstracts to follow. meetings.asco.org/2024-asco-annual-meeting/15728?presenta…
Friends of Cancer Research
@CancerResrch
Friends ctMoniTR Project is using ctDNA as an early endpoint to predict long-term survival outcomes in patients being treated for early-stage cancer. #ctdnafriends
friendsofcancerresearch.org/ctdna/ -
Friends of Cancer Research
@CancerResrch
#asco24 session, “State of the Art in Gynecologic Cancer: New Drugs and Companion Diagnostics” will focus on companion diagnostics and differences between germline and genomic testing for patients with gynecologic cancers. meetings.asco.org/2024-asco-annual-meeting/15749?presenta… (1/3)
Friends of Cancer Research
@CancerResrch
Appropriate use of HRD testing and PARP inhibitors in patients will be discussed. This discussion is critical to Friends HRD Project. (2/3)
Friends of Cancer Research
@CancerResrch
Friends HRD Project works to align on a solution to improve consistency across assays and interpreting results from assays.
Learn more about our #hrdfriends project here: friendsofcancerresearch.org/hrd/ (3/3) -
Friends of Cancer Research
@CancerResrch
#asco24 session, “Solving Decades of Drug Shortages in Oncology: What, Who, and When?” discussed factors that can improve resiliency in the sterile injectable drug market and potential changes to mitigate future drug shortages. meetings.asco.org/2024-asco-annual-meeting/15864?presenta…
-
Friends of Cancer Research
@CancerResrch
#asco24 poster session will feature a Friends’ collaborative project poster entitled, “Impact of the COVID-19 pandemic mitigation strategies on cancer treatment trials: A meta-analysis of industry and @theNCI studies.” meetings.asco.org/2024 ASCO Annual Meeting/15793?presenta…
Friends of Cancer Research
@CancerResrch
Findings indicate pandemic-related procedural flexibility did not lead to increased reporting of protocol deviations or dropouts and highlight how use of mitigation strategies likely corresponded with the temporary disruption to trial conduct during the pandemic’s peak.
-
Friends of Cancer Research
@CancerResrch
New #asco24 results demonstrate the importance of molecular subtypes in patient selection – including HER2-low and ultralow in breast cancer. Emerging digital pathology tools are aiding the identification of #patient subsets for delivering the next gen of targeted therapies.
Friends of Cancer Research
@CancerResrch
Friends Digital PATH Project uses HER2 as a case example to help align HER2 assessment across multiple computational pathology platforms leveraging a common set of 1100+ digitized breast cancer slides. Our working group met @ASCO to review initial results friendsofcancerresearch.org/digital-pathology
-
Friends of Cancer Research reposted
SWOG Cancer Research Network
@SWOG
2 Pragmatica-Lung @SWOG S2302 posters #asco24 Mon, June 3:
➡️Outreach to improve representative recruitment @DCarrizosaMD
9-12, Hall A - Qual Care/Hlth Svcs - Ab 11019 - Poster 214
➡️Trial-in-progress update @ReckampK
1:30-4:30, Hall A - Lung-NSC Met - Ab TPS8657 - Poster 516b -
Friends of Cancer Research
@CancerResrch
Today’s #asco24 abstracts session, “Emerging Role of ctDNA in Breast Cancer” will analyze recent data findings in the field, helping to bring ctDNA from concept to clinical use. meetings.asco.org/2024-asco-annual-meeting/15678?presenta…
Friends of Cancer Research
@CancerResrch
New ctDNA manuscript highlights the imperative of standardized methodologies in #ctdna analysis. Providing a comprehensive analysis of ctDNA levels and variability across various cancer types and stages to support future data harmonization efforts. www.mdpi.com/2075-4418/14/9/912
-
Friends of Cancer Research
@CancerResrch
Friends is deeply honored to receive this year's @HemOncToday Patient Voice award at #asco24. The award is in recognition of a patient advocacy group that embodies the three core principals of research, patients, and policy.
Friends of Cancer Research
@CancerResrch
Every year @GoHealio and collaborators recognize awardees for pioneering the future of #hematology and #oncology. Thank you for hosting the Healio Disruptive Innovators Awards event last night @ASCO.
-
Friends of Cancer Research reposted
HemOnc Today
@HemOncToday
The Healio Patient Voice award, goes to a patient advocacy group that addresses the three core aspects of this award:
🔬Research
🏥 Patients
🏛️ Policy
The embodiment of these core aspects, and our winner, is @CancerResrch!
Congratulations! -
Friends of Cancer Research
@CancerResrch
Today’s timely #asco24 session, “Using “Artificial” Intelligence to Achieve “Real” Improvements in Cancer Care” will give an overview of the current AI cancer care field. meetings.asco.org/2024-asco-annual-meeting/15868?presenta…
Friends of Cancer Research
@CancerResrch
Friends recently launched Digital Pathology project to address the use of computational pathology platforms with AI/machine learning algorithms to aid pathologists in tissue analysis.
View our #digitalpath project page here: friendsofcancerresearch.org/digital-pathology/
#aioncology -
Friends of Cancer Research
@CancerResrch
Today, #asco24's “Integrating Patient-Reported Outcomes and Tolerability Assessment” at 2:45 PM CDT highlights how PROs may inform treatment tolerability. meetings.asco.org/2024-asco-annual-meeting/15759?presenta… We wrote a white paper about
PROs in dose optimization in 2022 here: friendsofcancerresearch.org/wp-content/uploads/Supporting… -
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
SO excited about the new Advocacy page on the @CancerResrch website - it provides information about our 2 advocacy training programs and highlights our incredible Advisory Advocates.
friendsofcancerresearch.org/patients-and-advocates/ -
Friends of Cancer Research
@CancerResrch
Friends is excited to attend #asco24! Over the coming days we will highlight conference sessions related to our scientific portfolio - including diagnostic harmonization projects, policy and regulatory initiatives, and the ctMoniTR project.
friendsofcancerresearch.org/projects -
Friends of Cancer Research reposted
HemOnc Today
@HemOncToday
Our dedicated Patient Voice nominees are:
@FacingOurRisk
@EGFRResisters
@PanCAN
@Pap_Corps
@PicklesGroup
@CancerResrch
#healioinnovators -
Friends of Cancer Research
@CancerResrch
Friends public #advocate webinar on May 23 delved into the rapid development and potential of #crispr-based immunotherapies particularly in improving #trials, treatments, and access for patients.
Friends of Cancer Research
@CancerResrch
Dr. Alex Marson's (@MarsonLab) scientific insights combined with @MucosalMelanoma's personal experience with cell therapies provided a comprehensive look at the current landscape and future prospect of #celltherapies in #cancer care.
Friends of Cancer Research
@CancerResrch
The webinar bridged the gap between research and opportunities for patient engagement to support the development and use of cell therapies by facilitating an open dialogue and an engaging Q&A session.
Watch here: youtube.com/live/ZdslWjgUcvA
#cgtfriends -
Friends of Cancer Research
@CancerResrch
"From a patient perspective, they are willing and wanting to do anything they can to live. They are really just looking for a chance." Chris White live during #cgt webinar discussing cost barriers that #patients face to receiving treatment.
www.youtube.com/watch?v=ZdslWjgUcvA -
Friends of Cancer Research
@CancerResrch
"We are testing every gene in the genome to see which genes will boost the cancer killing functions of T cells." Alex Marson presenting live at Friends Cell Therapies #advocates webinar discussing how his team is programming immune cells to cure disease.
www.youtube.com/watch?v=ZdslWjgUcvA -
Friends of Cancer Research
@CancerResrch
Starting now! Cell Therapies #advocates webinar, building on the discussions from Friends recent #cgt event with @parkerici. This webinar will round-up panel discussions from 5/6 & will include a Q&A featuring Dr. Alex Marson & @MucosalMelanoma
Join live: www.youtube.com/watch?v=ZdslWjgUcvA -
Friends of Cancer Research reposted
Penn Medicine
@PennMedicine
During an expert panel hosted by @CancerResrch and @parkerici, #cartcelltherapy pioneer @carlhjune discussed why CAR T cells are considered a "living drug" and how far the technology has come since he first started working on it. www.healio.com/news/hematology-oncology/20240521/racing-m…
-
Friends of Cancer Research
@CancerResrch
Tomorrow! Join @CancerResrch’s public “Friends’ Cell Therapies Webinar for Advocates” at 12:00 PM ET! #register here: friendsofcancerresearch.org/event/friends-cell-therapies-…
Learn about Friends CGT work here: www.youtube.com/watch?v=hNgPU0wsrwI
#cgtfriends #friendsadvocates -
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
Looking forward to the @CancerResrch cell therapies advocates event tomorrow! You can still register - advocate attendees are encouraged to watch the initial meeting from May 6th as it will serve as a foundation for the discussions. Click the link for more
friendsofcancerresearch.org/event/friends-cell-therapies-… -
Friends of Cancer Research
@CancerResrch
What a powerful moment from our #celltherapies event with @parkerici! @MucosalMelanoma, Patient Advocate & author of “Killing Cancer with TILs,” offers insights on balancing the risks & benefits of TIL therapy during Session 2 panel discussion. Watch here: www.youtube.com/watch?v=-QJXlB9SNwI&t=014s
-
Friends of Cancer Research reposted
Abigail Johnston
@AMJohnston1315
Advocates: Want to learn more about cell therapies and broaden your understanding of the current research!? Look no further — check out @CancerResrch’s cell therapies seminar this week!! #bcsm @ThanksCancer @BSBreastCancer
-
Friends of Cancer Research reposted
Brittany Avin McKelvey
@BrittanyAnne340
Check out our @CancerResrch blog on the impact of the RACE Act on required pediatric study and oncology drug development friendsofcancerresearch.org/blog/assessing-the-impact-of-…. Timely in light of the upcoming pedsODAC!
Friends of Cancer Research
@CancerResrch
provides an updated analysis of the RACE Act’s impact on required pediatric studies, highlighting remaining challenges to conducting #pediatric studies in #oncology. friendsofcancerresearch.org/blog/assessing-the-impact-of-…
-
Friends of Cancer Research
@CancerResrch
This week the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee will meet to discuss perspectives relating to implementation of the RACE Act and its impact on pediatric cancer drug development. www.fda.gov/advisory-committees/advisory-committee-calend…
A new blog from Friends....
Friends of Cancer Research
@CancerResrch
provides an updated analysis of the RACE Act’s impact on required pediatric studies, highlighting remaining challenges to conducting #pediatric studies in #oncology. friendsofcancerresearch.org/blog/assessing-the-impact-of-…
-
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
Feel free to send your questions ahead of time to advocacy@focr.org!
Friends of Cancer Research
@CancerResrch
Our 5/23 cell therapies #advocates webinar will build on the discussions from our recent CGT event with @parkerici. This public webinar will round-up panel discussions from 5/6 & will include a Q&A session featuring Dr. Alex Marson & @MucosalMelanoma
friendsofcancerresearch.org/event/friends-cell-therapies-… -
Friends of Cancer Research reposted
Chris White
@MucosalMelanoma
I’m excited to attend @CancerResrch’s upcoming public “Friends’ Cell Therapies Webinar for Advocates” on May 23rd – you should join too! Learn more and #register here: friendsofcancerresearch.org/event/friends-cell-therapies-… #yourtilspeaker #mucosalmelanomasurvivor
-
Friends of Cancer Research
@CancerResrch
Our 5/23 cell therapies #advocates webinar will build on the discussions from our recent CGT event with @parkerici. This public webinar will round-up panel discussions from 5/6 & will include a Q&A session featuring Dr. Alex Marson & @MucosalMelanoma
friendsofcancerresearch.org/event/friends-cell-therapies-… -
Friends of Cancer Research reposted
Lung-MAP
@LungMAP
The @LungMAP trial is built on a unique public-private partnership including @theNCI @FNIH_Org @CancerResrch @SWOG
#nctnpartnership benefits:
- Shared costs & risks of testing therapies
- Drug combination collaborations between companies
- Large network shortens timeframes -
Friends of Cancer Research
@CancerResrch
Last week’s public #cgt meeting session 2 focused on “Discovering & Developing the Next Generation of Cell-based Gene Therapies: Considerations for First-in-Human Trials.” #ctdnafriends
Watch the session here: www.youtube.com/watch?v=-QJXlB9SNwI&t=12238s -
Friends of Cancer Research reposted
Judith Fitzgerald
@JFBCAdvocate
I’m excited to attend @CancerResrch’s upcoming public “Friends’ Cell Therapies Webinar for Advocates” on May 23rd – you should join too! Learn more and #register here: friendsofcancerresearch.org/event/friends-cell-therapies-… Register for free. Register here: friendsofcancerresearch.org/event/friends-cell-therapies-… #cgtfriends #friendsadvocates
-
Friends of Cancer Research
@CancerResrch
Thank you Ambassador @DKambUSA for a great evening and inviting @CancerResrch's President & CEO Jeff Allen to share our work and ongoing collaboration with @Genmab.
Jesper Møller Sørensen 🇩🇰
@DKambUSA
Privilege to host celebration of @Genmab’s 25 years of transformative contributions to cancer research & biotechnology. Honored to have Congresswoman @RepMMM, prominent advocate for healthcare to acknowledge Genmab's role in shaping biotechnology landscape & its impact across 🇺🇸
-
Friends of Cancer Research reposted
Jesper Møller Sørensen 🇩🇰
@DKambUSA
Privilege to host celebration of @Genmab’s 25 years of transformative contributions to cancer research & biotechnology. Honored to have Congresswoman @RepMMM, prominent advocate for healthcare to acknowledge Genmab's role in shaping biotechnology landscape & its impact across 🇺🇸
-
Friends of Cancer Research
@CancerResrch
Last week’s public #cgt meeting session 1 focused on “Shaping the Future of Cell and Gene Therapies: Challenges & Opportunities.” Watch the session here: www.youtube.com/watch?v=-QJXlB9SNwI&t=4998s
-
Friends of Cancer Research
@CancerResrch
New ctDNA baseline publication in @MDPIOpenAccess! We collaborated with 8 ctDNA assay developers to analyze baseline ctDNA levels across five cancer types at different stages, setting the stage to use ctDNA as a biomarker that predicts clinical response. www.mdpi.com/2075-4418/14/9/912
-
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
Cant wait for this! Come one come all!
Please feel free to submit your questions to advocacy@focr.org ahead of time (even if you can’t make it - we’ll be recording).
Friends of Cancer Research
@CancerResrch
@CancerResrch's public #advocate webinar on May 23 will delve into advancing proposals in the ever-evolving realm of cell and gene therapy, particularly in improving trials and treatments for #patients.
Register here: friendsofcancerresearch.org/event/friends-cell-therapies-…
#cgtfriends #friendsadvocates -
Friends of Cancer Research
@CancerResrch
@CancerResrch's public #advocate webinar on May 23 will delve into advancing proposals in the ever-evolving realm of cell and gene therapy, particularly in improving trials and treatments for #patients.
Register here: friendsofcancerresearch.org/event/friends-cell-therapies-…
#cgtfriends #friendsadvocates -
Friends of Cancer Research
@CancerResrch
Missed our public #cgt meeting “Unlocking Complex Cell-based Gene Therapies” last week?
Watch the full event here: www.youtube.com/watch?v=-QJXlB9SNwI&t=014s -
Friends of Cancer Research
@CancerResrch
New manuscript in @MDPIOpenAccess outlines key learnings and considerations to support future alignment of ctDNA as an early endpoint.
Click to read the full publication: www.mdpi.com/2075-4418/14/9/912
#ctdnafriends -
Friends of Cancer Research
@CancerResrch
Missed our public #cgt meeting with @parkerici “Unlocking Complex Cell-based Gene Therapies” this week?
Watch the full event here: www.youtube.com/watch?v=-QJXlB9SNwI&t=014s -
Friends of Cancer Research reposted
Tempus
@TempusAI
Excited to share research published with @CancerResrch in @MDPIOpenAccess in which we evaluate #ctdna levels prior to cancer treatment in an effort to identify overall trends & considerations to inform the use of ctDNA in onco drug development. Read more: www.mdpi.com/2075-4418/14/9/912
-
Friends of Cancer Research
@CancerResrch
New manuscript in @MDPIOpenAccess outlines key learnings and considerations to support future alignment of ctDNA as an early endpoint. #ctdnafriends
Click to read the full publication: www.mdpi.com/2075-4418/14/9/912 -
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
Incredible meeting from @CancerResrch and @parkerici demonstrating the value of collaboration to advance cell-based gene therapies.
Next, we have an advocate webinar on May 23 with a round-up and Q&A with Alex Marson and @MucosalMelanoma.
Register today! focr-org.zoom.us/webinar/register/WN_yRJpR9V-RFmxdgjY2LX2AA
Friends of Cancer Research
@CancerResrch
And that's a wrap! Thank you for joining us today for "Unlocking Complex Cell-based Gene Therapies."
Watch the full meeting here: www.youtube.com/watch?v=-QJXlB9SNwI
#cgt -
Friends of Cancer Research
@CancerResrch
We are excited to announce a new @CancerResrch publication in @MDPI Journal Diagnostics evaluating ctDNA levels prior to cancer treatment to identify overall trends and considerations to inform the use of #ctdna in oncology drug development. www.mdpi.com/2075-4418/14/9/912
#ctdnafriends -
Friends of Cancer Research
@CancerResrch
And that's a wrap! Thank you for joining us today for "Unlocking Complex Cell-based Gene Therapies."
Watch the full meeting here: www.youtube.com/watch?v=-QJXlB9SNwI
#cgt -
Friends of Cancer Research
@CancerResrch
“Thinking back to it now, given the option I would have totally taken the risk with cell therapies from the get-go if I had known about it.” @MucosalMelanoma reflecting on his experience and the potential of cell-based gene therapies during "Session 2.
www.youtube.com/watch?v=-QJXlB9SNwI -
Friends of Cancer Research reposted
John Connolly
@John_E_Connolly
An absolutely amazing talk by @MarcelaMaus Systematically laying out a path for improving patient care. Intentional heterogeneity to select for cell therapy enhancements where in matters, in vivo. @harvardmed @MassGenBrigham
-
Friends of Cancer Research reposted
Parker Institute
@parkerici
Our 2nd panel discussion is underway as PICI Center Director @Stanford Crystal Mackall (@MackallLab), MD, guides conversation on immunotherapy treatments w/ PICI Investigators Phil Greenberg, MD, (@fredhutch), @marcelamaus, MD, PhD, @US_FDA experts & patient advocates.
-
Friends of Cancer Research reposted
Aaron Edwards
@aedwards02
A MUST watch event through @parkerici and @CancerResrch on "Unlocking Complex Cell-Based Gene Therapies". A few slides/comments shown by @MarcelaMaus that are important to reiterate on recent studies of possible secondary T cell malignancies from lenti/gene edited products.
Parker Institute
@parkerici
PICI Investigator @marcelamaus MD, PhD, of Massachusetts General Hospital discusses the role of heterogeneity in CAR T therapies at our #cgt workshop w/ @CancerRsrch.
We’re excited to have a front row seat to this type of important scientific exchange: www.youtube.com/watch?v=-QJXlB9SNwI -
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
To kick off our afternoon, @MarcelaMaus shares approaches for incorporating multiple gene edits into cells for cell therapy. #friendscgt
-
Friends of Cancer Research
@CancerResrch
Starting now! Session 2: Discovering & Developing the Next Generation of Cell-based Gene Therapies: Considerations for First-in-Human Trials.
www.youtube.com/watch?v=-QJXlB9SNwI
#cgt @parkerici @CancerResrch -
Friends of Cancer Research reposted
Jessica Foglesong MD 👩🏻⚕️
@foglesong_md
@MarcelaMaus Discussing how to incorporate more safety thru #productdesign #protocoldesign #characterization #releasecriteria to innovate #firstinhuman #clinicaltrial. #cancer #celltherapy #cgt @parkerici @CancerResrch @FDACBER @FDAOncology
-
Friends of Cancer Research reposted
Parker Institute
@parkerici
“I knew there were risks with my treatment, but I wanted to see my children grow up, so I took that risk,” said patient advocate @MzDesNY, on her experience as a patient during this important discussion at our #cgt workshop w/ @CancerResrch on cellular therapy development.
-
Friends of Cancer Research
@CancerResrch
Unlocking Complex Cell-based Gene Therapies Session 2 is starting now! “Shaping the Future of Cell and Gene Therapies: Challenges & Opportunities.”
Watch live: www.youtube.com/watch?v=-QJXlB9SNwI
#cgt -
Friends of Cancer Research reposted
Jessica Foglesong MD 👩🏻⚕️
@foglesong_md
How do you balance safety, innovation, regulation, access a panel of #patientadvocates #academia #fda to discuss how we can #worktogether to advance medicine. @parkerici @CancerResrch @FDAOncology
-
Friends of Cancer Research
@CancerResrch
“We need to understand the limitations of these models. They are each going to have their advantages and disadvantages. This needs to be considered when interpreting the data.” Iwen Wu, CBER, @US_FDA discussing gene editing live during session 1.
www.youtube.com/watch?v=-QJXlB9SNwI
#cgt -
Friends of Cancer Research
@CancerResrch
“I knew there were risks with my treatment, but I wanted to see my children grow up, so I took that risk.” Patient advocate Desiree Walker speaking live at Friends & Parker's #cgt meeting about her experience as a #patient.
www.youtube.com/watch?v=-QJXlB9SNwI
#cgt -
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
The first panel at @CancerResrch and @parkerici’s focuses on challenges and opportunities for shaping the future of cell and gene therapies. #friendscgt
-
Friends of Cancer Research
@CancerResrch
Starting now! Panel 1 Discussion and Q&A
Shaping the Future of Cell and Gene Therapies: Challenges & Opportunities
www.youtube.com/watch?v=-QJXlB9SNwI -
Friends of Cancer Research reposted
David Mitchell
@DavidP4AD
Very exciting to learn about CRISPR editing that can delete genes that interfere w/effectiveness of CAR-T to make the CAR-T more effective. Technology being developed at Gladstone Institutes and elsewhere.
Friends of Cancer Research
@CancerResrch
Alex Marson, from Gladstone Institutes is presenting live on "Opportunities to Enhance Adoptive T Cell Therapies using CRISPR Gene Editing."
Join us here: www.youtube.com/watch?v=-QJXlB9SNwI -
Friends of Cancer Research
@CancerResrch
Alex Marson, from Gladstone Institutes is presenting live on "Opportunities to Enhance Adoptive T Cell Therapies using CRISPR Gene Editing."
Join us here: www.youtube.com/watch?v=-QJXlB9SNwI -
Friends of Cancer Research reposted
Jessica Foglesong MD 👩🏻⚕️
@foglesong_md
Alex Marson discussing how #clinicaltrials can both advance a #livingdrug but also through competitive #cart persistence can guide future #cart #innovation #cgt @CancerResrch @parkerici
-
Friends of Cancer Research
@CancerResrch
"Hundreds of genes have been identified where disruption may improve function, and screening in humans will identify promising cell candidates with improved function.” @carlhjune live at @CancerResrch & @parkerici #cgt meeting.
www.youtube.com/watch?v=-QJXlB9SNwI
#cgt -
Friends of Cancer Research reposted
Shaad Essa Abedin
@shaadessa
Excited to hear @carlhjune speaking at Unlocking complex cell-based gene therapies. Thanks to @CancerResrch @parkerici
-
Friends of Cancer Research
@CancerResrch
Unlocking Complex Cell-based Gene Therapies Session 1 presentation by @carlhjune is starting now.
"The Evolution of Cell and Gene Therapies: Current Advances and Challenges."
www.youtube.com/watch?v=-QJXlB9SNwI
#cgt -
Friends of Cancer Research
@CancerResrch
“We want to facilitate innovative progress but need to balance that with the number of changes or number of different types of cells going into a person.”
Peter Marks discussing Cell-based Gene Therapies live: www.youtube.com/watch?v=-QJXlB9SNwI -
Friends of Cancer Research reposted
Lee Jones
@LeeJonesMBA
Drs. Marks and Bumpus @US_FDA talking about regulatory issues related to cell and gene therapies @CancerResrch #cgt
-
Friends of Cancer Research
@CancerResrch
Starting now! Unlocking Complex Cell-based Gene Therapies Keynote Conversation. Featuring @lauriemcginley2, @DrBumpusFDA, Peter Marks.
Join us live: www.youtube.com/watch?v=-QJXlB9SNwI -
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
Starting now! @CancerResrch and @parkerici’s Cell Therapies Meeting. Join us online by registering here: friendsofcancerresearch.org/event/unlocking-complex-cell-…
-
Friends of Cancer Research
@CancerResrch
Starting now! “Unlocking Complex Cell-based Gene Therapies.” Join us live here: focr-org.zoom.us/j/84439041141
#cgt -
Friends of Cancer Research reposted
Parker Institute
@parkerici
There’s still time to virtually attend today’s “Unlocking Complex Cell-based Gene Therapies” public meeting, hosted by PICI and Friends of Cancer Research. The workshop begins at 10 am ET and can be viewed at: focr-org.zoom.us/j/84439041141.
Friends of Cancer Research
@CancerResrch
Join Friends and PICI for our public meeting virtually today! “Unlocking Complex Cell-based Gene Therapies." #cgt
Join here: focr-org.zoom.us/j/84439041141 -
Friends of Cancer Research reposted
David Mitchell
@DavidP4AD
On my way to this very important meeting to learn more about how we can ensure cell & gene therapies are accessible & affordable for all who need them. Right now, our system works poorly for patients. 1 out of 4 multiple myeloma patients dies waiting for CAR-T. Unacceptable.
Friends of Cancer Research
@CancerResrch
Join Friends and PICI for our public meeting virtually today! “Unlocking Complex Cell-based Gene Therapies." #cgt
Join here: focr-org.zoom.us/j/84439041141 -
Friends of Cancer Research
@CancerResrch
Join Friends and PICI for our public meeting virtually today! “Unlocking Complex Cell-based Gene Therapies." #cgt
Join here: focr-org.zoom.us/j/84439041141 -
Friends of Cancer Research
@CancerResrch
Join @CancerResrch and @parkerici tomorrow at 10AM ET! “Unlocking Complex Cell-based Gene Therapies” in Washington, DC. #cgt
View the agenda and register here: friendsofcancerresearch.org/event/unlocking-complex-cell-… -
Friends of Cancer Research reposted
Georgetown Lombardi
@LombardiCancer
🎉🔬 Our Comprehensive Cancer Center was awarded top designation by the federal gov't again! The "comprehensive cancer center" status from @theNCI recognizes our high-impact research, community outreach & cancer care. lombardi.georgetown.edu/national-cancer-institute-renews-… #wearencidesignated
-
Friends of Cancer Research
@CancerResrch
We are just three days away! See you on May 6th for our co-event with @parkerici, "Unlocking Complex Cell-based Gene Therapies," both in Washington, DC, and online. #cgt
Haven't registered yet? View the agenda and register here: friendsofcancerresearch.org/event/unlocking-complex-cell-… -
Friends of Cancer Research reposted
Parker Institute
@parkerici
All new edition of The Immuno-Oncology Digest is here! Tune in to the latest #picinetwork news, including a joint public meeting w/ @CancerResrch in DC, new research collaboration w/ @BostonGeneCorp, recent PICI-supported studies & more. Read here: mailchi.mp/parkerici/the-immuno-oncology-digest-20237390
-
Friends of Cancer Research reposted
Chris White
@MucosalMelanoma
@CancerResrch & @parkerici’s public meeting in Washington, DC “Unlocking Complex Cell- based Gene Therapies” will enable the next generation of proposals in the rapidly changing #cell and #gene therapy space.
Join us in person or virtually friendsofcancerresearch.org/event/unlocking-complex-cell-… -
Friends of Cancer Research
@CancerResrch
During @CancerResrch & @parkerici’s Unlocking Complex Cell-based Gene Therapies Session 2 we’ll discuss “Discovering & Developing the Next Generation of Cell-based Gene Therapies: Considerations for First-in-Human Trials.”
Register here: friendsofcancerresearch.org/event/unlocking-complex-cell-… -
Friends of Cancer Research
@CancerResrch
During @CancerResrch & @parkerici’s Unlocking Complex Cell-based Gene Therapies Session 1 we’ll discuss “Shaping the Future of Cell and Gene Therapies: Challenges & Opportunities.”
Register here: friendsofcancerresearch.org/event/unlocking-complex-cell-… -
Friends of Cancer Research
@CancerResrch
On Saturday evening at @LombardiCancer's Gala, Ellen Sigal, and Marlene A. Malek, were honored with The Director’s Champion in Research Award.
A special thank you to @LombardiCancer for this honor and their world-renowned research and tireless work on behalf of #patients. -
Friends of Cancer Research reposted
Chris White
@MucosalMelanoma
I’m excited to be a panelist during @CancerResrch & @parkerici’s public meeting in Washington, DC “Unlocking Complex Cell-based Gene Therapies” on Monday, May 6 from 10:00AM – 2:15PM ET.
Join us in person or virtually by registering here: friendsofcancerresearch.org/event/unlocking-complex-cell-… -
Friends of Cancer Research
@CancerResrch
Read Friends of Cancer Research's President & CEO Jeff Allen's statement on the @US_FDA's final rule to amend regulation related to oversight of diagnostic tests.
-
Friends of Cancer Research
@CancerResrch
Only a week away! Join @CancerResrch and @parkerici in person or virtually for an exciting public meeting “Unlocking Complex Cell-based Gene Therapies” in Washington, DC. #cgt
View the agenda and register here: friendsofcancerresearch.org/event/unlocking-complex-cell-… -
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
Last night, @LombardiCancer honored @CancerResrch founders Ellen Sigal and Marlene Malek at the Lombardi Gala. It was such an honor to attend and made me so incredibly proud to be part of such a wonderful organization!
-
Friends of Cancer Research
@CancerResrch
During @CancerResrch & @parkerici’s Unlocking Complex Cell-based Gene Therapies Session 2 we’ll discuss “Discovering & Developing the Next Generation of Cell-based Gene Therapies: Considerations for First-in-Human Trials.”
Register here: friendsofcancerresearch.org/event/unlocking-complex-cell-… -
Friends of Cancer Research
@CancerResrch
During @CancerResrch & @parkerici’s Unlocking Complex Cell-based Gene Therapies Session 1 we’ll discuss “Shaping the Future of Cell and Gene Therapies: Challenges & Opportunities.”
Register here: friendsofcancerresearch.org/event/unlocking-complex-cell-… -
Friends of Cancer Research
@CancerResrch
Bring Your Kid to Work Day at @CancerResrch has been a blast! We kept the kids busy with oncology-themed games. #inspiringfutureresearchers #startemyoung #tyktwd
-
Friends of Cancer Research
@CancerResrch
Cell therapies, such as chimeric antigen receptor (CAR) T-Cell therapies, are a type of immunotherapy in which immune cells are engineered to help a patient’s immune system fight cancer. Watch our explainer video to learn more: www.youtube.com/watch?v=hNgPU0wsrwI
#cgtfriends -
Friends of Cancer Research
@CancerResrch
Lung-MAP is a first-of-its-kind clinical trial model that uses a multi-drug, targeted screening approach to match patients with sub-studies testing investigational new treatments based on their unique tumor profiles. #lungmap
friendsofcancerresearch.org/lung-map/ -
Friends of Cancer Research
@CancerResrch
Under two weeks away! Register for “Unlocking Complex Cell-based Gene Therapies.” In Washington, DC on May 6th hosted by @CancerResrch and @parkerici featuring @US_FDA’s @DrBumpusFDA and Peter Marks.
Register here: friendsofcancerresearch.org/event/unlocking-complex-cell-… -
Friends of Cancer Research
@CancerResrch
@CancerResrch’s recent manuscript in @cytotherapy “Accelerated Development of Genetically Engineered #cellulartherapies: A Framework for Extrapolating #data Across Related Products” is a key output from our recent work in this space.
Read the manuscript: linkinghub.elsevier.com/retrieve/pii/S1465324924000975
Friends of Cancer Research
@CancerResrch
Next step is our public meeting! Register for our May 6th event with @parkerici: friendsofcancerresearch.org/event/unlocking-complex-cell-…
-
Friends of Cancer Research
@CancerResrch
Join @CancerResrch and @parkerici in person for an exciting public meeting “Unlocking Complex Cell-based Gene Therapies” in Washington, DC on May 6th.
Read the agenda and register: friendsofcancerresearch.org/event/unlocking-complex-cell-… -
Friends of Cancer Research reposted
Dr. Anthony Letai
@NCIDirector
As part of National Cancer Prevention and Early Detection Month, @theNCI is dedicated to the #cancermoonshot goal to prevent more cancers before they start + detect cancer early, when it’s most treatable. The #nationalcancerplan helps guide these efforts. nationalcancerplan.cancer.gov/goals
-
Friends of Cancer Research
@CancerResrch
New manuscript in @cytotherapy examines the current opportunities and challenges with development approaches of genetically engineered #cellulartherapies & proposes potential solutions to optimize development. #cgtfriends
Read the full publication: linkinghub.elsevier.com/retrieve/pii/S1465324924000975 -
Friends of Cancer Research
@CancerResrch
Register for “Unlocking Complex Cell-based Gene Therapies.” In Washington, DC on May 6th hosted by @CancerResrch and @parkerici featuring @US_FDA’s @DrBumpusFDA and Peter Marks.
Register here: friendsofcancerresearch.org/event/unlocking-complex-cell-… -
Friends of Cancer Research
@CancerResrch
Just published. New @CancerResrch manuscript in @cytotherapy “Accelerated Development of Genetically Engineered #cellular Therapies: A Framework for Extrapolating #data Across Related Products.” linkinghub.elsevier.com/retrieve/pii/S1465324924000975
-
Friends of Cancer Research
@CancerResrch
"Francis Collins' bravery in revealing his prostate cancer diagnosis inspires us all. His dedication to health and medical research has touched countless lives, and I am confident that his strength and resilience will guide him through this journey."
www.washingtonpost.com/health/2024/04/12/francis-collins-… -
Friends of Cancer Research
@CancerResrch
And that’s a wrap! Thank you @AACR for a great #aacr24 Annual meeting! @HillStirSci @BrittanyAnne340 @md_stewart
www.aacr.org/meeting/aacr-annual-meeting-2024/program/ -
Friends of Cancer Research reposted
Dr. Anthony Letai
@NCIDirector
We had an inspiring discussion this afternoon, building on the vision of the #cancermoonshot and the #nationalcancerplan. Thanks to my fellow panelists, our moderator, and everyone who attended! #aacr24
AACR
@AACR
The Cancer Moonshot: Opportunities to Fulfill the Vision of the National Cancer Plan—@DrRoyHerbstYale moderated an #aacrsciencepolicy session today at #aacr24, featuring @NCIDirector Kimryn Rathmell, @AACRPres Patricia M. LoRusso, @DrLizJaffee, and @biancaislam.
-
Friends of Cancer Research reposted
John Connolly
@John_E_Connolly
Looking forward to this amazing meeting with @CancerResrch covering models to move next generation cell and gene therapies to the clinic. #cagt
Friends of Cancer Research
@CancerResrch
Friends and @parkerici are proud to announce our upcoming meeting, Unlocking Complex Cell-based Gene Therapies. Discussions will enable the next generation of proposals in the cell and gene therapy space, reimagining trials and treatments for #patients. friendsofcancerresearch.org/event/unlocking-complex-cell-…
-
Friends of Cancer Research
@CancerResrch
We are excited to attend #aacr24! Friends’ Science team will be taking part in #aacr24! Follow along at #aacrfriends to stay up to date! @md_stewart @HillStirSci @BrittanyAnne340
www.aacr.org/meeting/aacr-annual-meeting-2024/program/ -
Friends of Cancer Research
@CancerResrch
Friends and @parkerici are proud to announce our upcoming meeting, Unlocking Complex Cell-based Gene Therapies. Discussions will enable the next generation of proposals in the cell and gene therapy space, reimagining trials and treatments for #patients. friendsofcancerresearch.org/event/unlocking-complex-cell-…
-
Friends of Cancer Research reposted
Georgetown Lombardi
@LombardiCancer
Ellen V. Sigal & Marlene A. Malek will receive the Director's Champion in Research Award for their unwavering dedication to Friends of Cancer Research (@CancerResrch), an organization that aims to accelerate the progress in cancer treatment.
-
Friends of Cancer Research reposted
Brem Foundation
@bremfoundation
Shout out to the Friends of @CancerResrch for being an Emerald Sponsor for Empower Hour 2024. Their support helps Brem Foundation to empower women through education and to break down access barriers.
Visit www.bremfoundation.org to support and secure your ticket by 5 pm today! -
Friends of Cancer Research
@CancerResrch
The ctMoniTR project is validating if blood biomarkers, such as #ctdna can be used to easily determine if a drug is working. By getting this information quickly & in a less invasive way, physicians & patients will understand if the treatment is effective.
friendsofcancerresearch.org/ctdna -
Friends of Cancer Research
@CancerResrch
Tune in this morning at 11AM ET to hear @CancerResrch's @HillStirSci speaking at @FredNatLab's #standardshub discussing "High Fidelity: Advancing Use Of Novel #technologies Through Collaboration."
Learn more and join live here: frederick.cancer.gov/events/high-fidelity-advancing-use-n… -
Friends of Cancer Research reposted
Double Whammy
@double_whammied
SO great 2C see this changing! Thx @DrJoeUnger
"The @ASCO/@CancerResrch/@US_FDA task force recs were associated w/a shift in patterns of brain mets exclusion criteria. These findings demonstrate #cancer #clinicaltrials are ... becoming more inclusive."
ascopubs.org/doi/abs/10.1200/JCO.23.01777 -
Friends of Cancer Research
@CancerResrch
Join @CancerResrch and @parkerici for an exciting public meeting “Unlocking Complex Cell-based Gene Therapies.” In Washington, DC on May 6th. Click here to read the agenda and register: friendsofcancerresearch.org/event/unlocking-complex-cell-…
-
Friends of Cancer Research reposted
Fight Colorectal Cancer
@FightCRC
As March comes to a close, our commitment to #colorectalcancer screening advocacy remains steadfast. With advocates nationwide, we're dedicated to advancing policies that enhance access to screenings in all communities.
Grateful for @ExactSciences support in our State Advocacy Priorities! #prioritizecrc
fightcolorectalcancer.org/advocacy/state-priorities/ -
Friends of Cancer Research
@CancerResrch
Friends is leading a new research partnership, the Digital PATH Project, to support robust development of digital and computational pathology platforms for use in oncology drug development. View our project page here: friendsofcancerresearch.org/digital-pathology/
-
Friends of Cancer Research
@CancerResrch
“Digital pathology tools can be even more precise than some diagnostic tests currently used to determine biomarker status and are enabling the next generation of #targeted therapies.” Learn more about the Digital PATH project here. #aioncology
friendsofcancerresearch.org/blog/digital-path-project-fut… -
Friends of Cancer Research
@CancerResrch
We continue to shape and inform the landscape of oncology drug development and regulatory policy through collaborative and innovative initiatives. Read our recently released 2023 impact report here: friendsofcancerresearch.org/impact-reports/2023-impact-re…
-
Friends of Cancer Research reposted
Targeted Onc
@TargetedOnc
Jeff Allen, PhD, explains the important work of Friends of Cancer Research in crafting policy to better optimize care for patients with cancer. @CancerResrch
www.targetedonc.com/view/allen-analyzes-initiatives-and-c… -
Friends of Cancer Research reposted
Marymount University
@marymountu
Our next #womenhistorymonth feature is on Marlene Malek ‘79. She is a devoted Marymount alumna, longtime Board member, Halo Award winner and dedicated supporter of the institution.
She also serves as Vice Chair of @CancerResrch, advocating for patient-friendly policies. -
Friends of Cancer Research
@CancerResrch
"Action to ensure high-quality test performance is needed, and progress to that end can no longer be stalled. The future of precision medicine and the health and lives of patients depends on the accuracy of these tests."
Jeff Allen @HouseCommerce hearing www.youtube.com/watch?v=U2YKx7H6pEw -
Friends of Cancer Research
@CancerResrch
"It is imperative that these tests’ performance and accuracy be well characterized before their results are used for important treatment decisions."
Friends Jeff Allen live at a @HouseCommerce
hearing discussing #diagnostic test regulation. Watch here: www.youtube.com/watch?v=U2YKx7H6pEw -
Friends of Cancer Research
@CancerResrch
We are excited to share our 2023 highlights and the strides we continue to make for patients. Click to view a snapshot of our 2023 policy and research programs and outcomes. friendsofcancerresearch.org/impact-reports/2023-impact-re…
-
Friends of Cancer Research
@CancerResrch
Friends continues to shape and inform the landscape of oncology drug development and regulatory policy through collaborative and innovative initiatives. Read our recently released impact report here: friendsofcancerresearch.org/impact-reports/2023-impact-re…
-
Friends of Cancer Research
@CancerResrch
We are proud to sign on to this Call to Action to ensure policymakers have the tools and facts they need to mitigate and prevent US #drugshortages.
USP
@USPharmacopeia
Every day, patients and providers face impossible choices when they can’t access the medicines they need, when they need them. Policymakers must work together to enact systemic solutions to #drugshortages. Get the facts and get involved ⤵️ and #repost to spread the word.
-
Friends of Cancer Research
@CancerResrch
Today, @US_FDA is convening it’s Oncologic Drugs Advisory Committee to review new clinical data for two CAR-T therapies—Carvykti & Abecma. This meeting will provide important insights into the safety and effectiveness for this emerging class of therapy.
www.fda.gov/advisory-committees/advisory-committee-calend… -
Friends of Cancer Research
@CancerResrch
Watch Friends #patient #advocate Patsy Hinson share her perspective on the importance of the (HRD) Harmonization Project. #hrdfriends
www.youtube.com/watch?v=cdVxeF4rga0 -
Friends of Cancer Research
@CancerResrch
Selecting the optimal dosage requires a robust understanding of a therapy’s efficacy, safety, and tolerability. Visit Friends tolerability page to learn more about our work in this critical space. friendsofcancerresearch.org/tolerability/
#friendsdosing #doseoptimization -
Friends of Cancer Research reposted
Cancer Research Institute
@CancerResearch
Limiting eligibility criteria, recruiting trusted community messengers, and reducing financial burdens can help improve diversity of clinical trial enrollees, a panel of professionals shared during a @CancerResrch webinar. More in @GoHealio: www.healio.com/news/hematology-oncology/20240219/expandin… #clinicaltrial
-
Friends of Cancer Research
@CancerResrch
Cell and gene therapies are emerging therapies that represent a new treatment paradigm for many diseases including cancer. Watch Friends explainer video and learn about our important work. #cgtfriends
www.youtube.com/watch?v=hNgPU0wsrwI -
Friends of Cancer Research
@CancerResrch
Missed #friends #diagnostic meeting? Click the link to watch the full event:
www.youtube.com/watch?v=OzWzZH5Bhrk&t=4283s -
Friends of Cancer Research reposted
Dr. Anthony Letai
@NCIDirector
March is #colorectalcancerawarenessmonth! There’s exciting @NCI-funded research underway to advance our understanding of how to prevent, detect, and treat #colorectalcancer. www.cancer.gov/types/colorectal/research
-
Friends of Cancer Research
@CancerResrch
Watch #hrd project partner Lisa McShane from the NIH speaking to the importance of the HRD biomarker for patients. #hrdfriends
-
Friends of Cancer Research reposted
Ashley Love Sumrall, MD, FACP, FASCO
@AshleySumrallMD
The Carolinas team from @OVACInfo is headed out to meet w lawmakers from NC & SC. Let's ENSURE funding for cancer research & prevention for #fy24 & #fy25. The goal for Congress to decide is March 22. @ASCO #onctwitter Help us. Tell your lawmakers 👉🏻 asco.quorum.us/campaign/45495/
-
Friends of Cancer Research
@CancerResrch
Missed our public meeting, Enhancing Diversity in Clinical Trials: Implementation of Diversity Plans? #diversetrials
Watch the full event here: www.youtube.com/watch?v=oCRin9sdNBs -
Friends of Cancer Research reposted
Lung-MAP
@LungMAP
Basket trials. Umbrella trials. Platform trials. What's the difference? Here's a clear explanation from Andrew Ciupek of @GO2forLungCancr: go2.org/blog/new-clinical-trial-designs-in-the-era-of-pre…. @LungMAP is an umbrella trial in #nsclc #lungcancer. Patients are matched to targeted therapy by #biomarker testing.
-
Friends of Cancer Research
@CancerResrch
Friends created a series of interactive dashboards as a tool to gain data driven insights into the landscape of oncology drug development and FDA drug approvals. Access this great resource here: friendsofcancerresearch.org/drug-development-dashboard/
-
Friends of Cancer Research
@CancerResrch
Missed Friends #clinicaltrials discussion on how to improve clinical trials #diversity to better represent patient needs and improve study generalizability? Click to read the meetings discussion document here: adobe.ly/3T61Ktz
-
Friends of Cancer Research
@CancerResrch
In 2023, Friends shaped the landscape of oncology drug development and regulatory policy, bringing advancements in treatment to #patients.
Read our full report here: friendsofcancerresearch.org/wp-content/uploads/Friends-Sc… -
Friends of Cancer Research
@CancerResrch
Today, @CancerResrch President & CEO Jeff Allen presented results at #io360 from our ctMoniTR Project, suggesting that changes in ctDNA levels may provide early indication of treatment response and predict long-term outcomes
Friends #ctmonitr Project Page: friendsofcancerresearch.org/ctdna/ -
Friends of Cancer Research
@CancerResrch
Tune in today to watch @md_stewart live at #io360 discussing #data extrapolation to accelerate next gen #cellular immunotherapies.
io360summit.com -
Friends of Cancer Research
@CancerResrch
Missed Friends #diagnostic meeting? Click to watch the full event here: www.youtube.com/watch?v=OzWzZH5Bhrk
-
Friends of Cancer Research reposted
Harpreet Singh, MD
@harpreet_md
OCE past and present ! Amy McKee, Gideon Blumenthal, Rick Pazdur, Julia Beaver, Geoff Kim, Jenny Gao at the FOCR and Prevision Policy BioPharma Congress ✨ @FDAOncology reunion
-
Friends of Cancer Research
@CancerResrch
“We spend a lot of time prepping our members to infuse patients in our decision making.” Jennifer Dexter from the @NHCouncil discussing drug payment and access live at #biopharmacongress24
-
Friends of Cancer Research reposted
Timil Patel, MD
@timilpatel
An OCE reunion at Biopharma Congress! A fun & interesting discussion led by Rick Pazdur on misconceptions of the FDA and industry from individuals who know both arenas very well! @FDAOncology @CancerResrch @PrevisionPolicy
-
Friends of Cancer Research
@CancerResrch
“What matters is if your data can convince them.” Amy McKee from @Parexel speaking to the importance of a data first approach to working with the @US_FDA.
#biopharmacongress24 -
Friends of Cancer Research
@CancerResrch
“There are all of these verbal and nonverbal cues in-person, you are less likely to interject in a virtual meeting.” @realrickpazdur emphasizing the importance of shift advisory committee meetings back to in person.
#biopharmacongress24 -
Friends of Cancer Research
@CancerResrch
"I would recommend that rather than just sending a platform statute, come in to the FDA and have a conversation with us." CBER Director Peter Marks live at Biopharma Congress. #biopharma24
-
Friends of Cancer Research
@CancerResrch
Today! #biopharmacongress featuring @realrickpazdur @DrWoodcockFDA
@US_FDA
@FDAOncology -
Friends of Cancer Research
@CancerResrch
Register for #biopharmacongress this Monday in Washington, DC. Featuring @US_FDA's Richard Pazdur, Peter Marks and Former Principal Deputy Commissioner, Janet Woodcock.
Register here: biopharmacongress.com/register -
Friends of Cancer Research
@CancerResrch
In 2023, Friends shaped and informed the landscape of oncology drug development and regulatory policy, bringing advancements in treatment to #patients through collaborative initiatives.
Read our 2023 Scientific Report here: friendsofcancerresearch.org/wp-content/uploads/Friends-Sc… -
Friends of Cancer Research
@CancerResrch
Missed our public meeting, Enhancing Diversity in Clinical Trials: Implementation of Diversity Plans?
Watch the full event here : www.youtube.com/live/oCRin9sdNBs
#diversetrials -
Friends of Cancer Research reposted
Ramsey Baghdadi
@Ramsey_Baghdadi
Should be fun! Advisory Committee panel with Pazdur, CBER's Celia Witten, CDER's Peter Stein, and Caleb Alexander; CMS/CMMI Deputy Director Ellen Lukens to talk gene therapy models. And of course, Peter Marks to kick things off.
Friends of Cancer Research
@CancerResrch
Join @PrevisionPolicy and @CancerResrch next week on February 26th in Washington, DC for #biopharmacongress featuring @realrickpazdur @DrWoodcockFDA
Click to register: biopharmacongress.com
@US_FDA -
Friends of Cancer Research
@CancerResrch
Join @PrevisionPolicy and @CancerResrch next week on February 26th in Washington, DC for #biopharmacongress featuring @realrickpazdur @DrWoodcockFDA
Click to register: biopharmacongress.com
@US_FDA -
Friends of Cancer Research reposted
Mark Wildgust (he/him)
@MAWildgust
@CancerResrch event has been excellent today! So much potential for Real World Data use! More work to be done to support changes! These changes have the potential to positively inform care for patients and also support regulatory approvals which has the potential to provide more access for patients!
-
Friends of Cancer Research
@CancerResrch
“We are looking into how we can limit clinical documentation burden with technology and improved data capture structure.” @flatironhealth's Neal Meropol discussing opportunities to improve data collection and standardization. #rwe
Watch here: advancingrwdinoncologyworkshop.splashthat.com/virtual?gue… -
Friends of Cancer Research
@CancerResrch
“We know patients are moving around. 2% of patients using Epic have 4 or more organizations they are being seen at.” Phil Lindemann speaking live at "Advancing Real-World Data to Generate Regulatory Grade Real-World Evidence in Oncology."
Join live: advancingrwdinoncologyworkshop.splashthat.com/virtual?gue… -
Friends of Cancer Research
@CancerResrch
Starting now! Session 3: An exploration of efforts to improve data collection and standardization. #rwe
Join us live here: advancingrwdinoncologyworkshop.splashthat.com/virtual?gue… -
Friends of Cancer Research
@CancerResrch
Starting now! Session 2: A deep dive into opportunities for patient-centered real-world data.
Featuring: Dr. Rachele Hendricks-Sturrup, Amanda Borens, Erlyn Macarayan, Laura Esserman, Laura Fernandes.
Join us live here: advancingrwdinoncologyworkshop.splashthat.com/virtual?gue… -
Friends of Cancer Research
@CancerResrch
"Why is it so hard for clinicians to see and find relevant information about patient healthcare records?"
Data scientist and cancer patient Amanda Borens sharing her experience. #rwe
Join us live here: advancingrwdinoncologyworkshop.splashthat.com/virtual?gue… -
Friends of Cancer Research
@CancerResrch
Starting now! Session 1: Discussion of recent experiences and the state of play.
Featuring: Carla Rodriguez, Nicole Mahoney, Donna Rivera, Ulka Campbell, Jeff Allen.
Join us live here: advancingrwdinoncologyworkshop.splashthat.com/virtual?gue… -
Friends of Cancer Research
@CancerResrch
"As we talk today about the regulatory applications of real world data it's important to keep in mind that the regulatory use is just one data quality check." Jeff Allen speaking live at, "Advancing RWD to Generate Regulatory Grade RWE in Oncology."
duke.zoom.us/w/93348014768?tk=-EiPKFgtVlGb4JCJ7fB7ICALoYm… -
Friends of Cancer Research
@CancerResrch
Today! Free public meeting, “Advancing Real-World Data to Generate Regulatory Grade Real-World Evidence in Oncology.” Co-hosted with @DukeMargolis @aetioninc @reaganudall
Register: advancingrwdinoncologyworkshop.splashthat.com
#rwefriends -
Friends of Cancer Research
@CancerResrch
Join us tomorrow virtually for a free public meeting, “Advancing Real-World Data to Generate Regulatory Grade Real-World Evidence in Oncology.” Co-hosted with @DukeMargolis @aetioninc @reaganudall
Register: friendsofcancerresearch.org/event/advancing-real-world-da… -
Friends of Cancer Research
@CancerResrch
Missed last week’s Enhancing Diversity in Clinical Trials: Implementation of Diversity Plans meeting? Click the link to watch the full event: www.youtube.com/live/oCRin9sdNBs
#diversetrials -
Friends of Cancer Research reposted
Fight Colorectal Cancer
@FightCRC
Watch Now ▶️: @CancerResrch hosted an "Enhancing Diversity in Clinical Trials" meeting featuring #fightcrc president @AnjeeDavis, highlighting insights & recommendations for implementing diversity plans!
www.youtube.com/watch?v=oCRin9sdNBs&t=82s -
Friends of Cancer Research
@CancerResrch
Missed yesterday's @CancerResrch Enhancing Diversity in Clinical Trials meeting? Click the link to watch the full meeting: www.youtube.com/watch?v=oCRin9sdNBs&t=83s
#clinicaltrials #diversetrials -
Friends of Cancer Research
@CancerResrch
Former U.S. FDA Commissioner @ScottGottliebMD highlights the #validact as an effective framework for regulating #ai medical devices, noting its compatibility with #ivds and #ldts.
-
Friends of Cancer Research
@CancerResrch
Former U.S. FDA Commissioner @ScottGottliebMD discusses the transformative potential of easing regulatory burdening, evolving commercial dynamics in #diagnostics, and FDA’s proactive approach to risk mitigation in diagnostic tests.
-
Friends of Cancer Research
@CancerResrch
That’s a wrap! Thank you to all of our incredible speakers and panelists for joining us to discuss enhancing diversity in Clinical Trials.
Watch the full event here: www.youtube.com/watch?v=oCRin9sdNBs
#diversetrials -
Friends of Cancer Research
@CancerResrch
“You have to show up. You have to show up in your community. What’s really important is that the faculty and staff you hire are representative of these communities.” @DrEdKim from @cityofhope speaking live at Friends Virtual Meeting.
Join us now: www.youtube.com/watch?v=oCRin9sdNBs -
Friends of Cancer Research
@CancerResrch
Starting now! Session 2: Operational Approaches and Insights for More Inclusive Clinical Trials.
Featuring:
@AnjeeDavis, Lucy Gansauer, @DrEdKim , Kristi Mitchell, Nicole Richie
Watch here: www.youtube.com/watch?v=oCRin9sdNBs -
Friends of Cancer Research
@CancerResrch
“It is critical that the development and implementation of AI models assess and mitigate algorithmic biases.” Cleo A. Ryals, @flatironhealth live at Session 1: Data-Driven Approaches for Establishing Diversity Enrollment Targets.
www.youtube.com/watch?v=oCRin9sdNBs
#diversetrials -
Friends of Cancer Research
@CancerResrch
“It’s so important to establish a multidisciplinary team.” Xoli Belgrave, @Parexel live at Session 1: Data-Driven Approaches for Establishing Diversity Enrollment Targets.
www.youtube.com/watch?v=oCRin9sdNBs
#diversetrials -
Friends of Cancer Research
@CancerResrch
Starting now! Session 1: Data-Driven Approaches for Establishing Diversity Enrollment Targets.
Featuring: Riha Vaidya, Xoli Belgrave, Henry Bennett, Lola Fashoyin-Aje, Anne-Michelle Noone, Cleo A. Ryals
Watch live: www.youtube.com/watch?v=oCRin9sdNBs -
Friends of Cancer Research
@CancerResrch
“This is a time of unique opportunity to advance clinical trial diversity. Implementation of the appropriate compliment of tools holds great promise.” @DrBumpusFDA speaking @CancerResrch's virtual meeting, Enhancing Diversity in Clinical Trials: Implementation of Diversity Plans.
-
Friends of Cancer Research
@CancerResrch
“Patients and their families should not have to wait any longer to be a part of life changing clinical trials." @RepAnnaEshoo speaking @CancerResrch's virtual meeting, Enhancing Diversity in Clinical Trials: Implementation of Diversity Plans.
www.youtube.com/watch?v=oCRin9sdNBs -
Friends of Cancer Research
@CancerResrch
Starting now! "Enhancing Diversity in Clinical Trials." The meeting will highlight recommendations for implementing diversity plans, the use of various #data sources to create them, & current practices to establish enrollment goals.
Join us live: focr-org.zoom.us/j/89723224244 -
Friends of Cancer Research
@CancerResrch
Starting soon! "Enhancing Diversity in Clinical Trials Virtual Meeting." The meeting will highlight recommendations for implementing diversity plans, the use of various #data sources to create them, & current practices to establish enrollment goals.
friendsofcancerresearch.org/event/enhancing-diversity-in-… -
Friends of Cancer Research
@CancerResrch
Register for @CancerResrch’s virtual meeting tomorrow! The meeting will highlight insights & recommendations for implementing diversity plans, the use of various data sources to create them, & current practices to establish enrollment goals.
Register: friendsofcancerresearch.org/event/enhancing-diversity-in-… -
Friends of Cancer Research reposted
The Cancer Letter
@TheCancerLetter
Friends of Cancer Research (@CancerResrch) initiates Digital PATH research partnership.
cancerletter.com/drugs-and-targets/20240209_7b/ -
Friends of Cancer Research
@CancerResrch
In 2023, @CancerResrch shaped the landscape of oncology drug development and regulatory policy, bringing advancements in treatment to #patients.
Read our full report here: friendsofcancerresearch.org/wp-content/uploads/Friends-Sc… -
Friends of Cancer Research reposted
NMQF
@NMQF
Jeff Allen of @CancerResrch discusses Early Detection Screenings in Underserved Communities at last month's #cancercareequitysummit.
View more from the event. shiftcancer.org/gallery/2024-cancer-care-equity-summit/
#bidencancermoonshot #cces2024 @CEOCancerfight -
Friends of Cancer Research reposted
The Cancer Letter
@TheCancerLetter
.@DrRoyHerbstYale and @Esigal discuss how drug sponsors and researchers should focus on building and utilizing rich real-world evidence databases that can be used to complement clinical trials as AI becomes an indispensable tool in cancer research.
cancerletter.com/conversation-with-the-cancer-letter/2024… -
Friends of Cancer Research
@CancerResrch
Join @CancerResrch on Feb. 15 at 12pm ET to explore strategies for inclusive #clinicaltrials! We'll discuss how to improve clinical trials #diversity to better represent patient needs and improve study generalizability.
Read the discussion document here: adobe.ly/3T61Ktz -
Friends of Cancer Research
@CancerResrch
This week! @CancerResrch’s Enhancing Diversity in Clinical Trials virtual meeting on February 15 at 12:0PM ET.
Register here: friendsofcancerresearch.org/event/enhancing-diversity-in-…
#diversetrials -
Friends of Cancer Research
@CancerResrch
At @CancerResrch’s Enhancing Diversity in Clinical Trials meetings Session 1, our panelists will discuss “Data-Driven Approaches for Establishing Diversity Enrollment Targets.” #diversetrials
Register here: friendsofcancerresearch.org/event/enhancing-diversity-in-… -
Friends of Cancer Research reposted
The Cancer Letter
@TheCancerLetter
Ellen Sigal (@Esigal), Roy Herbst (@DrRoyHerbstYale): Friends (@CancerResrch) and @FDAOncology to focus on real-world evidence, AI, and streamlined trials in 2024.
cancerletter.com/conversation-with-the-cancer-letter/2024… -
Friends of Cancer Research reposted
Foundation for FDA
@reaganudall
Connect with regulatory experts, academia, clinicians, patients, and representatives across various sectors to discuss optimizing #rwd in #oncology on Tuesday, February 20, at 9am (eastern). @DukeMargolis @CancerResrch @aetioninc
Learn more and register: advancingrwdinoncologyworkshop.splashthat.com -
Friends of Cancer Research
@CancerResrch
Missed last weeks meeting? Watch Friends #patient #advocate Patsy Hinson share her perspective on the importance of the (HRD) Harmonization Project. youtu.be/cdVxeF4rga0
-
Friends of Cancer Research
@CancerResrch
Our virtual meeting on February 15 will highlight insights and recommendations for implementing diversity plans, the use of various data sources, and current practices to establish enrollment goals.
Register here: friendsofcancerresearch.org/event/enhancing-diversity-in-… -
Friends of Cancer Research
@CancerResrch
Join @PrevisionPolicy and @CancerResrch on February 26th in Washington, DC for #biopharmacongress featuring @realrickpazdur @DrWoodcockFDA
Click to register: biopharmacongress.com
@US_FDA @FDAOncology -
Friends of Cancer Research
@CancerResrch
In 2023, Friends shaped and informed the landscape of oncology drug development and regulatory policy, bringing advancements in treatment to #patients through collaborative initiatives.
Read our 2023 Scientific Report here: friendsofcancerresearch.org/wp-content/uploads/Friends-Sc… -
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
So lucky to work with @2020VisionGirl and our other Advisory Advocates on the #digitalpath Project!
Friends of Cancer Research
@CancerResrch
“The Digital PATH project is very important for consistency in getting an accurate diagnosis so patients can get the correct treatment.” #patientadvocate Joan Mancuso discussing why Friends new #digitalpath project is critical for #patients. #aioncology
www.youtube.com/watch?v=G54lEsVnLso -
Friends of Cancer Research
@CancerResrch
“The Digital PATH project is very important for consistency in getting an accurate diagnosis so patients can get the correct treatment.” #patientadvocate Joan Mancuso discussing why Friends new #digitalpath project is critical for #patients. #aioncology
www.youtube.com/watch?v=G54lEsVnLso -
Friends of Cancer Research reposted
Parexel
@Parexel
The FDA emphasizes the importance of establishing diversity plans to ensure #diversetrials and treatments that are equally safe and effective across all populations. Xoli Belgrave joins @CancerResrch to discuss strategies for implementing diversity plans in clinical trials:
-
Friends of Cancer Research
@CancerResrch
Missed Friends #diagnostic meeting last week’s? Click to watch the full meeting: www.youtube.com/watch?v=OzWzZH5Bhrk&t=13211s
-
Friends of Cancer Research
@CancerResrch
During Friends Enhancing Diversity in Clinical Trials virtual meeting on February 15, panelists in Session 1 will discuss the steps to establish enrollment targets. #diversetrials
Register here: friendsofcancerresearch.org/event/enhancing-diversity-in-… -
Friends of Cancer Research
@CancerResrch
Missed yesterday's @CancerResrch #diagnostic meeting? Click the link to watch the full meeting: www.youtube.com/watch?v=OzWzZH5Bhrk&t=13211s
#friendsdx -
Friends of Cancer Research
@CancerResrch
Join Friends virtual meeting on February 15 at 12:00PM ET! Discussions will highlight insights and recommendations for implementing diversity plans, the use of various data sources, and current practices to establish enrollment goals.
Register here: friendsofcancerresearch.org/event/enhancing-diversity-in-… -
Friends of Cancer Research
@CancerResrch
And thats a wrap! Thank you to everyone for joining us in room and virtually for todays #frienddx meeting. We are deeply appreciative of our numerous project partners and for everyones involvement in this critical work.
Click to watch the full event: www.youtube.com/watch?v=OzWzZH5Bhrk -
Friends of Cancer Research
@CancerResrch
Packed house at #friendsdx Public Meeting! Join us virtually for our final session of the day "Navigating an Evolving Regulatory and Policy Landscape."
www.youtube.com/watch?v=OzWzZH5Bhrk -
Friends of Cancer Research
@CancerResrch
“The quality that we are trying to standardize requires a regulatory and policy landscape that effects all elements to ensure you have a high quality diagnostic.” Joe Lennerz at #friendsdx Session 3: Navigating an Evolving Regulatory and Policy Landscape.
www.youtube.com/watch?v=OzWzZH5Bhrk -
Friends of Cancer Research
@CancerResrch
“The reliability of testing is so critical because it informs treatment decisions and ultimately impacts #patient outcomes.” Patient Advocate Lia Ridout discussing how crucial testing reliability is from the patient perspective at #friendsdx.
Watch here: www.youtube.com/watch?v=OzWzZH5Bhrk -
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
And our final panel includes a variety of perspectives to discuss regulatory paradigms and proposed policies for diagnostic tests. @CancerResrch #friendsdx
-
Friends of Cancer Research
@CancerResrch
Starting now, Session 3: Navigating an Evolving Regulatory and Policy Landscape. Moderated by @Kate_Rawson
www.youtube.com/watch?v=OzWzZH5Bhrk
Featuring speakers from the following organizations:
@PrevisionPolicy @MFBerger1 @MSKCancerCenter @RocheDia @LoxoLillyOnc @US_FDA -
Friends of Cancer Research
@CancerResrch
Former @US_FDA Commissioner @ScottGottliebMD responds live to recent FDA action on diagnostics at Friends Public Meeting.
Listen to his remarks live here: www.youtube.com/watch?v=OzWzZH5Bhrk
#aioncology #friendsdx #hrdfriends -
Friends of Cancer Research
@CancerResrch
“Near term ai applications are going to be on the delivery side and the discovery side.” Former @US_FDA Commissioner @ScottGottliebMD discussing the impact of #ai on healthcare with @LaurenRSilvis live at Friends of Cancer Research's Public Meeting.
www.youtube.com/watch?v=OzWzZH5Bhrk -
Friends of Cancer Research
@CancerResrch
Just announced! @CancerResrch Digital PATH Project. This project will identify factors that may contribute to variability in biomarker assessment, propose areas for alignment in the field, and provide regulatory process insights.
Press release: friendsofcancerresearch.org/news/friends-of-cancer-resear…
#aioncology -
Friends of Cancer Research
@CancerResrch
“We need to reduce variability and the best way to do that is to ensure more research training.” Brandon Gallas @FDAcdrhIndustry during Session 2.
www.youtube.com/watch?v=OzWzZH5Bhrk
@US_FDA @FDAcdrhIndustry @FredNatLab @AstraZeneca @4DPath -
Friends of Cancer Research reposted
Angela
@AngelaHecyk
@CancerResrch facilitates collaborative initiatives oncology drug development and regulatory policy. Join the conversation:
Friends of Cancer Research
@CancerResrch
Starting now! Join us @CancerResrch ’s Public Meeting “The Future of Diagnostic Tests: New Data & Modern Policy.”
Join live: focr-org.zoom.us/j/86588238443 #friendsdx
www.youtube.com/watch?v=lF57vDeogS8&t=6s -
Friends of Cancer Research
@CancerResrch
Join us live for Session 2: Supporting Digital and Computational #pathology: Launching a Demonstration Project.
www.youtube.com/watch?v=OzWzZH5Bhrk
Featuring speakers from the following organizations:
@US_FDA @FDAcdrhIndustry @FredNatLab @AstraZeneca @4DPath -
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
Now some representatives from our HRD Harmonization working group are discussing findings and implications for the field. #hrdfriends
Learn more about the project here: friendsofcancerresearch.org/hrd/ -
Friends of Cancer Research
@CancerResrch
“The goal is to answer, can we identify more accurately those who will benefit from these agents.”
Lisa McShane @theNCI live at "Session 1: Aligning on Approaches to Measuring #hrd: Findings from the HRD Harmonization Project"
www.youtube.com/watch?v=OzWzZH5Bhrk
#hrdfriends -
Friends of Cancer Research
@CancerResrch
Starting now, Session 1: Aligning on Approaches to Measuring #hrd: Findings from the HRD Harmonization Project
www.youtube.com/watch?v=OzWzZH5Bhrk
#friendsdx #aioncology #hrdfriends -
Friends of Cancer Research
@CancerResrch
Watch @HillStirSci's presentation on #hrd Harmonization project findings.
www.youtube.com/watch?v=OzWzZH5Bhrk
#friendsdx #aioncology #hrdfriends -
Friends of Cancer Research
@CancerResrch
“At the FDA we are trying to answer the question, how do we move care out of healthcare institutions and take it to where people are?" Jeff Shuren @FDAcdrhIndustry @US_FDA live at Friends public meeting
Watch here: www.youtube.com/watch?v=OzWzZH5Bhrk
#friendsdx -
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
Starting the @CancerResrch The Future of Diagnostic Tests: New Data & Modern Policy with a presentation from Dr. Jeff Shuren of @FDADeviceInfo. Join us!
friendsofcancerresearch.org/event/the-future-of-diagnosti… -
Friends of Cancer Research
@CancerResrch
Watch Friends opening keynote conversation with Jeff Shuren, Director, CDRH, @USFDA @FDAcdrhIndustry
Join live: www.youtube.com/watch?v=OzWzZH5Bhrk
#friendsdx -
Friends of Cancer Research
@CancerResrch
Starting now! Join us @CancerResrch ’s Public Meeting “The Future of Diagnostic Tests: New Data & Modern Policy.”
Join live: focr-org.zoom.us/j/86588238443 #friendsdx
www.youtube.com/watch?v=lF57vDeogS8&t=6s -
Friends of Cancer Research
@CancerResrch
Starting soon! Join us @CancerResrch’s Public Meeting “The Future of Diagnostic Tests: New Data & Modern Policy.”
Join live: focr-org.zoom.us/j/86588238443
#friendsdx friendsofcancerresearch.org/event/the-future-of-diagnosti… -
Friends of Cancer Research reposted
Kate Rawson Powell
@Kate_Rawson
Looking forward to moderating at @CancerResrch’s Public Meeting “The Future of Diagnostic Tests: New Data & Modern Policy” Thursday, Feb. 1st, 2024 from 10:00AM - 2:30PM ET. Click to register here: friendsofcancerresearch.org/event/the-future-of-diagnosti…
#aioncology #friendsdx #hrdfriends -
Friends of Cancer Research
@CancerResrch
Tomorrow! Join Friends Public Meeting “The Future of Diagnostic Tests: New Data & Modern Policy” Thursday, Feb. 1st, 2024 from 10:00AM - 2:30PM ET – in Washington DC and streamed virtually.
Register here: friendsofcancerresearch.org/event/the-future-of-diagnosti… -
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
So proud of all we accomplished in 2023 and so excited for what’s to come in 2024! @CancerResrch
Friends of Cancer Research
@CancerResrch
In 2023, @CancerResrch played a key role in shaping and informing the landscape of oncology drug development and regulatory policy to bring advancements in treatment to #patients through collaborative initiatives.
Read our 2023 Scientific Report here: friendsofcancerresearch.org/wp-content/uploads/Friends-Sc… -
Friends of Cancer Research reposted
BostonGeneCorp
@BostonGeneCorp
BostonGene's CSO, Dr. Joe Lennerz, MD, PhD, will join a panel on 2/1 at @CancerResrch's #diagnostic meeting to discuss regulatory methods for accurate diagnostic tests in Session 3.
Register: friendsofcancerresearch.org/event/the-future-of-diagnosti…
#aioncology #friendsdx #hrdfriends -
Friends of Cancer Research
@CancerResrch
In 2023, @CancerResrch played a key role in shaping and informing the landscape of oncology drug development and regulatory policy to bring advancements in treatment to #patients through collaborative initiatives.
Read our 2023 Scientific Report here: friendsofcancerresearch.org/wp-content/uploads/Friends-Sc… -
Friends of Cancer Research reposted
The Cancer Letter
@TheCancerLetter
"My 25-year friendship with @DrWoodcockFDA began at a time when skepticism about the FDA’s role in cancer was rampant. Yet, it was her openness to addressing these challenges that marked the start of a transformative era." - Ellen V. Sigal (@CancerResrch)
cancerletter.com/guest-editorial/20240126_5/ -
Friends of Cancer Research
@CancerResrch
This Thursday, Jeff Shuren from @FDADeviceInfo, @ScottGottliebMD and @LaurenRSilvis will discuss the importance of regulatory frameworks and policy to support innovative test development during @CancerResrch’s Public Meeting.
Register here: friendsofcancerresearch.org/event/the-future-of-diagnosti…
#friendsdx -
Friends of Cancer Research
@CancerResrch
"The story of Janet Woodcock's illustrious career is not just one of professional achievements; it's a tale of enduring partnerships, empathetic leadership, and unwavering commitment to science and patient care that will continue as she leaves public service this year." @Esigal
The Cancer Letter
@TheCancerLetter
Reflecting on Janet Woodcock’s (@DrWoodcockFDA) retirement from @US_FDA. Guest editorial by Ellen Sigal (@Esigal).
cancerletter.com/guest-editorial/20240126_5/ -
Friends of Cancer Research reposted
FDLI
@foodanddruglaw
Join our sponsors @EliLillyandCo, PWR, and our partners @CancerResrch, @ResearchAmerica @NHCouncil @EveryLifeOrg on Feb. 7-8 to learn the essentials of drug and device law and how to engage with FDA to better support your organization's advocacy efforts. www.fdli.org/2024/02/2024-essentials-of-the-fda-landscape…
-
Friends of Cancer Research
@CancerResrch
Click below to watch a sneak peak of next week’s meeting! “The Future of Diagnostic Tests: New Data & Modern Policy.”
www.youtube.com/watch?v=5v8_wdjuQvw -
Friends of Cancer Research
@CancerResrch
“New technologies, like multi-cancer detection tests, hold the potential for significant impact to cancer care." Jeff Allen @NMQF Summit highlighting our collaborative efforts regarding the role of #rwe
friendsofcancerresearch.org/wp-content/uploads/MCED_Scree…
www.youtube.com/watch?v=3a3-QfEOx4s
#bidencancermoonshot #cces -
Friends of Cancer Research
@CancerResrch
Only a week away! Join @CancerResrch’s Public Meeting “The Future of Diagnostic Tests: New Data & Modern Policy” Thursday, Feb. 1st, 2024 from 10:00AM - 2:30PM ET – in Washington DC and streamed virtually.
Register here: friendsofcancerresearch.org/event/the-future-of-diagnosti… -
Friends of Cancer Research
@CancerResrch
During Session 1 of @CancerResrch’s Enhancing Diversity in Clinical Trials meeting, we will discuss the data used to establish enrollment targets for #diversity action plans.
Register here: friendsofcancerresearch.org/event/enhancing-diversity-in-… -
Friends of Cancer Research
@CancerResrch
Join @CancerResrch’s virtual meeting on February 15 at 12PM ET! Discussions will highlight insights & recommendations for implementing diversity plans, the use of various data sources, & current practices to establish enrollment goals.
Register here: friendsofcancerresearch.org/event/enhancing-diversity-in-… -
Friends of Cancer Research
@CancerResrch
Next Thursday Feb 1, Jeff Shuren @FDADeviceInfo, @ScottGottliebMD & @LaurenRSilvis will discuss the importance of regulatory frameworks & policy to support innovative test development during @CancerResrch’s Public Meeting.
Register here: friendsofcancerresearch.org/event/the-future-of-diagnosti…
#friendsdx -
Friends of Cancer Research reposted
Foundation for FDA
@reaganudall
Connect with regulatory experts, academia, clinicians, patients, and representatives across various sectors to discuss optimizing #rwd in #oncology on Tuesday, February 20, at 9am (eastern). @DukeMargolis @CancerResrch @aetioninc
Learn more and register: advancingrwdinoncologyworkshop.splashthat.com -
Friends of Cancer Research
@CancerResrch
Join Friends' Public Meeting “The Future of Diagnostic Tests: New Data & Modern Policy” featuring Jeff Shuren, Scott Gottlieb, and Lauren Silvis
Register here: friendsofcancerresearch.org/event/the-future-of-diagnosti…
#friendsdx -
Friends of Cancer Research
@CancerResrch
During the #diagnostic meeting, we will share findings from the HRD Harmonization Project, launch a new #research partnership in Digital and Computational Pathology, and have a policy discussion focused on advancing diagnostic regulation and development.
friendsofcancerresearch.org/event/the-future-of-diagnosti… -
Friends of Cancer Research reposted
BioCentury
@BioCentury
An @US_FDA icon steps down: Janet Woodcock redefined drug regulation, modernized FDA and opened its doors to patients www.biocentury.com/article/651146/an-fda-icon-steps-down
-
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
Join @CancerResrch for our meeting "The Future of Diagnostic Tests: New Data & Modern Policy" on February 1 in Washington, DC and streamed virtually. friendsofcancerresearch.org/event/the-future-of-diagnosti…
This video provides some background about the event - watch and register today! www.youtube.com/watch?v=5v8_wdjuQvw -
Friends of Cancer Research
@CancerResrch
Join @CancerResrch’s virtual meeting “Enhancing Diversity in Clinical Trials: Implementation of Diversity Plans” Thursday, February 15, 2024 from 12:00PM - 1:30PM ET.
Register here: friendsofcancerresearch.org/event/enhancing-diversity-in-… -
Friends of Cancer Research reposted
The Cancer Letter
@TheCancerLetter
Roy Herbst (@DrRoyHerbstYale) elected to Friends (@CancerResrch) board of directors.
cancerletter.com/in-brief/20240112_6a/ -
Friends of Cancer Research
@CancerResrch
During @CancerResrch’s #diagnostic meeting Session 2, we will announce the launch of a pilot project that will establish methods to assess computational pathology platforms and promote alignment.
Register here: friendsofcancerresearch.org/event/the-future-of-diagnosti…
#aioncology #friendsdx -
Friends of Cancer Research reposted
Clemson University College of Science
@ClemsonScience
“I’m fortunate that what I get to do every day is a great intersection of all my experiences and training.”
clemson.world/a-voice-for-patients/ -
Friends of Cancer Research
@CancerResrch
Join @CancerResrch’s Public Meeting “The Future of Diagnostic Tests: New Data & Modern Policy” featuring Jeff Shuren, Scott Gottlieb, and Lauren Silvis
Register here: friendsofcancerresearch.org/event/the-future-of-diagnosti…
#friendsdx -
Friends of Cancer Research reposted
Richard Schilsky
@rschilsky
Great addition. Looking forward to working with him on the Board.
Friends of Cancer Research
@CancerResrch
@CancerResrch is excited to announce the addition of @DrRoyHerbstYale to our board of directors.
“I am honored to have the opportunity to work more closely together with the leadership of Friends."
Read Friends statement here: friendsofcancerresearch.org/news/friends-of-cancer-resear…
@YaleCancer @SmilowCancer -
Friends of Cancer Research
@CancerResrch
@CancerResrch is excited to announce the addition of @DrRoyHerbstYale to our board of directors.
“I am honored to have the opportunity to work more closely together with the leadership of Friends."
Read Friends statement here: friendsofcancerresearch.org/news/friends-of-cancer-resear…
@YaleCancer @SmilowCancer -
Friends of Cancer Research reposted
Brittany Avin McKelvey
@BrittanyAnne340
Happy to share @CancerResrch work aligning methodologies for measuring endpoints in #rwd in @TheEviBase interview! #rwefriends
Friends of Cancer Research
@CancerResrch
Great article from @TheEviBase featuring @CancerResrch's @BrittanyAnne340 discussing Friends Real-World Evidence project.
www.evidencebaseonline.com/infographics/infographic-miles…
The Evidence Base
@TheEviBase
Here we speak with Brittany McKelvey of
@CancerResrch to learn more about their research exploring the use of #realworldevidence to support #oncology drug development and regulatory decision-making.
Read here >>> evidencebaseonline.com/harnessing-real-world-evidence-in-……
#rwe #realworlddata #rwd -
Friends of Cancer Research
@CancerResrch
Great article from @TheEviBase featuring @CancerResrch's @BrittanyAnne340 discussing Friends Real-World Evidence project.
www.evidencebaseonline.com/infographics/infographic-miles…
The Evidence Base
@TheEviBase
Here we speak with Brittany McKelvey of
@CancerResrch to learn more about their research exploring the use of #realworldevidence to support #oncology drug development and regulatory decision-making.
Read here >>> evidencebaseonline.com/harnessing-real-world-evidence-in-……
#rwe #realworlddata #rwd -
Friends of Cancer Research
@CancerResrch
At @CancerResrch’s #diagnostic meeting in Session 1, we’ll share final findings from the HRD Harmonization Project and propose solutions to improve agreement in the future.
Register for our Feb. 1st diagnostic meeting here: friendsofcancerresearch.org/event/the-future-of-diagnosti…
#hrdfriends #friendsdx -
Friends of Cancer Research reposted
Foundation for FDA
@reaganudall
Join us Tuesday, February 20 as we partner with @DukeMargolis, @CancerResrch, and @aetioninc to connect with regulatory experts, academia, clinicians, patients, and representatives across various sectors to discuss optimizing #rwd in #oncology.
Register: advancingrwdinoncologyworkshop.splashthat.com -
Friends of Cancer Research
@CancerResrch
At our #diagnostic meeting, we'll share findings from the HRD Harmonization Project, launch a new #research partnership in Digital and Computational Pathology,& have a discussion on advancing diagnostic regulation & development.
Register here: friendsofcancerresearch.org/event/the-future-of-diagnosti…
#friendsdx -
Friends of Cancer Research
@CancerResrch
Thank you for supporting Friends' end-of-year matching campaign. We deeply appreciate your continued support of our work on behalf of patients.
www.youtube.com/watch?v=mGZ1pyweqZQ -
Friends of Cancer Research
@CancerResrch
Join @CancerResrch’s Public Meeting “The Future of Diagnostic Tests: New Data & Modern Policy” Thursday, Feb. 1st, 2024 from 10:00AM - 2:30PM ET.
Register here: friendsofcancerresearch.org/event/the-future-of-diagnosti…
#aioncology #friendsdx #hrdfriends -
Friends of Cancer Research reposted
Foundation for FDA
@reaganudall
Join us in February 2024 as we partner with @DukeMargolis, @CancerResrch, and @aetioninc to connect with regulatory experts, academia, clinicians, patients, and representatives across various sectors to discuss optimizing #rwd in #oncology.
Register: advancingrwdinoncologyworkshop.splashthat.com -
Friends of Cancer Research
@CancerResrch
New @CancerResrch publication in @CCR_AACR’s Clinical Cancer Research shows that a majority of oncology drugs undergo additional dose evaluation after approval through Postmarketing Requirements (PMRs). Read the publication here: aacrjournals.org/clincancerres/article/doi/10.1158/1078-0…
-
Friends of Cancer Research
@CancerResrch
Thank you so much for your incredible support helping Friends meet its end of year matching goal. Our work is possible because of you. Click to learn more about our work: www.youtube.com/watch?v=mGZ1pyweqZQ
-
Friends of Cancer Research
@CancerResrch
Friends' new publication shows a substantial number of oncology drugs undergo additional dose evaluation after approval through PMRs. youtu.be/ZDw1q3WKZ-c
-
Friends of Cancer Research
@CancerResrch
The fourth edition of the @CancerResrch’s Quarterly #advocacy Newsletter is live! Learn more about the Friends’ Annual Meeting #friendsam23, upcoming events with free or reduced advocate registration, interesting news, and our 2023 year in review. friendsofcancerresearch.org/blog/quarterly-advocacy-newsl…
-
Friends of Cancer Research reposted
Oncology Times
@OncologyTimes
The Friends of Cancer Research devoted its 16th annual meeting, held in Washington, DC, to ways of improving the nation's clinical trial infrastructure. Learn the key strategies discussed to improve the clinical trial system. journals.lww.com/oncology-times/fulltext/2023/12200/key_s… @CancerResrch
-
Friends of Cancer Research
@CancerResrch
$150,000 is available to Friends if we successfully match this contribution by the end of 2023.
Donate here: friendsofcancerresearch.org/donate/ -
Friends of Cancer Research
@CancerResrch
Friends’ new publication shows that a majority of oncology drugs undergo additional dose evaluation after approval through PMRs. youtu.be/ZDw1q3WKZ-c
-
Friends of Cancer Research reposted
Foundation for FDA
@reaganudall
Join us in February 2024 as we partner with @DukeMargolis, @CancerResrch, and @aetioninc to connect with regulatory experts, academia, clinicians, patients, and representatives across various sectors to discuss optimizing #rwd in #oncology.
Register: advancingrwdinoncologyworkshop.splashthat.com -
Friends of Cancer Research
@CancerResrch
A generous gift of $150,000 is available to Friends if we successfully match this contribution by the end of 2023.
Donate here: friendsofcancerresearch.org/donate/ -
Friends of Cancer Research
@CancerResrch
Watch our #diagnostic video to learn more about @CancerResrch’s work on diagnostics in oncology: www.youtube.com/watch?v=lF57vDeogS8
#aioncology #friendsdx #hrdfriends -
Friends of Cancer Research
@CancerResrch
New @CancerResrch publication in @CCR_AACR’s Clinical Cancer Research shows that a majority of oncology drugs undergo additional dose evaluation after approval through Postmarketing Requirements (PMRs).
Read the publication here: aacrjournals.org/clincancerres/article/doi/10.1158/1078-0… -
Friends of Cancer Research reposted
David Gandara
@drgandara
The Lung MAP master protocol is really “cooking” now. Another innovative Biomarker trial activated: S1900K in MET-mutated NSCLC. Over 5,000 patients enrolled in Lung MAP to date. Over 750 cIRB-approved sites. Nothing else like it in Oncology research. @LungMAP @CancerResrch
Lung-MAP
@LungMAP
Just activated! @LungMAP's newest biomarker sub-study: S1900K. For patients with MET exon 14 skipping #nsclc. Hypothesis: resistance to MET inhibition in these patients is due to VEGFR2 signaling. Tests adding ramucirumab to MET inhibitor tepotinib.
clinicaltrials.gov/study/NCT06031688 -
Friends of Cancer Research reposted
Lung-MAP
@LungMAP
Just activated! @LungMAP's newest biomarker sub-study: S1900K. For patients with MET exon 14 skipping #nsclc. Hypothesis: resistance to MET inhibition in these patients is due to VEGFR2 signaling. Tests adding ramucirumab to MET inhibitor tepotinib.
clinicaltrials.gov/study/NCT06031688 -
Friends of Cancer Research
@CancerResrch
#friendsadvocates are pivotal in shaping recommendations that will contribute to more meaningful #cancer research. Click to read the Friends’ Q4 Advocacy Newsletter to learn more about @CancerResrch’s work and how you can get involved. friendsofcancerresearch.org/blog/quarterly-advocacy-newsl…
#friendsadvocacy -
Friends of Cancer Research reposted
Lung-MAP
@LungMAP
The unique public-private partnership underlying the @LungMAP precision medicine #nsclc trial can serve as a model for #clinicalresearch that's more innovative & #inclusive. A special report in @CCR_AACR doi.org/10.1158/1078-0432.CCR-23-2690 @theNCI @FNIH_Org @CancerResrch @SWOG #lcsm
-
Friends of Cancer Research reposted
Hillary Andrews, PhD
@HillStirSci
So excited for the final @CancerResrch Quarterly Advocacy Newsletter of 2023! Thanks to our Advisory Advocates who participated in our #friendsam23 working groups.
We launched this resource this year and look forward to more in 2024 and beyond. We'd love your thoughts!
Friends of Cancer Research
@CancerResrch
The fourth edition of the Quarterly #advocacy Newsletter is live! Learn more about the Friends’ Annual Meeting #friendsam23, upcoming events with free or reduced advocate registration, interesting news, and a 2023 year in review.
friendsofcancerresearch.org/blog/quarterly-advocacy-newsl… -
Friends of Cancer Research
@CancerResrch
The fourth edition of the Quarterly #advocacy Newsletter is live! Learn more about the Friends’ Annual Meeting #friendsam23, upcoming events with free or reduced advocate registration, interesting news, and a 2023 year in review.
friendsofcancerresearch.org/blog/quarterly-advocacy-newsl… -
Friends of Cancer Research reposted
4D Path
@4DPath
.@4DPath recently had the honor of participating in a Friends of @CancerResrch panel alongside other industry leaders to discuss the promise of #computationalpathology in #oncology #drugdevelopment & clinical care. Learn more in the white paper. friendsofcancerresearch.org/wp-content/uploads/Supporting…
-
Friends of Cancer Research
@CancerResrch
Final agenda available for @CancerResrch’s virtual meeting "Expediting Drug Development: Use of #ctdna as an Early Endpoint."
Register now: friendsofcancerresearch.org/event/expediting-drug-develop… #ctdnafriends -
Friends of Cancer Research
@CancerResrch
@CancerResrch is excited to announce a new publication highlighting findings from collaborative working group discussions about ways to define and measure #hrd. This manuscript sets the foundation for the ongoing #hrdharmonization Project. doi.org/10.1093/oncolo/oyab053
-
Friends of Cancer Research
@CancerResrch
Starting NOW: Day 1 of our event "An International Framework of Real-World Evidence" w/ presentations from @OWKINscience, @IQVIA_global and more. You may watch it here focr-org.zoom.us/j/91521383588 and be sure to follow along w/ #progressforpatients.








































































































































































































































































































































































































































































































































































































































































































